This is a Validated Antibody Database (VAD) review about human Bcl 2, based on 517 published articles (read how Labome selects the articles), using Bcl 2 antibody in all methods. It is aimed to help Labome visitors find the most suited Bcl 2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Bcl 2 synonym: Bcl-2; PPP1R50

Santa Cruz Biotechnology
mouse monoclonal (C-2)
  • western blot; human; loading ...; fig 1g
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-7382) was used in western blot on human samples (fig 1g). Front Oncol (2022) ncbi
mouse monoclonal (367.Ser 70)
  • western blot; human; loading ...; fig 1g
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-293128) was used in western blot on human samples (fig 1g). Front Oncol (2022) ncbi
mouse monoclonal (C-2)
  • immunohistochemistry - paraffin section; rat; loading ...; fig 4a
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-7382) was used in immunohistochemistry - paraffin section on rat samples (fig 4a). Oxid Med Cell Longev (2022) ncbi
mouse monoclonal (C-2)
  • western blot; human; 1:2000
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz Biotechnology, sc-7382) was used in western blot on human samples at 1:2000. Bioeng Transl Med (2021) ncbi
mouse monoclonal (C-2)
  • western blot; human; loading ...; fig 5a
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-7382) was used in western blot on human samples (fig 5a). Sci Rep (2021) ncbi
mouse monoclonal (C-2)
  • western blot; human; 1:500; loading ...; fig 2d
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz Biotechnology, sc-7382) was used in western blot on human samples at 1:500 (fig 2d). Cancers (Basel) (2021) ncbi
mouse monoclonal (C-2)
  • western blot; human; 1:1000; loading ...; fig 5g
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-7382) was used in western blot on human samples at 1:1000 (fig 5g). Front Cell Dev Biol (2021) ncbi
mouse monoclonal (C-2)
  • western blot; mouse; loading ...; fig 6b
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz Biotechnology, sc-7382) was used in western blot on mouse samples (fig 6b). Redox Biol (2021) ncbi
mouse monoclonal (C-2)
  • immunohistochemistry - frozen section; mouse; 1:200; loading ...; fig 6a
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz Biotechnology, sc-7382) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig 6a). Neural Regen Res (2020) ncbi
mouse monoclonal (C-2)
  • western blot; mouse; 1:300; loading ...; fig 4b
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-7382) was used in western blot on mouse samples at 1:300 (fig 4b). Med Sci Monit (2020) ncbi
mouse monoclonal (C-2)
  • western blot; human; 1:500; loading ...; fig 4a
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-7382) was used in western blot on human samples at 1:500 (fig 4a). Cancer Lett (2020) ncbi
mouse monoclonal (100)
  • western blot; rat; 1:1000; loading ...; fig 2c
Santa Cruz Biotechnology Bcl 2 antibody (Santa, sc-509) was used in western blot on rat samples at 1:1000 (fig 2c). Biomolecules (2019) ncbi
mouse monoclonal (C-2)
  • western blot; human; fig 2k
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-7382) was used in western blot on human samples (fig 2k). Oncogene (2020) ncbi
mouse monoclonal (100)
  • western blot; human; 1:1000; loading ...; fig 1e
Santa Cruz Biotechnology Bcl 2 antibody (Santa, sc-509) was used in western blot on human samples at 1:1000 (fig 1e). Aging (Albany NY) (2019) ncbi
mouse monoclonal (100)
  • immunocytochemistry; human; loading ...; fig s6a
  • western blot; human; loading ...; fig 7a
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, 100) was used in immunocytochemistry on human samples (fig s6a) and in western blot on human samples (fig 7a). Cell Death Dis (2019) ncbi
mouse monoclonal (C-2)
  • western blot; human; loading ...; fig 5d
Santa Cruz Biotechnology Bcl 2 antibody (Santa, sc-7382) was used in western blot on human samples (fig 5d). Cells (2019) ncbi
mouse monoclonal (C-2)
  • western blot; human; 1:1000; loading ...; fig 3b
Santa Cruz Biotechnology Bcl 2 antibody (Santa, sc-7382) was used in western blot on human samples at 1:1000 (fig 3b). Biosci Rep (2019) ncbi
mouse monoclonal (C-2)
  • western blot; human; loading ...; fig 4b
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz Biotechnology, C-2) was used in western blot on human samples (fig 4b). Cell Death Dis (2019) ncbi
mouse monoclonal (C-2)
  • western blot; rat; 1:2000; loading ...; fig 2c
Santa Cruz Biotechnology Bcl 2 antibody (Santa, sc-7382) was used in western blot on rat samples at 1:2000 (fig 2c). BMC Complement Altern Med (2019) ncbi
mouse monoclonal (C-2)
  • western blot; human; 1:500; loading ...; fig 4a
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz Biotechnology, sc-7382) was used in western blot on human samples at 1:500 (fig 4a). Oncol Rep (2019) ncbi
mouse monoclonal (C-2)
  • western blot; human; loading ...; fig 4e
Santa Cruz Biotechnology Bcl 2 antibody (Santa, sc-7382) was used in western blot on human samples (fig 4e). BMC Cancer (2019) ncbi
mouse monoclonal (C-2)
  • western blot; mouse; loading ...; fig 7a
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz Biotechnology, sc-7382) was used in western blot on mouse samples (fig 7a). Biomolecules (2019) ncbi
mouse monoclonal (C-2)
  • western blot; mouse; 1:200; loading ...; fig 4b
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-7382) was used in western blot on mouse samples at 1:200 (fig 4b). Cardiovasc Res (2018) ncbi
mouse monoclonal (C-2)
  • western blot; human; 1:500; loading ...; fig 5a
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-7382) was used in western blot on human samples at 1:500 (fig 5a). J Biol Chem (2018) ncbi
mouse monoclonal (C-2)
  • western blot; human; 1:100; loading ...; fig 4f
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz Biotechnology, Inc, SC7382) was used in western blot on human samples at 1:100 (fig 4f). Mol Med Rep (2018) ncbi
mouse monoclonal (C-2)
  • western blot; mouse; loading ...; fig 4c
  • western blot; human; loading ...; fig 4h
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz Biotechnology, sc-7382) was used in western blot on mouse samples (fig 4c) and in western blot on human samples (fig 4h). Cell Death Differ (2018) ncbi
mouse monoclonal (100)
  • western blot; human; 1:200; loading ...; fig 3a
Santa Cruz Biotechnology Bcl 2 antibody (SantaCruz, SC-509) was used in western blot on human samples at 1:200 (fig 3a). EMBO Mol Med (2018) ncbi
mouse monoclonal (100)
  • western blot; human; loading ...; fig 2a
Santa Cruz Biotechnology Bcl 2 antibody (Santa, sc-509) was used in western blot on human samples (fig 2a). Oncotarget (2018) ncbi
mouse monoclonal (C-2)
  • western blot; mouse; 1:500; loading ...; fig 6a
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-7382) was used in western blot on mouse samples at 1:500 (fig 6a). Restor Neurol Neurosci (2018) ncbi
mouse monoclonal (C-2)
  • western blot; mouse; 1:1000; loading ...; fig 7c
Santa Cruz Biotechnology Bcl 2 antibody (SantaCruz, sc-7382) was used in western blot on mouse samples at 1:1000 (fig 7c). Biomed Pharmacother (2018) ncbi
mouse monoclonal (C-2)
  • western blot; mouse; fig 2d
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz Biotechnology, sc-7382) was used in western blot on mouse samples (fig 2d). Cell (2018) ncbi
mouse monoclonal (C-2)
  • western blot; mouse; loading ...; fig 5a
Santa Cruz Biotechnology Bcl 2 antibody (Santa, sc-7382) was used in western blot on mouse samples (fig 5a). Proc Natl Acad Sci U S A (2018) ncbi
mouse monoclonal (100)
  • western blot; human; loading ...; fig 3c
Santa Cruz Biotechnology Bcl 2 antibody (SantaCruz, sc-509) was used in western blot on human samples (fig 3c). Oncotarget (2017) ncbi
mouse monoclonal (C-2)
  • western blot; human; loading ...; fig 4c
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, SC-7382) was used in western blot on human samples (fig 4c). Nat Med (2017) ncbi
mouse monoclonal (C-2)
  • immunoprecipitation; mouse; loading ...; fig 1b
  • western blot; mouse; 1:500; loading ...; fig 1b
Santa Cruz Biotechnology Bcl 2 antibody (SantaCruz, 7382) was used in immunoprecipitation on mouse samples (fig 1b) and in western blot on mouse samples at 1:500 (fig 1b). PLoS Genet (2017) ncbi
mouse monoclonal (100/D5)
  • western blot; human; 1:1000; loading ...; fig 3c
Santa Cruz Biotechnology Bcl 2 antibody (SantaCruz, sc-56015) was used in western blot on human samples at 1:1000 (fig 3c). Exp Ther Med (2017) ncbi
mouse monoclonal (C-2)
  • western blot; human; loading ...; fig 5d
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz Biotechnology, sc-7382) was used in western blot on human samples (fig 5d). Cell Physiol Biochem (2017) ncbi
mouse monoclonal (100)
  • western blot; human; 1:2000; loading ...; fig 2C
Santa Cruz Biotechnology Bcl 2 antibody (Santa cruz, sc-509) was used in western blot on human samples at 1:2000 (fig 2C). Mol Med Rep (2017) ncbi
mouse monoclonal (100/D5)
  • western blot; human; 1:1000; loading ...; fig 3b
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-56015) was used in western blot on human samples at 1:1000 (fig 3b). Apoptosis (2017) ncbi
mouse monoclonal (C-2)
  • western blot; human; loading ...; fig 6
Santa Cruz Biotechnology Bcl 2 antibody (SC Biotech, C-2) was used in western blot on human samples (fig 6). Oncotarget (2017) ncbi
mouse monoclonal (C-2)
  • western blot; human; loading ...; fig 4b
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz Biotechnology, sc-7382) was used in western blot on human samples (fig 4b). Anticancer Res (2017) ncbi
mouse monoclonal (C-2)
  • western blot; mouse; 1:500; fig 5d
  • western blot; human; 1:500; loading ...; fig 6f
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-7382) was used in western blot on mouse samples at 1:500 (fig 5d) and in western blot on human samples at 1:500 (fig 6f). PLoS ONE (2017) ncbi
mouse monoclonal (C-2)
  • western blot; human; loading ...; fig 1d
In order to report the effects of long-term lipopolysaccharide exposure on monocytes, Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz Biotechnology, sc7382) was used in western blot on human samples (fig 1d). Toxicol In Vitro (2017) ncbi
mouse monoclonal (C-2)
  • western blot; human; 1:1000; loading ...; fig 2d
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-7382) was used in western blot on human samples at 1:1000 (fig 2d). Int J Mol Med (2017) ncbi
mouse monoclonal (C-2)
  • immunohistochemistry - paraffin section; human; 1:500; fig 4G
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-7382) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 4G). Oncotarget (2017) ncbi
mouse monoclonal (C-2)
  • western blot; human; loading ...; fig 6a
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, SC-7382) was used in western blot on human samples (fig 6a). Nat Commun (2017) ncbi
mouse monoclonal (C-2)
  • western blot; gerbils; 1:1000; loading ...; fig 5
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, SC-7382) was used in western blot on gerbils samples at 1:1000 (fig 5). Exp Ther Med (2017) ncbi
mouse monoclonal (C-2)
  • western blot; mouse; 1:500; loading ...; fig 7a
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, SC7382) was used in western blot on mouse samples at 1:500 (fig 7a). Exp Ther Med (2016) ncbi
mouse monoclonal (100/D5)
  • western blot; human; 1:2000; loading ...; fig 4a
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz Biotechnology, sc-56015) was used in western blot on human samples at 1:2000 (fig 4a). Exp Ther Med (2016) ncbi
mouse monoclonal (C-2)
  • western blot; human; loading ...; fig 3e
In order to show that ROS-induced DNA damage reduces metabolic activity, inhibits proliferation, and induces cell cycle arrest followed by activation of p16-, p21-, and p27- mediated DNA damage response pathways, premature senescence, and apoptosis induction, Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-7382) was used in western blot on human samples (fig 3e). Exp Cell Res (2017) ncbi
mouse monoclonal (7)
  • western blot; human; loading ...; fig s7
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz Biotechnology, sc-130308) was used in western blot on human samples (fig s7). PLoS Med (2016) ncbi
mouse monoclonal (C-2)
  • western blot; human; fig 3a, b
In order to examine the effect of acidic-pepsin on the NF-kappaB oncogenic pathway, Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, C-2) was used in western blot on human samples (fig 3a, b). PLoS ONE (2016) ncbi
mouse monoclonal
  • western blot; human; loading ...; fig 2d
In order to explore the role of chaperone-mediated autophagy in non-small-cell lung cancer, Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, C-2) was used in western blot on human samples (fig 2d). Biochem Biophys Res Commun (2017) ncbi
mouse monoclonal (C-2)
  • western blot; human; loading ...; fig 2d
In order to explore the role of chaperone-mediated autophagy in non-small-cell lung cancer, Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, C-2) was used in western blot on human samples (fig 2d). Biochem Biophys Res Commun (2017) ncbi
mouse monoclonal (100/D5)
  • western blot; human; loading ...; fig 1a
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-56015) was used in western blot on human samples (fig 1a). Oncotarget (2016) ncbi
mouse monoclonal (C-2)
  • western blot; human; loading ...; fig 6a
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, SC-7382) was used in western blot on human samples (fig 6a). Oncotarget (2016) ncbi
mouse monoclonal (C-2)
  • western blot; rat; 1:1000; loading ...; fig 7a
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz Biotechnology, sc-7382) was used in western blot on rat samples at 1:1000 (fig 7a). Exp Ther Med (2016) ncbi
mouse monoclonal (C-2)
  • western blot; human; fig 5
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-7382) was used in western blot on human samples (fig 5). Mol Med Rep (2016) ncbi
mouse monoclonal (100)
  • western blot; human; loading ...; fig 3e
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, Sc-509) was used in western blot on human samples (fig 3e). Cell Death Discov (2016) ncbi
mouse monoclonal (100)
  • western blot; human; fig 5e
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-509) was used in western blot on human samples (fig 5e). Oncotarget (2016) ncbi
mouse monoclonal (C-2)
  • immunohistochemistry - paraffin section; human; 1:100; fig 4
Santa Cruz Biotechnology Bcl 2 antibody (santa Cruz, sc-7382) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 4). Cancer Gene Ther (2016) ncbi
mouse monoclonal (C-2)
  • western blot; human; fig 7a
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-7382) was used in western blot on human samples (fig 7a). Oncotarget (2016) ncbi
mouse monoclonal (100)
  • western blot; human; 1:1000; fig 4
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz Biotechnology, sc509) was used in western blot on human samples at 1:1000 (fig 4). Oncol Lett (2016) ncbi
mouse monoclonal (100)
  • western blot; human; fig 2
In order to investigate the effect of a microtubule inhibitor, MPT0B098, on STAT3 signaling in oral squamous cell carcinoma, Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-509) was used in western blot on human samples (fig 2). PLoS ONE (2016) ncbi
mouse monoclonal (100)
  • western blot; human; fig 2
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-509) was used in western blot on human samples (fig 2). Cancer Cell Int (2016) ncbi
mouse monoclonal (100)
  • western blot; human; loading ...; fig 4a
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-509) was used in western blot on human samples (fig 4a). Cell Biochem Biophys (2016) ncbi
mouse monoclonal (C-2)
  • immunohistochemistry; human; 1:1000; fig 3
  • western blot; human; 1:1000; fig 4
In order to study the transduction of MITF-driven prosurvival signals by BPTF in melanoma cells, Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-7382) was used in immunohistochemistry on human samples at 1:1000 (fig 3) and in western blot on human samples at 1:1000 (fig 4). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (C-2)
  • immunocytochemistry; human; fig 1
  • western blot; human; fig 1
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-7382) was used in immunocytochemistry on human samples (fig 1) and in western blot on human samples (fig 1). Autophagy (2016) ncbi
mouse monoclonal (C-2)
  • western blot; human; fig 2
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-7382) was used in western blot on human samples (fig 2). Biomed Rep (2016) ncbi
mouse monoclonal (C-2)
  • western blot; human; loading ...; fig 4g
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-7382) was used in western blot on human samples (fig 4g). Oncotarget (2017) ncbi
mouse monoclonal (100)
  • flow cytometry; human; loading ...; fig 4a
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-509) was used in flow cytometry on human samples (fig 4a). Eur J Cell Biol (2016) ncbi
mouse monoclonal (100)
  • western blot; human; fig 1
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-509) was used in western blot on human samples (fig 1). Genes Dev (2016) ncbi
mouse monoclonal (C-2)
  • western blot; human; loading ...
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-7382) was used in western blot on human samples . J Mol Med (Berl) (2016) ncbi
mouse monoclonal (100)
  • western blot; human; fig 5c
Santa Cruz Biotechnology Bcl 2 antibody (SantaCruz Biotechnology, Sc-509) was used in western blot on human samples (fig 5c). Urol Oncol (2016) ncbi
mouse monoclonal (C-2)
  • western blot; rat; 1:1000; fig 4
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz Biotechnology, sc-7382) was used in western blot on rat samples at 1:1000 (fig 4). Int J Mol Med (2016) ncbi
mouse monoclonal (C-2)
  • western blot; human; fig 4b
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz Biotechnology, sc-7382) was used in western blot on human samples (fig 4b). PLoS ONE (2016) ncbi
mouse monoclonal (100)
  • western blot; human; fig 4
Santa Cruz Biotechnology Bcl 2 antibody (Santa cruz, sc-509) was used in western blot on human samples (fig 4). BMC Cancer (2016) ncbi
mouse monoclonal (C-2)
  • western blot; human; 1:200; fig 5
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-7382) was used in western blot on human samples at 1:200 (fig 5). Oncol Lett (2016) ncbi
mouse monoclonal (C-2)
  • western blot; human; fig 5
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-7382) was used in western blot on human samples (fig 5). Oncotarget (2016) ncbi
mouse monoclonal (100)
  • flow cytometry; human; loading ...; fig 3a, 3b, 3c, 3d
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-509 FITC) was used in flow cytometry on human samples (fig 3a, 3b, 3c, 3d). Nutr Cancer (2016) ncbi
mouse monoclonal (100)
  • western blot; human; fig 1
Santa Cruz Biotechnology Bcl 2 antibody (santa Cruz, sc-509) was used in western blot on human samples (fig 1). Oncotarget (2016) ncbi
mouse monoclonal (100)
  • western blot; human; 1:300; fig 2
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-509) was used in western blot on human samples at 1:300 (fig 2). Oxid Med Cell Longev (2016) ncbi
mouse monoclonal (C-2)
  • other; human; loading ...; fig st1
In order to use size exclusion chromatography-microsphere-based affinity proteomics to study clinical samples obtained from pediatric acute leukemia patients, Santa Cruz Biotechnology Bcl 2 antibody (SCBT, C-2) was used in other on human samples (fig st1). Mol Cell Proteomics (2016) ncbi
mouse monoclonal
  • other; human; loading ...; fig st1
In order to use size exclusion chromatography-microsphere-based affinity proteomics to study clinical samples obtained from pediatric acute leukemia patients, Santa Cruz Biotechnology Bcl 2 antibody (SCBT, C-2) was used in other on human samples (fig st1). Mol Cell Proteomics (2016) ncbi
mouse monoclonal (C-2)
  • western blot; mouse; fig 1d
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz Biotechnology, sc-7382) was used in western blot on mouse samples (fig 1d). Int J Mol Med (2016) ncbi
mouse monoclonal (C-2)
  • western blot; mouse; 1:1000; fig s2
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-7382) was used in western blot on mouse samples at 1:1000 (fig s2). Nat Med (2016) ncbi
mouse monoclonal
  • western blot; mouse; fig 5
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz Biotechnology, SC-377576) was used in western blot on mouse samples (fig 5). Aging Cell (2016) ncbi
mouse monoclonal (C-2)
  • immunohistochemistry; rat; fig 2
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-7382) was used in immunohistochemistry on rat samples (fig 2). Nutr Cancer (2016) ncbi
mouse monoclonal (C-2)
  • western blot; human; fig 2
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, SC-7382) was used in western blot on human samples (fig 2). Oncotarget (2016) ncbi
mouse monoclonal (100)
  • western blot; human; loading ...; fig 4a
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-509) was used in western blot on human samples (fig 4a). Mol Carcinog (2016) ncbi
mouse monoclonal (C-2)
  • western blot; human; 1:2000; loading ...; fig 5a
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-7382) was used in western blot on human samples at 1:2000 (fig 5a). Mol Med Rep (2016) ncbi
mouse monoclonal (100)
  • western blot; human; fig 3
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-509) was used in western blot on human samples (fig 3). BMC Cancer (2015) ncbi
mouse monoclonal (100)
  • western blot; human; fig 6
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-509) was used in western blot on human samples (fig 6). Oncotarget (2015) ncbi
mouse monoclonal (100)
  • western blot; human; loading ...; fig 2a
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-509) was used in western blot on human samples (fig 2a). Oncotarget (2015) ncbi
mouse monoclonal (C-2)
  • western blot; hamsters; fig 6
Santa Cruz Biotechnology Bcl 2 antibody (santa Cruz, sc-7382) was used in western blot on hamsters samples (fig 6). Int J Mol Sci (2015) ncbi
mouse monoclonal (C-2)
  • western blot; mouse; loading ...; fig 2h
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz Biotechnology, sc-7382) was used in western blot on mouse samples (fig 2h). J Biol Chem (2015) ncbi
mouse monoclonal (C-2)
  • western blot; rat; fig 4
In order to analyze acute pulmonary exposure to mountaintop removal mining particulate matter and cardiac and mitochondrial dysfunction, Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz Biotechnology, sc-7382) was used in western blot on rat samples (fig 4). Am J Physiol Heart Circ Physiol (2015) ncbi
mouse monoclonal (C-2)
  • western blot; human; 1:1000; fig 4
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-7382) was used in western blot on human samples at 1:1000 (fig 4). Endocr Relat Cancer (2016) ncbi
mouse monoclonal (C-2)
  • western blot; human; 1:1000; loading ...; fig 3d
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-7382) was used in western blot on human samples at 1:1000 (fig 3d). Cell Death Dis (2015) ncbi
mouse monoclonal (C-2)
  • western blot; human; fig 1
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-7382) was used in western blot on human samples (fig 1). Oncotarget (2015) ncbi
mouse monoclonal (C-2)
  • western blot; human; fig 4
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-7382) was used in western blot on human samples (fig 4). PLoS ONE (2015) ncbi
mouse monoclonal (100)
  • western blot; human; loading ...; fig 5e
Santa Cruz Biotechnology Bcl 2 antibody (Santa, sc-509) was used in western blot on human samples (fig 5e). BMC Cancer (2015) ncbi
mouse monoclonal (C-2)
  • western blot; human; loading ...; fig 4b
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz Biotechnology, sc-7382) was used in western blot on human samples (fig 4b). Cancer Cell Int (2015) ncbi
mouse monoclonal (C-2)
  • western blot; human; loading ...; fig 6b
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-7382) was used in western blot on human samples (fig 6b). Oncotarget (2015) ncbi
mouse monoclonal (100)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; tbl 3
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, 100) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 3). PLoS ONE (2015) ncbi
mouse monoclonal (100)
  • western blot; human; loading ...; fig 6c
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz Biotechnology, sc-509) was used in western blot on human samples (fig 6c). BMC Cancer (2015) ncbi
mouse monoclonal (C-2)
  • western blot; human; loading ...; fig st2
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-7382) was used in western blot on human samples (fig st2). Oncotarget (2015) ncbi
mouse monoclonal (C-2)
  • western blot; human; fig 7d
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-7382) was used in western blot on human samples (fig 7d). J Interferon Cytokine Res (2015) ncbi
mouse monoclonal (C-2)
  • western blot; human; fig 3
Santa Cruz Biotechnology Bcl 2 antibody (santa Cruz, sc-7382) was used in western blot on human samples (fig 3). Sci Rep (2015) ncbi
mouse monoclonal (C-2)
  • western blot; human; fig 4
Santa Cruz Biotechnology Bcl 2 antibody (santa Cruz, sc7382) was used in western blot on human samples (fig 4). Oncotarget (2015) ncbi
mouse monoclonal (100)
  • western blot; human; fig 5
Santa Cruz Biotechnology Bcl 2 antibody (santa Cruz, sc-509) was used in western blot on human samples (fig 5). PLoS ONE (2015) ncbi
mouse monoclonal (100)
  • western blot; human; fig 5
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc509) was used in western blot on human samples (fig 5). BMC Genomics (2015) ncbi
mouse monoclonal (100)
  • western blot; human; loading ...; fig 6A
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-509) was used in western blot on human samples (fig 6A). Int J Oncol (2015) ncbi
mouse monoclonal (C-2)
  • western blot; human; fig 4
Santa Cruz Biotechnology Bcl 2 antibody (santa Cruz, sc-7382) was used in western blot on human samples (fig 4). Oncotarget (2015) ncbi
mouse monoclonal (C-2)
  • flow cytometry; mouse; 2 ug/ml
  • western blot; mouse
In order to study NGF in E-Reeler retinogenesis, Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-7382) was used in flow cytometry on mouse samples at 2 ug/ml and in western blot on mouse samples . Neuromolecular Med (2015) ncbi
mouse monoclonal (C-2)
  • western blot; human; fig 2
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-7382) was used in western blot on human samples (fig 2). Oncotarget (2015) ncbi
mouse monoclonal (C-2)
  • western blot; human; 1:1000; fig 5a
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-7382) was used in western blot on human samples at 1:1000 (fig 5a). Cancer Cell Int (2015) ncbi
mouse monoclonal (C-2)
  • western blot; rat; fig 7
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-7382) was used in western blot on rat samples (fig 7). Biomed Res Int (2015) ncbi
mouse monoclonal (C-2)
  • western blot; human
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz Biotech, sc-7382) was used in western blot on human samples . Ecancermedicalscience (2015) ncbi
mouse monoclonal (C-2)
  • western blot; rat; 1:200; fig 5
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz Biotechnology, sc-7382) was used in western blot on rat samples at 1:200 (fig 5). Mol Med Rep (2015) ncbi
mouse monoclonal (C-2)
  • western blot; human; 1:1000; fig 6
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-7382) was used in western blot on human samples at 1:1000 (fig 6). Mol Med Rep (2015) ncbi
mouse monoclonal (C-2)
  • western blot; human; fig 5
In order to provide evidence that GSK-3beta-dependent downregulation of gamma-taxilin and alphaNAC regulate hypoxia-induced ER stress responses, Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz Biotechnology, SC-7382) was used in western blot on human samples (fig 5). Cell Death Dis (2015) ncbi
mouse monoclonal (C-2)
  • western blot; human; fig f4, f3
Santa Cruz Biotechnology Bcl 2 antibody (santa cruz, sc-7382) was used in western blot on human samples (fig f4, f3). Oncotarget (2015) ncbi
mouse monoclonal (C-2)
  • western blot; human
In order to evaluate the effect of aspirin in mesenchymal to epithelial transition, Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz Biotechnologies, sc-7382) was used in western blot on human samples . Lab Invest (2015) ncbi
mouse monoclonal (12)
  • western blot; mouse; fig 4
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-130307) was used in western blot on mouse samples (fig 4). Oncotarget (2015) ncbi
mouse monoclonal (C-2)
  • western blot; rat; loading ...; fig 6c
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz Biotechnology, sc-7382) was used in western blot on rat samples (fig 6c). PLoS ONE (2015) ncbi
mouse monoclonal (C-2)
  • western blot; mouse; 1:200
In order to study the modulatory effect of TLR4/EGF signaling pathways on TPN-associated intestinal epithelial cell atrophy, Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz Biotechnology, sc-7382) was used in western blot on mouse samples at 1:200. FASEB J (2015) ncbi
mouse monoclonal (100)
  • western blot; rat; fig 5
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-509) was used in western blot on rat samples (fig 5). Int J Mol Sci (2015) ncbi
mouse monoclonal (C-2)
  • western blot; human; 1:250; fig 1
  • western blot; mouse; 1:250; fig 2
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-7382HRP) was used in western blot on human samples at 1:250 (fig 1) and in western blot on mouse samples at 1:250 (fig 2). Autophagy (2015) ncbi
mouse monoclonal (C-2)
  • western blot; human
In order to investigate if Chal-24 can be combined with cisplatin for better cancer therapy, Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-7382) was used in western blot on human samples . Oncotarget (2015) ncbi
mouse monoclonal (100)
  • western blot; human; fig 5
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-509) was used in western blot on human samples (fig 5). Oncogene (2015) ncbi
mouse monoclonal (C-2)
  • western blot; rat; 1:50
  • western blot; mouse; 1:50
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-7382) was used in western blot on rat samples at 1:50 and in western blot on mouse samples at 1:50. Reprod Toxicol (2015) ncbi
mouse monoclonal (C-2)
  • western blot; human; fig 2
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-7382) was used in western blot on human samples (fig 2). Cell Death Dis (2015) ncbi
mouse monoclonal (100)
  • western blot; human; 1:200; fig 3
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-509) was used in western blot on human samples at 1:200 (fig 3). Oncol Lett (2015) ncbi
mouse monoclonal (C-2)
  • western blot; human; 1:250; loading ...; fig 1A
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-7382) was used in western blot on human samples at 1:250 (fig 1A). Mol Med Rep (2015) ncbi
mouse monoclonal (C-2)
  • immunohistochemistry - paraffin section; dogs; fig 2
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, SC-7382) was used in immunohistochemistry - paraffin section on dogs samples (fig 2). J Vet Sci (2015) ncbi
mouse monoclonal (100)
  • western blot; human
In order to evaluate the role of leptin/STAT3 and HER2 receptor in tamoxifen resistance, Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-509) was used in western blot on human samples . Cell Oncol (Dordr) (2015) ncbi
mouse monoclonal (C-2)
  • immunoprecipitation; human; 2 ug/time
  • western blot; human; 1:1000
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz Biotechnology, sc-7382) was used in immunoprecipitation on human samples at 2 ug/time and in western blot on human samples at 1:1000. Biochim Biophys Acta (2015) ncbi
mouse monoclonal (C-2)
  • western blot; human
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz Biotechnology, sc-7382) was used in western blot on human samples . Oncotarget (2015) ncbi
mouse monoclonal (C-2)
  • western blot; human; 1:2000
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-7382) was used in western blot on human samples at 1:2000. Cell Death Dis (2014) ncbi
mouse monoclonal (C-2)
  • immunohistochemistry - paraffin section; mouse
In order to investigate the anti-tumor effect of CAMK2N1 on prostate cancer progression, Santa Cruz Biotechnology Bcl 2 antibody (Santa cruz, SC-7382) was used in immunohistochemistry - paraffin section on mouse samples . Oncotarget (2014) ncbi
mouse monoclonal (100)
  • western blot; human
Santa Cruz Biotechnology Bcl 2 antibody (Santa-Cruz, sc-509) was used in western blot on human samples . Biochimie (2014) ncbi
mouse monoclonal (C-2)
  • western blot; rat; 1:1000
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz Biotechnology, sc-7382) was used in western blot on rat samples at 1:1000. CNS Neurosci Ther (2014) ncbi
mouse monoclonal (C-2)
  • immunocytochemistry; human; 1:200; loading ...; fig 7
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, C-2) was used in immunocytochemistry on human samples at 1:200 (fig 7). J Cell Physiol (2015) ncbi
mouse monoclonal
  • immunocytochemistry; human; 1:200; loading ...; fig 7
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, C-2) was used in immunocytochemistry on human samples at 1:200 (fig 7). J Cell Physiol (2015) ncbi
mouse monoclonal (C-2)
  • western blot; kangaroo rats; 1:200; fig 3
Santa Cruz Biotechnology Bcl 2 antibody (santa cruz, sc-7382) was used in western blot on kangaroo rats samples at 1:200 (fig 3). Cell Mol Neurobiol (2015) ncbi
mouse monoclonal (100)
  • immunohistochemistry - paraffin section; human; 1:100
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-509) was used in immunohistochemistry - paraffin section on human samples at 1:100. Int J Ophthalmol (2014) ncbi
mouse monoclonal (C-2)
  • western blot; human
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz Biotechnology, sc-7382) was used in western blot on human samples . Cell Stress Chaperones (2015) ncbi
mouse monoclonal (100)
  • western blot; human
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz Biotechnology, sc-509) was used in western blot on human samples . Biochem Biophys Res Commun (2014) ncbi
mouse monoclonal (C-2)
  • western blot; rat; 1:500
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz Technology, sc-7382) was used in western blot on rat samples at 1:500. Age (Dordr) (2014) ncbi
mouse monoclonal (100)
  • immunoprecipitation; human
  • western blot; human
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz Biotechnology, sc-509) was used in immunoprecipitation on human samples and in western blot on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (C-2)
  • western blot; mouse; 1:300-1:600; loading ...; fig 6
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz Biotechnology, Sc-7382) was used in western blot on mouse samples at 1:300-1:600 (fig 6). J Neuroinflammation (2014) ncbi
mouse monoclonal (C-2)
  • western blot; human; fig 6d
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-7382) was used in western blot on human samples (fig 6d). Oncotarget (2014) ncbi
mouse monoclonal (C-2)
  • western blot; human; fig 1
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-7382) was used in western blot on human samples (fig 1). Cell Tissue Res (2014) ncbi
mouse monoclonal (100)
  • western blot; human
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-509) was used in western blot on human samples . J Biol Chem (2014) ncbi
mouse monoclonal (C-2)
  • immunohistochemistry; rat; 1:10
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz Biotechnology, sc-7382) was used in immunohistochemistry on rat samples at 1:10. Arthritis Res Ther (2014) ncbi
mouse monoclonal (7)
  • western blot; human
In order to study the relationship between USP2-MDM4 and p53 in tumorigenesis, Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-130308) was used in western blot on human samples . Carcinogenesis (2014) ncbi
mouse monoclonal (C-2)
  • western blot; human
In order to study the relationship between USP2-MDM4 and p53 in tumorigenesis, Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-7382) was used in western blot on human samples . Carcinogenesis (2014) ncbi
mouse monoclonal (12)
  • western blot; mouse
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-130307) was used in western blot on mouse samples . J Hepatol (2014) ncbi
mouse monoclonal (C-2)
  • western blot; rat; 1:1,000
In order to study the role of p21 in beta cell apoptosis, Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-7382) was used in western blot on rat samples at 1:1,000. Am J Physiol Endocrinol Metab (2013) ncbi
mouse monoclonal (100)
  • western blot; human
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz Biotechnology, 100) was used in western blot on human samples . Clin Cancer Res (2011) ncbi
mouse monoclonal (100)
  • western blot; human; fig s7c
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc 509) was used in western blot on human samples (fig s7c). J Neurochem (2008) ncbi
mouse monoclonal (100)
  • western blot; rhesus macaque
In order to study the activation of Bax during rotavirus-induced apoptosis, Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz, sc-509) was used in western blot on rhesus macaque samples . J Virol (2007) ncbi
mouse monoclonal (C-2)
  • western blot; human
Santa Cruz Biotechnology Bcl 2 antibody (Santa Cruz Biotechnology, sc-7382) was used in western blot on human samples . Int J Cancer (2001) ncbi
Abcam
domestic rabbit monoclonal (E17)
  • western blot; mouse; loading ...; fig 4a
Abcam Bcl 2 antibody (Abcam, ab32124) was used in western blot on mouse samples (fig 4a). iScience (2022) ncbi
domestic rabbit monoclonal (E17)
  • western blot; human; 1:1000; loading ...; fig 3c
Abcam Bcl 2 antibody (Abcam, ab32124) was used in western blot on human samples at 1:1000 (fig 3c). Oncol Lett (2022) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:100; loading ...
Abcam Bcl 2 antibody (abcam, Ab196495) was used in western blot on mouse samples at 1:100. Int J Mol Sci (2022) ncbi
domestic rabbit monoclonal (EPR17509)
  • immunohistochemistry; human; loading ...; fig 3a
Abcam Bcl 2 antibody (Abcam, ab182858) was used in immunohistochemistry on human samples (fig 3a). Cell Death Dis (2022) ncbi
domestic rabbit monoclonal (EPR17509)
  • western blot; human; 1:2000; loading ...; fig 4c
Abcam Bcl 2 antibody (Abcam, ab182858) was used in western blot on human samples at 1:2000 (fig 4c). Leukemia (2022) ncbi
mouse monoclonal (100/D5)
  • western blot; rat; 1:500; fig 2f, s1a
Abcam Bcl 2 antibody (Abcam, ab692) was used in western blot on rat samples at 1:500 (fig 2f, s1a). J Cell Mol Med (2022) ncbi
domestic rabbit monoclonal (E17)
  • western blot; human; loading ...; fig 6f
Abcam Bcl 2 antibody (Abcam, ab32124) was used in western blot on human samples (fig 6f). J Cancer (2021) ncbi
domestic rabbit monoclonal (EPR17509)
  • western blot; mouse; loading ...; fig 6a
Abcam Bcl 2 antibody (Abcam, ab18858) was used in western blot on mouse samples (fig 6a). Theranostics (2021) ncbi
domestic rabbit monoclonal
  • western blot; human; 1:500; loading ...; fig 4c
Abcam Bcl 2 antibody (Abcam, ab185002) was used in western blot on human samples at 1:500 (fig 4c). Int J Oncol (2021) ncbi
mouse monoclonal (100/D5)
  • western blot; rat; loading ...; fig 5c
Abcam Bcl 2 antibody (Abcam, ab692) was used in western blot on rat samples (fig 5c). Stem Cell Res Ther (2021) ncbi
domestic rabbit monoclonal (E17)
  • western blot; human; 1:1000; loading ...; fig 2c
Abcam Bcl 2 antibody (Abcam, ab32124) was used in western blot on human samples at 1:1000 (fig 2c). Aging (Albany NY) (2021) ncbi
domestic rabbit monoclonal (EPR17509)
  • western blot; human; 1:2000; loading ...; fig 4e
Abcam Bcl 2 antibody (Abcam, ab182858) was used in western blot on human samples at 1:2000 (fig 4e). Int J Oncol (2021) ncbi
domestic rabbit monoclonal (EPR17509)
  • western blot; mouse; loading ...; fig 5d, 1b
Abcam Bcl 2 antibody (Abcam, ab182858) was used in western blot on mouse samples (fig 5d, 1b). Aging (Albany NY) (2021) ncbi
domestic rabbit monoclonal (E17)
  • western blot; human; 1:1000; loading ...; fig 5f
Abcam Bcl 2 antibody (Abcam, ab32124) was used in western blot on human samples at 1:1000 (fig 5f). Front Pharmacol (2021) ncbi
domestic rabbit monoclonal (E17)
  • western blot; human; 1:1000; loading ...; fig 4a
Abcam Bcl 2 antibody (Abcam, ab32124) was used in western blot on human samples at 1:1000 (fig 4a). Front Oncol (2021) ncbi
domestic rabbit monoclonal (EPR17509)
  • western blot; human; loading ...; fig 3c
Abcam Bcl 2 antibody (Abcam, ab182858) was used in western blot on human samples (fig 3c). Aging (Albany NY) (2021) ncbi
domestic rabbit monoclonal (E17)
  • western blot; mouse; 1:1000; loading ...; fig 3g
Abcam Bcl 2 antibody (Abcam, ab32124) was used in western blot on mouse samples at 1:1000 (fig 3g). Front Cell Dev Biol (2021) ncbi
domestic rabbit polyclonal
  • western blot; rat; 1:100; loading ...; fig 5c
Abcam Bcl 2 antibody (Abcam, Ab196495) was used in western blot on rat samples at 1:100 (fig 5c). Front Pharmacol (2021) ncbi
domestic rabbit monoclonal (E17)
  • western blot; mouse; 1:2000; loading ...; fig 3g
Abcam Bcl 2 antibody (Abcam, ab32124) was used in western blot on mouse samples at 1:2000 (fig 3g). Aging (Albany NY) (2021) ncbi
domestic rabbit monoclonal (E17)
  • immunohistochemistry; mouse; 1:500; loading ...
Abcam Bcl 2 antibody (Abcam, ab32124) was used in immunohistochemistry on mouse samples at 1:500. Oncol Rep (2021) ncbi
domestic rabbit monoclonal (EPR17509)
  • western blot; human; 1:1000; loading ...; fig 6
Abcam Bcl 2 antibody (Abcam, ab182858) was used in western blot on human samples at 1:1000 (fig 6). Mol Med Rep (2021) ncbi
domestic rabbit monoclonal (EPR17509)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 2f, 5e
  • western blot; mouse; loading ...; fig 2g
Abcam Bcl 2 antibody (Abcam, ab182858) was used in immunohistochemistry - paraffin section on mouse samples (fig 2f, 5e) and in western blot on mouse samples (fig 2g). Blood (2021) ncbi
domestic rabbit monoclonal (EPR17509)
  • western blot; human; loading ...; fig 3a
Abcam Bcl 2 antibody (Abcam, ab182858) was used in western blot on human samples (fig 3a). Oncol Lett (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:100; loading ...; fig 5e
Abcam Bcl 2 antibody (Abcam, ab59348) was used in immunohistochemistry on mouse samples at 1:100 (fig 5e). Adv Sci (Weinh) (2021) ncbi
domestic rabbit monoclonal (E17)
  • western blot; rat; loading ...; fig 5d
  • western blot; human; 1:1000; loading ...; fig 1d
Abcam Bcl 2 antibody (Abcam, ab32124) was used in western blot on rat samples (fig 5d) and in western blot on human samples at 1:1000 (fig 1d). Ann Transl Med (2021) ncbi
domestic rabbit monoclonal
  • western blot; rat; 1:1000; loading ...; fig 4b
Abcam Bcl 2 antibody (Abcam, ab185002) was used in western blot on rat samples at 1:1000 (fig 4b). J Int Med Res (2021) ncbi
domestic rabbit monoclonal (EPR17509)
  • western blot; human; 1:2000; loading ...; fig 2f, 7e
Abcam Bcl 2 antibody (Abcam, ab182858) was used in western blot on human samples at 1:2000 (fig 2f, 7e). Redox Biol (2021) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; fig 5a
Abcam Bcl 2 antibody (Abcam, ab194583) was used in western blot on mouse samples at 1:1000 (fig 5a). Oxid Med Cell Longev (2021) ncbi
domestic rabbit monoclonal (E17)
  • western blot; human; 1:1000; fig 6h
Abcam Bcl 2 antibody (ABcam, ab32124) was used in western blot on human samples at 1:1000 (fig 6h). Aging (Albany NY) (2021) ncbi
domestic rabbit monoclonal (E17)
  • western blot; human; loading ...; fig 5c
Abcam Bcl 2 antibody (Abcam, ab32124) was used in western blot on human samples (fig 5c). J Exp Clin Cancer Res (2021) ncbi
domestic rabbit monoclonal
  • western blot; rat; 1:500; fig 6e
Abcam Bcl 2 antibody (Abcam, ab185002) was used in western blot on rat samples at 1:500 (fig 6e). Cell Death Dis (2021) ncbi
domestic rabbit polyclonal
  • western blot; rat; 1:1000; loading ...; fig 2e, 7e
Abcam Bcl 2 antibody (Abcam, ab194583) was used in western blot on rat samples at 1:1000 (fig 2e, 7e). Life Sci (2021) ncbi
domestic rabbit monoclonal (E17)
  • western blot; human; loading ...; fig s5h
Abcam Bcl 2 antibody (Abcam, ab32124) was used in western blot on human samples (fig s5h). Theranostics (2021) ncbi
domestic rabbit polyclonal
  • western blot; rat; 1:1000; loading ...; fig 2j
Abcam Bcl 2 antibody (Abcam, ab59348) was used in western blot on rat samples at 1:1000 (fig 2j). Cell Prolif (2021) ncbi
domestic rabbit monoclonal (E17)
  • western blot; human; 1:5000; loading ...; fig 7a
Abcam Bcl 2 antibody (Abcam, ab32124) was used in western blot on human samples at 1:5000 (fig 7a). Asian Pac J Cancer Prev (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 3c
Abcam Bcl 2 antibody (Abcam, ab59348) was used in western blot on human samples at 1:1000 (fig 3c). Aging (Albany NY) (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:2000; loading ...; fig 6a
Abcam Bcl 2 antibody (Abcam, ab59348) was used in western blot on human samples at 1:2000 (fig 6a). Int J Mol Med (2020) ncbi
domestic rabbit monoclonal (E17)
  • western blot; human; 1:1000; loading ...; fig 4f
Abcam Bcl 2 antibody (Abcam, ab32124) was used in western blot on human samples at 1:1000 (fig 4f). BMC Cancer (2020) ncbi
domestic rabbit polyclonal
  • western blot; rat; 1:2000; fig 5f
Abcam Bcl 2 antibody (Abcam, ab196495) was used in western blot on rat samples at 1:2000 (fig 5f). J Am Heart Assoc (2020) ncbi
domestic rabbit monoclonal (E17)
  • western blot; human; 1:1000; loading ...; fig 4a, 4b
Abcam Bcl 2 antibody (Abcam, ab32124) was used in western blot on human samples at 1:1000 (fig 4a, 4b). Int J Oncol (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 2b, 4d
Abcam Bcl 2 antibody (Abcam, ab59348) was used in western blot on human samples at 1:1000 (fig 2b, 4d). Mol Ther Nucleic Acids (2020) ncbi
domestic rabbit monoclonal (E17)
  • western blot; mouse; 1:1000; loading ...; fig 4h
Abcam Bcl 2 antibody (Abcam, ab32124) was used in western blot on mouse samples at 1:1000 (fig 4h). Mol Ther Nucleic Acids (2020) ncbi
domestic rabbit monoclonal (EPR17509)
  • western blot; mouse; 1:1000; loading ...; fig 6a
Abcam Bcl 2 antibody (Abcam, ab182858) was used in western blot on mouse samples at 1:1000 (fig 6a). J Transl Med (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2e
Abcam Bcl 2 antibody (Abcam, ab196495) was used in western blot on human samples (fig 2e). EBioMedicine (2020) ncbi
domestic rabbit monoclonal (E17)
  • western blot; human; 1:2000; loading ...; fig 5e
Abcam Bcl 2 antibody (Abcam, ab32124) was used in western blot on human samples at 1:2000 (fig 5e). Aging (Albany NY) (2020) ncbi
domestic rabbit polyclonal
  • western blot; rat; 1:1000; loading ...; fig 6e
Abcam Bcl 2 antibody (Abcam, ab59348) was used in western blot on rat samples at 1:1000 (fig 6e). Front Neurosci (2019) ncbi
domestic rabbit polyclonal
  • western blot; rat; 1:1000; loading ...; fig 1e, 2c, 5g
Abcam Bcl 2 antibody (Abcam, ab196495) was used in western blot on rat samples at 1:1000 (fig 1e, 2c, 5g). J Neuroinflammation (2020) ncbi
domestic rabbit monoclonal (EPR17509)
  • immunohistochemistry - frozen section; mouse; 1:500; loading ...; fig 9a
  • western blot; mouse; loading ...; fig 9c
Abcam Bcl 2 antibody (Abcam, ab182858) was used in immunohistochemistry - frozen section on mouse samples at 1:500 (fig 9a) and in western blot on mouse samples (fig 9c). Neurochem Res (2020) ncbi
mouse monoclonal (100/D5)
  • western blot; human; loading ...; fig 8
Abcam Bcl 2 antibody (Abcam, ab692) was used in western blot on human samples (fig 8). Biomolecules (2020) ncbi
domestic rabbit monoclonal (E17)
  • western blot; human; loading ...; fig 4h
Abcam Bcl 2 antibody (Abcam, ab32124) was used in western blot on human samples (fig 4h). Aging (Albany NY) (2019) ncbi
domestic rabbit monoclonal (EPR17509)
  • western blot; human; loading ...; fig 1f
Abcam Bcl 2 antibody (Abcam, ab182858) was used in western blot on human samples (fig 1f). BMC Cancer (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 1d
Abcam Bcl 2 antibody (Abcam, ab59348) was used in western blot on human samples at 1:1000 (fig 1d). Sci Rep (2019) ncbi
domestic rabbit polyclonal
  • western blot; rat; 1:1200; loading ...; fig 5b
Abcam Bcl 2 antibody (Abcam, ab196495) was used in western blot on rat samples at 1:1200 (fig 5b). Biosci Rep (2019) ncbi
domestic rabbit monoclonal
  • western blot; human; loading ...; fig 3c
Abcam Bcl 2 antibody (Abcam, ab185002) was used in western blot on human samples (fig 3c). Aging (Albany NY) (2019) ncbi
domestic rabbit monoclonal (E17)
  • western blot; human; 1:1000; loading ...; fig 2d, 2e
Abcam Bcl 2 antibody (Abcam, ab32124) was used in western blot on human samples at 1:1000 (fig 2d, 2e). Int J Oncol (2019) ncbi
domestic rabbit monoclonal (E17)
  • immunohistochemistry - paraffin section; human; fig 8d
  • western blot; human; 1:1000; loading ...; fig 2b
Abcam Bcl 2 antibody (Abcam, ab32124) was used in immunohistochemistry - paraffin section on human samples (fig 8d) and in western blot on human samples at 1:1000 (fig 2b). Cell Death Dis (2019) ncbi
domestic rabbit monoclonal (EPR17509)
  • western blot; human; 1:2000; loading ...; fig 5b
Abcam Bcl 2 antibody (Abcam, ab182858) was used in western blot on human samples at 1:2000 (fig 5b). Biol Res (2019) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 4d
Abcam Bcl 2 antibody (Cell Signaling, ab196495) was used in western blot on mouse samples (fig 4d). Cell Death Dis (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 9a
Abcam Bcl 2 antibody (Abcam, ab59348) was used in western blot on human samples at 1:1000 (fig 9a). Biosci Rep (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1c
Abcam Bcl 2 antibody (Abcam, ab196495) was used in western blot on human samples (fig 1c). Eur Rev Med Pharmacol Sci (2019) ncbi
domestic rabbit monoclonal (EPR17509)
  • western blot; human; 1:2000; loading ...; fig 8a, 8h
Abcam Bcl 2 antibody (Abcam, ab182858) was used in western blot on human samples at 1:2000 (fig 8a, 8h). Biosci Rep (2019) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:2000; loading ...; fig 3b
Abcam Bcl 2 antibody (Abcam, ab59348) was used in western blot on mouse samples at 1:2000 (fig 3b). Biosci Rep (2019) ncbi
domestic rabbit monoclonal (E17)
  • western blot; human; loading ...; fig 2c
Abcam Bcl 2 antibody (Abcam, ab32124) was used in western blot on human samples (fig 2c). Redox Biol (2019) ncbi
mouse monoclonal (100/D5)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 5c
Abcam Bcl 2 antibody (Abcam, ab692) was used in immunohistochemistry - paraffin section on mouse samples (fig 5c). Cell Metab (2019) ncbi
domestic rabbit monoclonal (EPR17509)
  • western blot; mouse; loading ...; fig 5a
Abcam Bcl 2 antibody (Abcam, ab182858) was used in western blot on mouse samples (fig 5a). Cell Metab (2019) ncbi
domestic rabbit monoclonal (E17)
  • western blot; human; 1:1000; loading ...; fig 5b
Abcam Bcl 2 antibody (Abcam, ab32124) was used in western blot on human samples at 1:1000 (fig 5b). Front Neurosci (2019) ncbi
domestic rabbit monoclonal (E17)
  • western blot; human; 1:2000; loading ...; fig 5a
Abcam Bcl 2 antibody (Abcam, ab32124) was used in western blot on human samples at 1:2000 (fig 5a). J Cell Physiol (2019) ncbi
domestic rabbit monoclonal (E17)
  • western blot; human; loading ...; fig s24b
Abcam Bcl 2 antibody (Abcam, ab32124) was used in western blot on human samples (fig s24b). Nucleic Acids Res (2019) ncbi
domestic rabbit monoclonal (E17)
  • immunohistochemistry - paraffin section; human; loading ...; fig s1b
  • western blot; human; loading ...; fig s1c
Abcam Bcl 2 antibody (Abcam, ab32124) was used in immunohistochemistry - paraffin section on human samples (fig s1b) and in western blot on human samples (fig s1c). Science (2018) ncbi
domestic rabbit monoclonal (E17)
  • western blot; human; 1:2000; loading ...; fig 4b
Abcam Bcl 2 antibody (Abcam, ab32124) was used in western blot on human samples at 1:2000 (fig 4b). Biosci Rep (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5a
Abcam Bcl 2 antibody (Abcam, ab59348) was used in western blot on human samples (fig 5a). J Mol Neurosci (2018) ncbi
domestic rabbit polyclonal
  • western blot; rat; 1:1000; loading ...; fig 7c
Abcam Bcl 2 antibody (Abcam, ab59348) was used in western blot on rat samples at 1:1000 (fig 7c). Neuropharmacology (2018) ncbi
domestic rabbit monoclonal (E17)
  • western blot; human; loading ...; fig 4c, 4d
Abcam Bcl 2 antibody (abcam, ab32124) was used in western blot on human samples (fig 4c, 4d). Oncotarget (2017) ncbi
monoclonal
  • western blot; mouse; 1:400; loading ...; fig 6a
Abcam Bcl 2 antibody (Abcam, ab117115) was used in western blot on mouse samples at 1:400 (fig 6a). Int J Mol Med (2017) ncbi
domestic rabbit monoclonal (E17)
  • western blot; human; 1:1000; loading ...; fig 8a
Abcam Bcl 2 antibody (Abcam, 32124) was used in western blot on human samples at 1:1000 (fig 8a). Sci Rep (2017) ncbi
domestic rabbit monoclonal (E17)
  • western blot; human; loading ...; fig 6a
Abcam Bcl 2 antibody (Abcam, ab32124) was used in western blot on human samples (fig 6a). FEBS Open Bio (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 2e
Abcam Bcl 2 antibody (Abcam, ab59348) was used in western blot on mouse samples at 1:1000 (fig 2e). J Mol Neurosci (2017) ncbi
domestic rabbit polyclonal
  • western blot; rat; 1:750; loading ...; fig 3a
Abcam Bcl 2 antibody (Abcam, ab196495) was used in western blot on rat samples at 1:750 (fig 3a). Sci Rep (2016) ncbi
mouse monoclonal (100/D5)
  • western blot; mouse; fig s2
Abcam Bcl 2 antibody (abcam, ab692) was used in western blot on mouse samples (fig s2). Biol Sex Differ (2016) ncbi
monoclonal
  • western blot; human; 1:1000; fig 4
Abcam Bcl 2 antibody (Abcam, ab117115) was used in western blot on human samples at 1:1000 (fig 4). Onco Targets Ther (2016) ncbi
domestic rabbit monoclonal (E17)
  • western blot; human; 1:1000; loading ...; fig 4c
Abcam Bcl 2 antibody (Abcam, ab32124) was used in western blot on human samples at 1:1000 (fig 4c). Oncotarget (2016) ncbi
mouse monoclonal (100/D5)
  • western blot; human; fig 4
Abcam Bcl 2 antibody (abcam, ab692) was used in western blot on human samples (fig 4). Cancer Gene Ther (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 7
Abcam Bcl 2 antibody (Abcam, ab59348) was used in western blot on human samples (fig 7). BMC Complement Altern Med (2016) ncbi
domestic rabbit monoclonal (E17)
  • western blot; human; fig 4B
Abcam Bcl 2 antibody (Abcam, ab32124) was used in western blot on human samples (fig 4B). PLoS Genet (2016) ncbi
domestic rabbit monoclonal (E17)
  • western blot; human; loading ...; fig 7a
Abcam Bcl 2 antibody (Abcam, ab32124) was used in western blot on human samples (fig 7a). Sci Rep (2016) ncbi
domestic rabbit monoclonal (E17)
  • western blot; human; 1:1000; loading ...; fig 4b
Abcam Bcl 2 antibody (Abcam, ab32124) was used in western blot on human samples at 1:1000 (fig 4b). Exp Ther Med (2016) ncbi
mouse monoclonal (100/D5)
  • western blot; domestic rabbit; 1:1000; fig 6
Abcam Bcl 2 antibody (abcam, 692) was used in western blot on domestic rabbit samples at 1:1000 (fig 6). Mol Med Rep (2016) ncbi
monoclonal
  • western blot; human; fig 5
Abcam Bcl 2 antibody (Abcam, ab117115) was used in western blot on human samples (fig 5). J Cancer (2016) ncbi
domestic rabbit monoclonal (E17)
  • western blot; mouse; loading ...; fig 2e
Abcam Bcl 2 antibody (Abcam, ab32124) was used in western blot on mouse samples (fig 2e). Mol Med Rep (2016) ncbi
domestic rabbit monoclonal (E17)
  • western blot; human; 1:500; loading ...; fig 3d
Abcam Bcl 2 antibody (Abcam, ab32124) was used in western blot on human samples at 1:500 (fig 3d). Sci Rep (2016) ncbi
monoclonal
  • western blot; human; 1:1000; fig 3
Abcam Bcl 2 antibody (Abcam, ab117115) was used in western blot on human samples at 1:1000 (fig 3). Oncol Lett (2015) ncbi
monoclonal
  • western blot; human; loading ...; fig 4e
Abcam Bcl 2 antibody (Abcam, ab117115) was used in western blot on human samples (fig 4e). Oncol Rep (2015) ncbi
domestic rabbit monoclonal (E17)
  • immunohistochemistry - paraffin section; human; fig 4
  • western blot; human; fig 5
Abcam Bcl 2 antibody (Abcam, ab32124) was used in immunohistochemistry - paraffin section on human samples (fig 4) and in western blot on human samples (fig 5). Phytother Res (2015) ncbi
domestic rabbit monoclonal (E17)
  • western blot; human
Abcam Bcl 2 antibody (Abcam, ab32124) was used in western blot on human samples . Mol Med Rep (2014) ncbi
mouse monoclonal (100/D5)
  • flow cytometry; mouse; 1:100
Abcam Bcl 2 antibody (Abcam, ab692) was used in flow cytometry on mouse samples at 1:100. Nat Genet (2013) ncbi
Invitrogen
mouse monoclonal (100/D5)
  • western blot; mouse; 1:1000; loading ...; fig 4d
Invitrogen Bcl 2 antibody (Thermo Fishers, MA5-11757) was used in western blot on mouse samples at 1:1000 (fig 4d). Antioxidants (Basel) (2021) ncbi
domestic rabbit monoclonal (R.65.1)
  • western blot; human; loading ...; fig 3a
Invitrogen Bcl 2 antibody (Thermo Fisher Scientific, MA5-15046) was used in western blot on human samples (fig 3a). Antioxidants (Basel) (2020) ncbi
mouse monoclonal (100/D5)
  • flow cytometry; human; 1:50; loading ...; fig 2d
Invitrogen Bcl 2 antibody (Thermo Fisher, MA5-11757) was used in flow cytometry on human samples at 1:50 (fig 2d). Oncotarget (2018) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; rat; 1:250; loading ...; fig 1d
In order to examine the structural and ultra-structural changes induced by nitrate in rat liver and assess the protective role of s-allylcysteine, Invitrogen Bcl 2 antibody (ThermoFisher Scientific, PA5-27094) was used in immunohistochemistry - paraffin section on rat samples at 1:250 (fig 1d). Ultrastruct Pathol (2017) ncbi
domestic sheep polyclonal
  • western blot; human; 1:200; loading ...; fig 5b
In order to determine the effect of 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one on the induction of apoptosis and cell cycle arrest in human bladder carcinoma cells, Invitrogen Bcl 2 antibody (Thermo Fisher Scientific, PA1-28275) was used in western blot on human samples at 1:200 (fig 5b). Mol Med Rep (2017) ncbi
mouse monoclonal (Bcl-2-100)
  • western blot; human; 1:250; loading ...; fig 1b
In order to elucidate how FADD contributes to mitochondrial-associated apoptosis, Invitrogen Bcl 2 antibody (Invitrogen, 138,800) was used in western blot on human samples at 1:250 (fig 1b). Mol Cell Biochem (2016) ncbi
mouse monoclonal (Bcl2/100)
  • flow cytometry; human; 1:50; loading ...; fig 4
In order to report the effects of mesenchymal stem cells derived from the umbilical cord on hepatocellular carcinoma cells, Invitrogen Bcl 2 antibody (Invitrogen, A15796) was used in flow cytometry on human samples at 1:50 (fig 4). Mol Med Rep (2016) ncbi
mouse monoclonal (Bcl-2-100)
  • western blot; human; 1:500; fig 4f
In order to show how FADD regulates NF-kappaB activation and promotes ubiquitination of cFLIPL, which induces apoptosis, Invitrogen Bcl 2 antibody (Invitrogen, 138800) was used in western blot on human samples at 1:500 (fig 4f). Sci Rep (2016) ncbi
mouse monoclonal (100/D5)
  • immunohistochemistry - paraffin section; human; 1:100; fig 1
In order to study the development of type-1 endometrial adenocarcinoma and the role of Bcl-2 expression and immunohistochemical adrenomedullin in the endometrium, Invitrogen Bcl 2 antibody (Thermo Scientific, 100/D5) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1). Pathol Res Pract (2016) ncbi
mouse monoclonal (Bcl-2-100)
  • western blot; human; 1:1000; fig 3
In order to study regulation of p53 dependent ubiquitination of Beclin-1 during autophagic stress and basal interaction of Bcl-2 with Beclin-1 by expression of cFLIPL, Invitrogen Bcl 2 antibody (Invitrogen, 138800) was used in western blot on human samples at 1:1000 (fig 3). J Cell Biochem (2016) ncbi
mouse monoclonal (100/D5)
  • flow cytometry; human; fig 1
  • western blot; human; fig s1
In order to study the use of bispecific T cell engager, Invitrogen Bcl 2 antibody (Thermo Scientific, 100/D5) was used in flow cytometry on human samples (fig 1) and in western blot on human samples (fig s1). PLoS ONE (2015) ncbi
mouse monoclonal (Bcl-2-100)
  • immunohistochemistry; human; 1:80; fig 5
In order to present two cases of primary sclerosing epithelioid fibrosarcoma of the kidney, Invitrogen Bcl 2 antibody (Invitrogen, Bcl-2-100) was used in immunohistochemistry on human samples at 1:80 (fig 5). Diagn Pathol (2015) ncbi
mouse monoclonal (Bcl-2-100)
  • western blot; chicken; 1:1000; fig 7a
In order to investigate the role of growth hormone in the Bursa, Invitrogen Bcl 2 antibody (Invitrogen, 13-8800) was used in western blot on chicken samples at 1:1000 (fig 7a). Gen Comp Endocrinol (2015) ncbi
mouse monoclonal (100/D5)
  • immunohistochemistry - paraffin section; human; 1:50
In order to examine Cox-2 and bcl-2 expression in the development of Paget's disease, Invitrogen Bcl 2 antibody (Pierce, 100/D5) was used in immunohistochemistry - paraffin section on human samples at 1:50. Asian Pac J Cancer Prev (2015) ncbi
mouse monoclonal (100/D5)
  • immunohistochemistry - paraffin section; human; 1:50
In order to use Romanian patients with gastric carcinomas and compare the demographic, clinical, and immunohistochemical aspects of each cancer, Invitrogen Bcl 2 antibody (LabVisio, 100/D5) was used in immunohistochemistry - paraffin section on human samples at 1:50. APMIS (2015) ncbi
mouse monoclonal (Bcl-2-100)
  • immunohistochemistry - paraffin section; human; 1:200
Invitrogen Bcl 2 antibody (Invitrogen, Bcl-2-100) was used in immunohistochemistry - paraffin section on human samples at 1:200. Int J Hematol (2015) ncbi
mouse monoclonal (Bcl-2-100)
  • immunohistochemistry - paraffin section; human; 1:100
Invitrogen Bcl 2 antibody (Invitrogen, Bcl-2-100) was used in immunohistochemistry - paraffin section on human samples at 1:100. Tumour Biol (2014) ncbi
mouse monoclonal (Bcl-2-100)
  • immunohistochemistry - paraffin section; human; 1:700
In order to investigate Bcl2 expression in colorectal adenocarcinoma, Invitrogen Bcl 2 antibody (Invitrogen, 13-8800) was used in immunohistochemistry - paraffin section on human samples at 1:700. J Am Coll Surg (2014) ncbi
mouse monoclonal (100/D5)
  • immunohistochemistry - paraffin section; human; 1:50
Invitrogen Bcl 2 antibody (Thermo Scientific, 100/D5) was used in immunohistochemistry - paraffin section on human samples at 1:50. J BUON (2014) ncbi
mouse monoclonal (Bcl2/100)
  • flow cytometry; human; 1:50
In order to measure the apoptotic potential of EGFR mAb-gold nanorods in Hep-2 cells in vitro and in vivo, Invitrogen Bcl 2 antibody (Life Technologies, A15764) was used in flow cytometry on human samples at 1:50. Int J Nanomedicine (2014) ncbi
mouse monoclonal (100/D5)
  • immunohistochemistry - paraffin section; human; 1:50
In order to assess beclin 1 and bcl-2 expression and investigate their relationship with clinicopathological parameters of prostate cancer and high grade prostatic intraepithelial neoplasia, Invitrogen Bcl 2 antibody (Thermo Labvision Fremont, MS-123-P0) was used in immunohistochemistry - paraffin section on human samples at 1:50. Pathol Res Pract (2014) ncbi
mouse monoclonal (Bcl-2-100)
  • immunohistochemistry; rat; 1:200
In order to study the effect of zinc deficiency on airway epithelium, Invitrogen Bcl 2 antibody (Zymed, Bcl-2) was used in immunohistochemistry on rat samples at 1:200. Biometals (2014) ncbi
mouse monoclonal (Bcl-2/100)
  • flow cytometry; human
Invitrogen Bcl 2 antibody (eBioscience, Bcl-2/100) was used in flow cytometry on human samples . J Hepatol (2014) ncbi
mouse monoclonal (Bcl-2-100)
  • immunohistochemistry - paraffin section; human; 1:50; fig 1
In order to measure bcl-2 and ki-67 antigen in pericoronal follicle of impacted third molars, Invitrogen Bcl 2 antibody (Zymed, Bcl-2-100) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 1). Dent Res J (Isfahan) (2012) ncbi
mouse monoclonal (Bcl-2-100)
  • immunoprecipitation; human; fig 2
  • western blot; human; fig 2
In order to present the first in vivo use of U1 Adaptors to target two different human genes implicated in melanomagenesis, B-cell lymphoma 2 and metabotropic glutamate receptor 1, Invitrogen Bcl 2 antibody (Invitrogen/Life Technologies, 13-8800) was used in immunoprecipitation on human samples (fig 2) and in western blot on human samples (fig 2). Mol Ther Nucleic Acids (2013) ncbi
mouse monoclonal (Bcl-2-100)
  • immunoprecipitation; human; fig 9
In order to compared the effects and mechanism of Bcl-2 and its functional variants on irradiated cell survival, Invitrogen Bcl 2 antibody (Invitrogen, 13-8800) was used in immunoprecipitation on human samples (fig 9). Apoptosis (2013) ncbi
mouse monoclonal (Bcl-2-100)
  • immunohistochemistry - paraffin section; human; fig 2
In order to determine the clinical significance of PPAR-gamma expression in non-small cell lung carcinoma, Invitrogen Bcl 2 antibody (Zymed, clone Bcl-2-100) was used in immunohistochemistry - paraffin section on human samples (fig 2). Pathol Oncol Res (2012) ncbi
mouse monoclonal (Bcl-2-100)
  • western blot; human; 1:500
In order to test if oleanolic acid circumvents the mechanisms of drug resistance in non-small cell lung cancer, Invitrogen Bcl 2 antibody (Zymed, Bcl2-100) was used in western blot on human samples at 1:500. PLoS ONE (2011) ncbi
mouse monoclonal (100)
  • flow cytometry; human; fig 5
In order to examine the apoptotic response to genotoxic stimuli using Treg and Teff, Invitrogen Bcl 2 antibody (Invitrogen, clone 100) was used in flow cytometry on human samples (fig 5). Cytometry A (2011) ncbi
mouse monoclonal (4D7)
  • western blot; human
Invitrogen Bcl 2 antibody (eBioscience, BMS1029) was used in western blot on human samples . Cell Cycle (2011) ncbi
mouse monoclonal (100)
  • flow cytometry; human; fig 2
In order to investigate IL-15-driven NK receptor induction in CD8+ T cells, Invitrogen Bcl 2 antibody (Caltag, 100) was used in flow cytometry on human samples (fig 2). Immunobiology (2011) ncbi
mouse monoclonal (Bcl-2-100)
  • immunohistochemistry - paraffin section; human; 1:500; fig 1, 2, 3
In order to report on four cases of idiopathic cervical fibrosis, Invitrogen Bcl 2 antibody (Zymed, Bcl-2-100) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 1, 2, 3). Am J Surg Pathol (2010) ncbi
mouse monoclonal (Bcl-2-100)
  • western blot; human; fig 4
In order to test if endothelial progenitor cells convey their resistance to oxidative stress to their differentiated daughter cells, Invitrogen Bcl 2 antibody (Invitrogen, 13-8800) was used in western blot on human samples (fig 4). Atherosclerosis (2010) ncbi
mouse monoclonal (Bcl-2-100)
  • immunohistochemistry - paraffin section; human; 1:100; tbl 2
In order to characterize cribriform-morular variant of papillary thyroid carcinoma, Invitrogen Bcl 2 antibody (Zymed, Bcl-2-100) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 2). Thyroid (2009) ncbi
mouse monoclonal (Bcl-2-100)
  • western blot; human
In order to challenge the hypothesis that the anti-apoptotic properties of Bcl-2 are linked to a global increase in antioxidant status, Invitrogen Bcl 2 antibody (Zymed Laboratories, Bcl-2-100) was used in western blot on human samples . Biochem Biophys Res Commun (2008) ncbi
mouse monoclonal (100/D5)
  • immunohistochemistry - paraffin section; human; 1:50; fig 2B
In order to define the relationship between progesterone receptor and Bcl-2 in meningiomas, Invitrogen Bcl 2 antibody (Biosource, 100/D5) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 2B). Neuropathology (2008) ncbi
mouse monoclonal (Bcl-2-100)
  • immunohistochemistry - paraffin section; human; 1:500
In order to present a case of complete regression of high-grade lymphoma, Invitrogen Bcl 2 antibody (Zymed/Invitrogen, bcl2-100) was used in immunohistochemistry - paraffin section on human samples at 1:500. Int J Surg Pathol (2007) ncbi
mouse monoclonal (Bcl-2-100)
  • immunohistochemistry - paraffin section; human
In order to study the immunohistochemistry of non-small cell lung cancer, Invitrogen Bcl 2 antibody (Zymed, bcl-2-100) was used in immunohistochemistry - paraffin section on human samples . J Korean Med Sci (2007) ncbi
mouse monoclonal (Bcl-2-100)
  • immunohistochemistry - paraffin section; human; fig 2
In order to correlate biomarkers in breast cancer and breast skin in the same patients, Invitrogen Bcl 2 antibody (Zymed, bcl-2-100) was used in immunohistochemistry - paraffin section on human samples (fig 2). J Clin Pathol (2007) ncbi
mouse monoclonal (Bcl-2-100)
  • immunohistochemistry - paraffin section; human
In order to use immunohistochemistry to study apoptosis-related proteins in cases of ameloblastoma, Invitrogen Bcl 2 antibody (Zymed, Bcl-2-100) was used in immunohistochemistry - paraffin section on human samples . Int J Oral Maxillofac Surg (2006) ncbi
mouse monoclonal (Bcl-2-100)
  • immunohistochemistry - paraffin section; human; 1:200
In order to examine apoptosis and cell proliferation in synovial sarcoma, Invitrogen Bcl 2 antibody (Zymed, Bcl-2-100) was used in immunohistochemistry - paraffin section on human samples at 1:200. Eur J Cancer Prev (2006) ncbi
mouse monoclonal (Bcl-2-100)
  • immunocytochemistry; human; tbl 1
In order to investigate how antibodies to double stranded-DNA induce apoptosis, Invitrogen Bcl 2 antibody (Zymed, Bcl2-100) was used in immunocytochemistry on human samples (tbl 1). J Autoimmun (2006) ncbi
mouse monoclonal (Bcl-2-100)
  • immunohistochemistry; rat; tbl 1
In order to examine the earlier sequential relationship of proliferative, growth factor, and histomorphometric changes after irradiation leading to the 1-week nadir, Invitrogen Bcl 2 antibody (Zymed, Bcl-2-100) was used in immunohistochemistry on rat samples (tbl 1). Clin Orthop Relat Res (2004) ncbi
mouse monoclonal (Bcl-2-100)
  • western blot; human; 1:1000; fig 3
In order to elucidate Bim regulation in T cells, Invitrogen Bcl 2 antibody (Zymed, Bcl-2-100) was used in western blot on human samples at 1:1000 (fig 3). Proc Natl Acad Sci U S A (2004) ncbi
mouse monoclonal (Bcl-2-100)
  • immunohistochemistry; rat; 1:100; fig 3
In order to study changes in the expression of apoptosis molecules and growth factors in rats after growth plate irradiation with or without radioprotectant, Invitrogen Bcl 2 antibody (Zymed, Bcl-2-100) was used in immunohistochemistry on rat samples at 1:100 (fig 3). J Histochem Cytochem (2004) ncbi
mouse monoclonal (Bcl-2-100)
  • immunohistochemistry - paraffin section; human; tbl 1
In order to present three cases of primary peritoneal malignant mixed mullerian tumors, Invitrogen Bcl 2 antibody (Zymed, BCL-2-100) was used in immunohistochemistry - paraffin section on human samples (tbl 1). Int J Gynecol Cancer (2003) ncbi
mouse monoclonal (Bcl-2-100)
  • immunohistochemistry - paraffin section; human; 1:50; tbl 2
In order to compare tumors involving endometrium and ovary and metastatic endometrial tumors, Invitrogen Bcl 2 antibody (Zymed, bcl-2-100) was used in immunohistochemistry - paraffin section on human samples at 1:50 (tbl 2). Int J Gynecol Cancer (2003) ncbi
mouse monoclonal (100)
  • flow cytometry; human; tbl 1
In order to optimize conditions to detect intracellular Bcl-2 and p53, Invitrogen Bcl 2 antibody (Caltag, 100) was used in flow cytometry on human samples (tbl 1). J Biol Regul Homeost Agents (2002) ncbi
mouse monoclonal (Bcl-2-100)
  • immunohistochemistry - paraffin section; human
In order to study the contribution of breast cysts to breast cancer, Invitrogen Bcl 2 antibody (Zymed, bcl 2-100) was used in immunohistochemistry - paraffin section on human samples . Breast Cancer Res Treat (2002) ncbi
mouse monoclonal (Bcl-2-100)
  • immunohistochemistry; human; 1:20; tbl 3
In order to study the role of Epstein-Barr virus infection in lymphomas in the nasal cavity, Invitrogen Bcl 2 antibody (Zymed, Bcl2-100) was used in immunohistochemistry on human samples at 1:20 (tbl 3). Hum Pathol (2002) ncbi
mouse monoclonal (Bcl-2-100)
  • western blot; human; fig 5
In order to study the relationship between FKBP12-rapamycin associated protein and mitochondrial dysfunction during osmatic stress, Invitrogen Bcl 2 antibody (Zymed, 13-8800) was used in western blot on human samples (fig 5). Proc Natl Acad Sci U S A (2002) ncbi
mouse monoclonal (Bcl-2-100)
  • flow cytometry; human
In order to separate synovial cells from rheumatoid arthritis synovium based on their proliferative or apoptotic features, Invitrogen Bcl 2 antibody (Zymed, Bcl-2/100) was used in flow cytometry on human samples . Arthritis Rheum (2000) ncbi
mouse monoclonal (Bcl-2-100)
  • immunohistochemistry - paraffin section; human; 1:20; fig 2, 3, 4
In order to assess the immunoexpression of the proliferation index, epidermal growth factor receptor, and bcl-2 as prognostic factors in patients with Grade 2 oligodendroglioma, Invitrogen Bcl 2 antibody (Zymed, bcl-2-100) was used in immunohistochemistry - paraffin section on human samples at 1:20 (fig 2, 3, 4). Cancer (2000) ncbi
mouse monoclonal (100)
  • immunohistochemistry - paraffin section; human; fig 1
In order to investigate Bcl-2 protein expression in MALT lymphomas, Invitrogen Bcl 2 antibody (noco, noca) was used in immunohistochemistry - paraffin section on human samples (fig 1). Histopathology (1995) ncbi
BioLegend
mouse monoclonal (BCL/10C4)
  • western blot; mouse; loading ...; fig 1c
BioLegend Bcl 2 antibody (BioLegend, BCL/10C4) was used in western blot on mouse samples (fig 1c). Cell Rep Methods (2022) ncbi
mouse monoclonal (100)
  • flow cytometry; human; 1:200; loading ...; fig s4f
BioLegend Bcl 2 antibody (BioLegend, 100) was used in flow cytometry on human samples at 1:200 (fig s4f). Nature (2021) ncbi
mouse monoclonal (BCL/10C4)
  • flow cytometry; mouse; 1:1000; loading ...; fig 1g
BioLegend Bcl 2 antibody (Biolegend, 633508) was used in flow cytometry on mouse samples at 1:1000 (fig 1g). PLoS Biol (2021) ncbi
mouse monoclonal (BCL/10C4)
  • flow cytometry; mouse; loading ...; fig s3o, 2j
BioLegend Bcl 2 antibody (BioLegend, BCL/10C4) was used in flow cytometry on mouse samples (fig s3o, 2j). Science (2019) ncbi
mouse monoclonal (100)
  • mass cytometry; human; loading ...; fig 3a
BioLegend Bcl 2 antibody (Biolegend, 658702) was used in mass cytometry on human samples (fig 3a). Cell (2019) ncbi
mouse monoclonal (100)
  • flow cytometry; human; fig 7.a','d
In order to examine the potential of IL-2 to enhance T regulatory cell therapy, BioLegend Bcl 2 antibody (BioLegend, 100) was used in flow cytometry on human samples (fig 7.a','d). Clin Exp Immunol (2017) ncbi
mouse monoclonal (BCL/10C4)
  • flow cytometry; mouse; 1:100; loading ...; fig 2d
In order to find an alternative pathway of NK-cell development driven by IL-12, BioLegend Bcl 2 antibody (BioLegend, BCL/10C4) was used in flow cytometry on mouse samples at 1:100 (fig 2d). Nat Commun (2016) ncbi
mouse monoclonal (BCL/10C4)
  • flow cytometry; mouse; fig 5
BioLegend Bcl 2 antibody (Biolegend, 633510) was used in flow cytometry on mouse samples (fig 5). PLoS Pathog (2016) ncbi
mouse monoclonal (BCL/10C4)
  • flow cytometry; mouse; loading ...; fig 5a
In order to test if T regulatory cells from mice lacking both DEF-6 and SWAP-70 have an increased capacity to become effector T regulatory cells due to altered IRF-4 activity, BioLegend Bcl 2 antibody (BioLegend, BCL10C4) was used in flow cytometry on mouse samples (fig 5a). Arthritis Rheumatol (2016) ncbi
mouse monoclonal (BCL/10C4)
  • flow cytometry; mouse; loading ...; fig 6c
In order to study the effect of atypical protein kinase C i on asymmetric division and CD8(+) T Lymphocyte, BioLegend Bcl 2 antibody (Biolegend, BCL/10C4) was used in flow cytometry on mouse samples (fig 6c). Sci Rep (2016) ncbi
mouse monoclonal (BCL/10C4)
  • western blot; mouse; fig 6
BioLegend Bcl 2 antibody (BioLegend, 633502) was used in western blot on mouse samples (fig 6). Cell Death Differ (2016) ncbi
mouse monoclonal (BCL/10C4)
  • flow cytometry; mouse
BioLegend Bcl 2 antibody (Biolegend, BCL/10C4) was used in flow cytometry on mouse samples . Eur J Immunol (2015) ncbi
mouse monoclonal (BCL/10C4)
  • flow cytometry; mouse
BioLegend Bcl 2 antibody (BioLegend, BCL/10C4) was used in flow cytometry on mouse samples . Sci Rep (2015) ncbi
Boster
mouse monoclonal (Bcl-2-100)
  • western blot; rat; 1:2500; loading ...; fig 7
Boster Bcl 2 antibody (Boster, Bcl-2-100) was used in western blot on rat samples at 1:2500 (fig 7). Brain Behav (2020) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D17C4)
  • western blot; human; loading ...; fig s1f
Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 3498) was used in western blot on human samples (fig s1f). Mol Ther Oncolytics (2022) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1g
Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 2875) was used in western blot on human samples (fig 1g). Front Oncol (2022) ncbi
mouse monoclonal (124)
  • immunohistochemistry - paraffin section; mouse; 1:400; loading ...; fig 6c
  • western blot; mouse; 1:1000; loading ...; fig 6b
Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 15071) was used in immunohistochemistry - paraffin section on mouse samples at 1:400 (fig 6c) and in western blot on mouse samples at 1:1000 (fig 6b). Physiol Rep (2022) ncbi
domestic rabbit monoclonal (D55G8)
  • western blot; human; 1:1000; loading ...; fig 7c
Cell Signaling Technology Bcl 2 antibody (CST, 4223) was used in western blot on human samples at 1:1000 (fig 7c). iScience (2022) ncbi
mouse monoclonal (124)
  • western blot; human; loading ...; fig 4c
Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 15071) was used in western blot on human samples (fig 4c). Cell Death Discov (2022) ncbi
domestic rabbit monoclonal (D17C4)
  • western blot; human; 1:300; loading ...; fig 5a
Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 3498s) was used in western blot on human samples at 1:300 (fig 5a). Front Physiol (2022) ncbi
domestic rabbit monoclonal (D17C4)
  • western blot; mouse; 1:1000; loading ...; fig 2c
Cell Signaling Technology Bcl 2 antibody (CST, 3498) was used in western blot on mouse samples at 1:1000 (fig 2c). J Cell Mol Med (2022) ncbi
domestic rabbit monoclonal (D55G8)
  • western blot; human; 1:1000; loading ...; fig 5a
Cell Signaling Technology Bcl 2 antibody (CST, 4223S) was used in western blot on human samples at 1:1000 (fig 5a). Cell Death Discov (2021) ncbi
mouse monoclonal (124)
  • western blot; human; loading ...; fig 9a
Cell Signaling Technology Bcl 2 antibody (CST, 15071) was used in western blot on human samples (fig 9a). Sci Adv (2021) ncbi
domestic rabbit monoclonal (D17C4)
  • western blot; human; loading ...; fig 5g
Cell Signaling Technology Bcl 2 antibody (Cell Signaling Technology, 3498S) was used in western blot on human samples (fig 5g). Cell Death Dis (2021) ncbi
domestic rabbit monoclonal (D17C4)
  • western blot; mouse; loading ...; fig 1e
Cell Signaling Technology Bcl 2 antibody (Cell Signaling Technology, 3498S) was used in western blot on mouse samples (fig 1e). Cells (2021) ncbi
domestic rabbit monoclonal (D17C4)
  • western blot; mouse; loading ...; fig s4c
Cell Signaling Technology Bcl 2 antibody (Cell signaling, 3498S) was used in western blot on mouse samples (fig s4c). Redox Biol (2021) ncbi
mouse monoclonal (124)
  • western blot; human; loading ...; fig 6f
Cell Signaling Technology Bcl 2 antibody (CST, 15071) was used in western blot on human samples (fig 6f). Cell Death Discov (2021) ncbi
mouse monoclonal (124)
  • western blot; human; 1:1000; loading ...; fig 2c
Cell Signaling Technology Bcl 2 antibody (Cell Signaling Technology, 15071) was used in western blot on human samples at 1:1000 (fig 2c). Cancer Res (2021) ncbi
domestic rabbit monoclonal (D17C4)
  • western blot; human; 1:1000; loading ...; fig 3g
Cell Signaling Technology Bcl 2 antibody (Cell Signaling Technology, D17C4) was used in western blot on human samples at 1:1000 (fig 3g). Theranostics (2021) ncbi
mouse monoclonal (124)
  • western blot; rat; 1:1000; loading ...; fig 2c
Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 15071S) was used in western blot on rat samples at 1:1000 (fig 2c). Exp Ther Med (2021) ncbi
domestic rabbit monoclonal (D55G8)
  • western blot; human; loading ...; fig 4a
Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 4223T) was used in western blot on human samples (fig 4a). Front Immunol (2021) ncbi
mouse monoclonal (124)
  • western blot; human; loading ...; fig 3c
Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 15071) was used in western blot on human samples (fig 3c). Cancers (Basel) (2021) ncbi
domestic rabbit monoclonal (D17C4)
  • western blot; mouse; 1:1000; loading ...; fig 1l
Cell Signaling Technology Bcl 2 antibody (CST, 3498T) was used in western blot on mouse samples at 1:1000 (fig 1l). Front Pharmacol (2021) ncbi
domestic rabbit monoclonal (D17C4)
  • western blot; mouse; 1:1000; loading ...; fig 5a
  • western blot; human; loading ...; fig 5b
Cell Signaling Technology Bcl 2 antibody (CST, 3498S) was used in western blot on mouse samples at 1:1000 (fig 5a) and in western blot on human samples (fig 5b). J Cancer (2021) ncbi
mouse monoclonal (124)
  • western blot; human; loading ...; fig 4a
Cell Signaling Technology Bcl 2 antibody (Cell Signaling Technology, 15071) was used in western blot on human samples (fig 4a). Nat Commun (2021) ncbi
domestic rabbit monoclonal (D55G8)
  • western blot; human; loading ...; fig 3f
Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 4223) was used in western blot on human samples (fig 3f). Cell Death Dis (2021) ncbi
mouse monoclonal (124)
  • western blot; human; 1:1000; loading ...; fig 7d
Cell Signaling Technology Bcl 2 antibody (CST, 15071) was used in western blot on human samples at 1:1000 (fig 7d). J Exp Clin Cancer Res (2021) ncbi
domestic rabbit monoclonal (D17C4)
  • western blot; mouse; 1:1000; loading ...; fig 5e
Cell Signaling Technology Bcl 2 antibody (Cell signaling, 3498) was used in western blot on mouse samples at 1:1000 (fig 5e). Acta Neuropathol Commun (2021) ncbi
domestic rabbit monoclonal (D17C4)
  • western blot; mouse; 1:1000; loading ...; fig 7c
Cell Signaling Technology Bcl 2 antibody (CST, 3498) was used in western blot on mouse samples at 1:1000 (fig 7c). Front Pharmacol (2021) ncbi
mouse monoclonal (124)
  • western blot; mouse; loading ...; fig 4h
  • western blot; human; 1:1000; loading ...; fig 4g
Cell Signaling Technology Bcl 2 antibody (Cell Signaling Technology, 15071) was used in western blot on mouse samples (fig 4h) and in western blot on human samples at 1:1000 (fig 4g). Cell Death Dis (2021) ncbi
domestic rabbit monoclonal (D17C4)
  • western blot; mouse; 1:1000; loading ...; fig 4a
Cell Signaling Technology Bcl 2 antibody (Cell Signaling Technology, 3,498) was used in western blot on mouse samples at 1:1000 (fig 4a). Front Pharmacol (2021) ncbi
domestic rabbit monoclonal (D17C4)
  • western blot; human; loading ...; fig 5a
  • western blot; mouse; loading ...; fig 5b
Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 3498) was used in western blot on human samples (fig 5a) and in western blot on mouse samples (fig 5b). Cell Death Dis (2021) ncbi
domestic rabbit monoclonal (D55G8)
  • western blot; human; 1:100; loading ...; fig 5b
Cell Signaling Technology Bcl 2 antibody (Cell Signaling Technology, 4223) was used in western blot on human samples at 1:100 (fig 5b). Int J Oral Sci (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 6b
Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 2872) was used in western blot on human samples at 1:1000 (fig 6b). Cell Death Dis (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig s5b
Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 2872) was used in western blot on human samples (fig s5b). Sci Adv (2021) ncbi
mouse monoclonal (124)
  • western blot; human; 1:1000; loading ...; fig 4d
Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 15071T) was used in western blot on human samples at 1:1000 (fig 4d). Oncol Rep (2021) ncbi
mouse monoclonal (124)
  • western blot; mouse; loading ...; fig 4h, 5h
Cell Signaling Technology Bcl 2 antibody (Cell signaling, 15071) was used in western blot on mouse samples (fig 4h, 5h). Transl Psychiatry (2021) ncbi
domestic rabbit monoclonal (D55G8)
  • western blot; mouse; 1:1000; loading ...; fig 4g
Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 4223) was used in western blot on mouse samples at 1:1000 (fig 4g). elife (2020) ncbi
domestic rabbit monoclonal (D55G8)
  • western blot; human; fig 2a
Cell Signaling Technology Bcl 2 antibody (Cell Signaling Technology, 4223) was used in western blot on human samples (fig 2a). BMC Complement Med Ther (2020) ncbi
mouse monoclonal (124)
  • western blot; human; loading ...; fig 4f
Cell Signaling Technology Bcl 2 antibody (CST, 15071) was used in western blot on human samples (fig 4f). Front Cell Dev Biol (2020) ncbi
domestic rabbit monoclonal (D55G8)
  • western blot; human; loading ...; fig 5a
Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 4223) was used in western blot on human samples (fig 5a). Cell Death Differ (2020) ncbi
domestic rabbit monoclonal (D17C4)
  • western blot; mouse; loading ...; fig 3d
Cell Signaling Technology Bcl 2 antibody (CST, 3498) was used in western blot on mouse samples (fig 3d). Hepatology (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:500; loading ...; fig 1c, 4c, 8b
Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 2872) was used in western blot on human samples at 1:500 (fig 1c, 4c, 8b). Commun Biol (2020) ncbi
domestic rabbit monoclonal (D17C4)
  • western blot; mouse; 1:500; loading ...; fig 7a
Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 3498) was used in western blot on mouse samples at 1:500 (fig 7a). Aging (Albany NY) (2020) ncbi
mouse monoclonal (124)
  • western blot; human; loading ...; fig 3d
Cell Signaling Technology Bcl 2 antibody (Cell Signaling Technology, 15071) was used in western blot on human samples (fig 3d). Theranostics (2020) ncbi
domestic rabbit monoclonal (D55G8)
  • western blot; human; 1:1000; loading ...; fig 5a
Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 4223) was used in western blot on human samples at 1:1000 (fig 5a). Nat Commun (2020) ncbi
domestic rabbit monoclonal (D55G8)
  • western blot; human; 1:1000; loading ...; fig 3b
Cell Signaling Technology Bcl 2 antibody (CST, 4223) was used in western blot on human samples at 1:1000 (fig 3b). Exp Ther Med (2020) ncbi
mouse monoclonal (124)
  • immunoprecipitation; human; loading ...; fig 5a
  • western blot; human; 1:1000; loading ...; fig 5a
Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 15071S) was used in immunoprecipitation on human samples (fig 5a) and in western blot on human samples at 1:1000 (fig 5a). Autophagy (2020) ncbi
domestic rabbit monoclonal (5H2)
  • western blot; human; 1:500; loading ...; fig 4c
Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 2827S) was used in western blot on human samples at 1:500 (fig 4c). Autophagy (2020) ncbi
domestic rabbit monoclonal (D55G8)
  • western blot; mouse; 1:1000; loading ...; fig 2f
Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 4223) was used in western blot on mouse samples at 1:1000 (fig 2f). Biosci Rep (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 1b
Cell Signaling Technology Bcl 2 antibody (Cell signaling, 2872) was used in western blot on human samples (fig 1b). Oncogenesis (2020) ncbi
domestic rabbit monoclonal (D17C4)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 5c
  • western blot; mouse; loading ...; fig 1d
Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 3498) was used in immunohistochemistry - paraffin section on mouse samples (fig 5c) and in western blot on mouse samples (fig 1d). Drug Des Devel Ther (2020) ncbi
domestic rabbit monoclonal (D17C4)
  • western blot; mouse; loading ...; fig 2c
Cell Signaling Technology Bcl 2 antibody (Cell Signaling Technology, 3498) was used in western blot on mouse samples (fig 2c). Aging (Albany NY) (2020) ncbi
domestic rabbit monoclonal (D17C4)
  • western blot; mouse; loading ...; fig 4c
Cell Signaling Technology Bcl 2 antibody (CST, 3498S) was used in western blot on mouse samples (fig 4c). Science (2019) ncbi
domestic rabbit monoclonal (D55G8)
  • western blot; human; 1:1000; loading ...; fig 2f
Cell Signaling Technology Bcl 2 antibody (CST, 4223S) was used in western blot on human samples at 1:1000 (fig 2f). Biol Open (2019) ncbi
mouse monoclonal (124)
  • western blot; human; loading ...; fig 8
Cell Signaling Technology Bcl 2 antibody (Cell Signaling Technology, 15071S) was used in western blot on human samples (fig 8). Biomolecules (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 4b
Cell Signaling Technology Bcl 2 antibody (cell signaling technologies, 2872) was used in western blot on human samples (fig 4b). Front Genet (2019) ncbi
mouse monoclonal (124)
  • western blot; human; loading ...; fig 7e
Cell Signaling Technology Bcl 2 antibody (Cell signaling, 15071) was used in western blot on human samples (fig 7e). Biomolecules (2019) ncbi
domestic rabbit monoclonal (D55G8)
  • western blot; human; loading ...; fig 2c
Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 4223) was used in western blot on human samples (fig 2c). Biomed Res Int (2019) ncbi
domestic rabbit monoclonal (D17C4)
  • western blot; mouse; loading ...; fig 3a
Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 3498) was used in western blot on mouse samples (fig 3a). Oxid Med Cell Longev (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 4f
Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 2872) was used in western blot on human samples (fig 4f). J Clin Invest (2019) ncbi
domestic rabbit monoclonal (D17C4)
  • western blot; mouse; loading ...; fig s3d, s6c, s6f
Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 3498) was used in western blot on mouse samples (fig s3d, s6c, s6f). Science (2019) ncbi
domestic rabbit monoclonal (D55G8)
  • western blot; human; loading ...; fig 4c
Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 4223) was used in western blot on human samples (fig 4c). Cancer Cell Int (2019) ncbi
domestic rabbit monoclonal (5H2)
  • western blot; human; loading ...; fig 4e
Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 2827) was used in western blot on human samples (fig 4e). BMC Cancer (2019) ncbi
domestic rabbit monoclonal (D17C4)
  • western blot; mouse; 1:1000; loading ...; fig 3a
Cell Signaling Technology Bcl 2 antibody (Cell Signaling Technology, 3498S) was used in western blot on mouse samples at 1:1000 (fig 3a). elife (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 6b
Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 2872) was used in western blot on human samples at 1:1000 (fig 6b). Cancer Sci (2019) ncbi
domestic rabbit monoclonal (D17C4)
  • western blot; mouse; 1:1000; loading ...; fig 2h
Cell Signaling Technology Bcl 2 antibody (Cell Signalling Technology, 3498) was used in western blot on mouse samples at 1:1000 (fig 2h). Redox Biol (2019) ncbi
domestic rabbit monoclonal (D17C4)
  • western blot; mouse; fig 1h
Cell Signaling Technology Bcl 2 antibody (cst, 3498) was used in western blot on mouse samples (fig 1h). J Mol Histol (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 3c
Cell Signaling Technology Bcl 2 antibody (Cell Signaling Technology, 2872) was used in western blot on human samples at 1:1000 (fig 3c). Nucleic Acids Res (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3b
Cell Signaling Technology Bcl 2 antibody (Cell Signaling Technology, 2872) was used in western blot on human samples (fig 3b). Oncoimmunology (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 4a
Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 2872) was used in western blot on human samples at 1:1000 (fig 4a). Am J Transl Res (2018) ncbi
domestic rabbit monoclonal (D17C4)
  • western blot; mouse; loading ...; fig 2f
Cell Signaling Technology Bcl 2 antibody (Cell Signaling Technology, 3498) was used in western blot on mouse samples (fig 2f). J Clin Invest (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3a
Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 2872) was used in western blot on human samples (fig 3a). Oncotarget (2017) ncbi
mouse monoclonal (124)
  • western blot; human; 1:1000; loading ...; fig 6b
Cell Signaling Technology Bcl 2 antibody (Cell signaling, 15071) was used in western blot on human samples at 1:1000 (fig 6b). Biochem Pharmacol (2017) ncbi
mouse monoclonal (124)
  • western blot; human; 1:1000; loading ...; fig 6a
In order to propose a potential effect of Hylomecon vernalis Maxim ethanol extracts for treating colorectal cancer, Cell Signaling Technology Bcl 2 antibody (Cell Signaling Technology, 15071S) was used in western blot on human samples at 1:1000 (fig 6a). Mol Med Rep (2017) ncbi
domestic rabbit monoclonal (D55G8)
  • western blot; rat; 1:1000; loading ...; fig 7a
Cell Signaling Technology Bcl 2 antibody (cell signalling, 4223) was used in western blot on rat samples at 1:1000 (fig 7a). Am J Transl Res (2017) ncbi
mouse monoclonal (124)
  • western blot; human; loading ...; fig 3
Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 15071) was used in western blot on human samples (fig 3). Oncol Lett (2017) ncbi
domestic rabbit monoclonal (D55G8)
  • western blot; human; 1:1000; loading ...; fig 8a
Cell Signaling Technology Bcl 2 antibody (cell signalling, 4223) was used in western blot on human samples at 1:1000 (fig 8a). Int J Oncol (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig s2
Cell Signaling Technology Bcl 2 antibody (cell signalling, 2872) was used in western blot on human samples at 1:1000 (fig s2). Sci Rep (2017) ncbi
domestic rabbit monoclonal (D17C4)
  • western blot; mouse; 1:500; loading ...; fig 4d
Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 3498) was used in western blot on mouse samples at 1:500 (fig 4d). Int J Mol Med (2017) ncbi
domestic rabbit monoclonal (D55G8)
  • western blot; human; 1:1000; loading ...; fig 4a
Cell Signaling Technology Bcl 2 antibody (Cell Signaling Technology, 4223) was used in western blot on human samples at 1:1000 (fig 4a). Oncotarget (2017) ncbi
domestic rabbit monoclonal (D55G8)
  • western blot; human; 1:1000; loading ...; fig 3a
Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 4223) was used in western blot on human samples at 1:1000 (fig 3a). Oncol Lett (2017) ncbi
domestic rabbit monoclonal (D55G8)
  • western blot; human; loading ...; fig 5
In order to elucidate a mutually regulatory relationship between signal transducer and activator of transcription 5 and nucleophosmin, Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 4223) was used in western blot on human samples (fig 5). Cell Death Dis (2016) ncbi
mouse monoclonal (124)
  • western blot; mouse; loading ...; fig 2b
Cell Signaling Technology Bcl 2 antibody (Cell signaling, 15071) was used in western blot on mouse samples (fig 2b). Lab Invest (2017) ncbi
domestic rabbit monoclonal (D55G8)
  • western blot; human; 1:3000; loading ...; fig 5a
Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 4223) was used in western blot on human samples at 1:3000 (fig 5a). Oncotarget (2017) ncbi
domestic rabbit monoclonal (D17C4)
  • western blot; mouse; fig 1a
In order to test if BAG3 protects the heart from reperfusion injury, Cell Signaling Technology Bcl 2 antibody (Cell signaling, 3498) was used in western blot on mouse samples (fig 1a). JCI Insight (2016) ncbi
mouse monoclonal (124)
  • western blot; human; 1:1000; loading ...; fig 7a
Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 15071) was used in western blot on human samples at 1:1000 (fig 7a). Int J Mol Sci (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5b
In order to examine the effects of curcumin treatment on myeloid leukemia cells, Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 2872) was used in western blot on human samples (fig 5b). PLoS ONE (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3a
In order to explore the role of the S100A7 in oral squamous cell carcinoma, Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 2872) was used in western blot on human samples (fig 3a). Cancer Gene Ther (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 10a
In order to study chaperome complexes in a large set of tumor specimens, Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 2872) was used in western blot on human samples (fig 10a). Nature (2016) ncbi
mouse monoclonal (124)
  • western blot; human; 1:500; fig 6
Cell Signaling Technology Bcl 2 antibody (CST, 15071) was used in western blot on human samples at 1:500 (fig 6). Oncol Lett (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:2000; loading ...; fig 6c
Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 2872) was used in western blot on human samples at 1:2000 (fig 6c). Oncotarget (2016) ncbi
domestic rabbit monoclonal (5H2)
  • western blot; human; fig 7a
In order to propose that ABHD5 has a PNPLA2-independent function in regulating autophagy and tumorigenesis, Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 2827) was used in western blot on human samples (fig 7a). Autophagy (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 7a
In order to propose that ABHD5 has a PNPLA2-independent function in regulating autophagy and tumorigenesis, Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 2875) was used in western blot on human samples (fig 7a). Autophagy (2016) ncbi
mouse monoclonal (124)
  • western blot; human; loading ...; fig 5b
Cell Signaling Technology Bcl 2 antibody (CST, 15071) was used in western blot on human samples (fig 5b). Int J Mol Sci (2016) ncbi
mouse monoclonal (124)
  • western blot; human; 1:1000; fig 2
In order to create and assess the potential use of Adpa manganese as an antitumor agent, Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 15071) was used in western blot on human samples at 1:1000 (fig 2). Mol Med Rep (2016) ncbi
domestic rabbit monoclonal (D55G8)
  • western blot; human; fig 5
Cell Signaling Technology Bcl 2 antibody (Cell Signaling, D55G8) was used in western blot on human samples (fig 5). Sci Rep (2016) ncbi
mouse monoclonal (124)
  • western blot; human; 1:800; fig 4a
Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 15071) was used in western blot on human samples at 1:800 (fig 4a). PLoS ONE (2016) ncbi
domestic rabbit monoclonal (D55G8)
  • western blot; human; fig 3
In order to study promotion of survival of breast cancer cells in response to hyper-fractionated radiation treatment by RAC1 GTPase, Cell Signaling Technology Bcl 2 antibody (Cell Signaling, D55G8) was used in western blot on human samples (fig 3). Oncogene (2016) ncbi
domestic rabbit monoclonal (5H2)
  • western blot; human; 1:1000; fig s5
Cell Signaling Technology Bcl 2 antibody (Cell signaling, 2827) was used in western blot on human samples at 1:1000 (fig s5). Autophagy (2016) ncbi
domestic rabbit monoclonal (D17C4)
  • immunohistochemistry; mouse; loading ...; fig 5c
Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 3498) was used in immunohistochemistry on mouse samples (fig 5c). PLoS ONE (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig s18
Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 2872) was used in western blot on human samples at 1:1000 (fig s18). Nat Commun (2016) ncbi
domestic rabbit monoclonal (D17C4)
  • western blot; mouse; fig 2
Cell Signaling Technology Bcl 2 antibody (Cell Signaling Technolog, 3498) was used in western blot on mouse samples (fig 2). Cell Death Differ (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 6b
Cell Signaling Technology Bcl 2 antibody (cell signalling, 2872) was used in western blot on human samples (fig 6b). J Biol Chem (2016) ncbi
domestic rabbit monoclonal (D55G8)
  • western blot; human; 1:2000; fig 3
Cell Signaling Technology Bcl 2 antibody (Cell Signaling Technology, 4223) was used in western blot on human samples at 1:2000 (fig 3). Int J Mol Med (2016) ncbi
domestic rabbit monoclonal (5H2)
  • western blot; human; fig 6
Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 2827) was used in western blot on human samples (fig 6). Oncotarget (2016) ncbi
domestic rabbit monoclonal (D17C4)
  • western blot; mouse; fig 5
In order to study the role of autophagy during pancreatitis, Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 3498) was used in western blot on mouse samples (fig 5). Proc Natl Acad Sci U S A (2015) ncbi
domestic rabbit monoclonal (5H2)
  • western blot; human; 1:1000; fig 4
In order to use a pharmaceutical screen to discover new mechanisms of autophagy activation, Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 2827) was used in western blot on human samples at 1:1000 (fig 4). Nat Commun (2015) ncbi
domestic rabbit monoclonal (5H2)
  • other; mouse; 1:1000; fig s1
In order to identify host signaling dynamics upon Burkholderia spp. infection by a reverse-phase protein microarray-based screen, Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 2827) was used in other on mouse samples at 1:1000 (fig s1). Front Microbiol (2015) ncbi
domestic rabbit monoclonal (D55G8)
  • immunoprecipitation; human; fig 6
  • western blot; human; fig 6
Cell Signaling Technology Bcl 2 antibody (Cell signaling, 4223) was used in immunoprecipitation on human samples (fig 6) and in western blot on human samples (fig 6). Leukemia (2016) ncbi
domestic rabbit monoclonal (D17C4)
  • western blot; human; fig 2b
  • western blot; mouse; fig 2a
In order to utilize an E-mu-TCL1 mouse model to study miR-181b as a therapeutic agent for chronic lymphocytic leukemia, Cell Signaling Technology Bcl 2 antibody (Cell Signaling Technology, 3498) was used in western blot on human samples (fig 2b) and in western blot on mouse samples (fig 2a). Oncotarget (2015) ncbi
domestic rabbit monoclonal (5H2)
  • western blot; human; 1:1000; fig 3
Cell Signaling Technology Bcl 2 antibody (Cell signaling, 2827) was used in western blot on human samples at 1:1000 (fig 3). Nat Commun (2015) ncbi
domestic rabbit monoclonal (D17C4)
  • western blot; mouse; 1:1000; loading ...; fig 6a
Cell Signaling Technology Bcl 2 antibody (Cell Signaling Technology, D17C4) was used in western blot on mouse samples at 1:1000 (fig 6a). Mol Brain (2015) ncbi
domestic rabbit monoclonal (D17C4)
  • western blot; mouse; 1:2000; fig 7
Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 3498) was used in western blot on mouse samples at 1:2000 (fig 7). PLoS ONE (2014) ncbi
domestic rabbit monoclonal (5H2)
  • western blot; human; fig 4c
Cell Signaling Technology Bcl 2 antibody (Cell Signaling, 2827) was used in western blot on human samples (fig 4c). Oncotarget (2014) ncbi
domestic rabbit monoclonal (D55G8)
  • western blot; human
Cell Signaling Technology Bcl 2 antibody (Cell Signaling Technologies, 4223) was used in western blot on human samples . PLoS ONE (2014) ncbi
domestic rabbit monoclonal (D17C4)
  • western blot; mouse
Cell Signaling Technology Bcl 2 antibody (Cell Signaling Technology, 3498) was used in western blot on mouse samples . J Neurosci (2013) ncbi
domestic rabbit monoclonal (D55G8)
  • western blot; mouse
Cell Signaling Technology Bcl 2 antibody (Cell Signaling, D55G8) was used in western blot on mouse samples . Mol Cancer Ther (2013) ncbi
Dako
mouse monoclonal (124)
  • immunohistochemistry; human; 1:100; loading ...
Dako Bcl 2 antibody (Dako, 124) was used in immunohistochemistry on human samples at 1:100. Mod Pathol (2020) ncbi
mouse monoclonal (124)
  • immunohistochemistry - paraffin section; human; loading ...; fig s1a
  • western blot; human; loading ...; fig s1a
Dako Bcl 2 antibody (Dako, MO887) was used in immunohistochemistry - paraffin section on human samples (fig s1a) and in western blot on human samples (fig s1a). Cell Death Dis (2020) ncbi
mouse monoclonal (124)
  • western blot; human; loading ...; fig 5a
Dako Bcl 2 antibody (Dako, M0887) was used in western blot on human samples (fig 5a). Nat Commun (2020) ncbi
mouse monoclonal (124)
  • other; human; loading ...; fig 4c
Dako Bcl 2 antibody (Dako, M0887) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi
mouse monoclonal (124)
  • immunohistochemistry - paraffin section; human; tbl 4
Dako Bcl 2 antibody (DakoCytomation, 124) was used in immunohistochemistry - paraffin section on human samples (tbl 4). Ann Hematol (2017) ncbi
mouse monoclonal (124)
  • immunohistochemistry - paraffin section; human; 1:100; fig 2e
Dako Bcl 2 antibody (Dako, 124) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 2e). Histopathology (2017) ncbi
mouse monoclonal (124)
  • reverse phase protein lysate microarray; human; loading ...; fig st6
In order to characterize the molecular identity of uterine carcinosarcomas., Dako Bcl 2 antibody (Dako, Dako M0887) was used in reverse phase protein lysate microarray on human samples (fig st6). Cancer Cell (2017) ncbi
mouse monoclonal (124)
  • immunohistochemistry - paraffin section; rat; 1:100; loading ...; fig st2
In order to outline the protocols for antibodies used for immunohistochemical studies, Dako Bcl 2 antibody (Dako, M0887) was used in immunohistochemistry - paraffin section on rat samples at 1:100 (fig st2). J Toxicol Pathol (2017) ncbi
mouse monoclonal (124)
  • reverse phase protein lysate microarray; human; loading ...; fig 3a
In order to describe the features of 228 primary cervical cancers, Dako Bcl 2 antibody (Dako, M0887) was used in reverse phase protein lysate microarray on human samples (fig 3a). Nature (2017) ncbi
mouse monoclonal (124)
  • immunocytochemistry; human; 1:100; loading ...; fig 6b
  • western blot; human; fig 6a
In order to investigate the impact of autophagy on Mycobacterium leprae infection, Dako Bcl 2 antibody (Dako, M088729) was used in immunocytochemistry on human samples at 1:100 (fig 6b) and in western blot on human samples (fig 6a). PLoS Pathog (2017) ncbi
mouse monoclonal (124)
  • western blot; human; loading ...
In order to analyze the context specificity of signaling networks within a causal conceptual framework using reverse-phase protein array time-course assays and network analysis approaches, Dako Bcl 2 antibody (Dako, M0887) was used in western blot on human samples . Cell Syst (2017) ncbi
mouse monoclonal (124)
  • immunohistochemistry - paraffin section; human; loading ...; fig 2f
  • immunohistochemistry; human; loading ...; fig 1f
In order to characterize three immunocompetent patients with primary cardiac diffuse large B-cell lymphoma, Dako Bcl 2 antibody (Dako, 124) was used in immunohistochemistry - paraffin section on human samples (fig 2f) and in immunohistochemistry on human samples (fig 1f). Ann Diagn Pathol (2016) ncbi
mouse monoclonal (124)
  • immunohistochemistry - paraffin section; human; 1:100; tbl 2
In order to compare leukemic non-nodal mantle cell lymphoma with classical mantle cell lymphoma and aggressive mantle cell lymphoma, Dako Bcl 2 antibody (Dako, 124) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 2). Virchows Arch (2016) ncbi
mouse monoclonal (124)
  • western blot; human; loading ...; fig 5b,5c,6b,6c,6d
Dako Bcl 2 antibody (Dako, M0887) was used in western blot on human samples (fig 5b,5c,6b,6c,6d). Oncotarget (2016) ncbi
mouse monoclonal (124)
  • immunohistochemistry - paraffin section; human; loading ...; tbl 2
  • flow cytometry; human
In order to assess the contribution of cytomorphology and flow cytometry to histopathological studies of brain biopsies, Dako Bcl 2 antibody (Dako, 124) was used in immunohistochemistry - paraffin section on human samples (tbl 2) and in flow cytometry on human samples . Cytometry B Clin Cytom (2018) ncbi
mouse monoclonal (124)
  • immunohistochemistry - paraffin section; human; loading ...; tbl 1
Dako Bcl 2 antibody (Dako, 124) was used in immunohistochemistry - paraffin section on human samples (tbl 1). Cancer Sci (2016) ncbi
mouse monoclonal (124)
  • western blot; human; 1:500; fig 5c
Dako Bcl 2 antibody (DAKO, M0887) was used in western blot on human samples at 1:500 (fig 5c). Sci Rep (2016) ncbi
mouse monoclonal (124)
  • immunohistochemistry - paraffin section; human; 1:50; tbl 1
Dako Bcl 2 antibody (Dako, 124) was used in immunohistochemistry - paraffin section on human samples at 1:50 (tbl 1). Rom J Morphol Embryol (2016) ncbi
mouse monoclonal (124)
  • immunohistochemistry - paraffin section; rat; 1:100; fig 3
Dako Bcl 2 antibody (Dako Corporation, M0887) was used in immunohistochemistry - paraffin section on rat samples at 1:100 (fig 3). Biomed Res Int (2016) ncbi
mouse monoclonal (124)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 2d
Dako Bcl 2 antibody (DAKO, 124) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 2d). Nat Commun (2016) ncbi
mouse monoclonal (124)
  • immunohistochemistry - paraffin section; human; 1:160; loading ...; fig 1c
In order to define features that distinguish follicular lymphoma without a BCL2 translocation from nodal marginal zone lymphoma, Dako Bcl 2 antibody (Dako, 124) was used in immunohistochemistry - paraffin section on human samples at 1:160 (fig 1c). J Hematop (2016) ncbi
mouse monoclonal (124)
  • immunohistochemistry - paraffin section; human; loading ...; tbl 4
Dako Bcl 2 antibody (Dako, 124) was used in immunohistochemistry - paraffin section on human samples (tbl 4). Chin J Cancer (2016) ncbi
mouse monoclonal (124)
  • immunohistochemistry; human; 1:50; fig 2
In order to perform an automated analysis of proliferation involving apoptotic markers in papillary thyroid cancinoma, Dako Bcl 2 antibody (DakoCytomation, M0887) was used in immunohistochemistry on human samples at 1:50 (fig 2). PLoS ONE (2016) ncbi
mouse monoclonal (124)
  • western blot; human; 1:1000; fig 6
Dako Bcl 2 antibody (Dako, M0887) was used in western blot on human samples at 1:1000 (fig 6). Oncotarget (2016) ncbi
mouse monoclonal (124)
  • flow cytometry; human; loading ...; fig 1a
In order to investigate exosomes release of global gene regulatory protein clusters and its contribution to drug resistance, Dako Bcl 2 antibody (DAKO, 124) was used in flow cytometry on human samples (fig 1a). Mol Cell Proteomics (2016) ncbi
mouse monoclonal (124)
  • immunohistochemistry - frozen section; rat; 1:40; fig 3
In order to study ethambutol-induced retinal injury and the effect of memantine, an NMDA receptor blocker, Dako Bcl 2 antibody (DAKO, 124) was used in immunohistochemistry - frozen section on rat samples at 1:40 (fig 3). Ann Anat (2016) ncbi
mouse monoclonal (124)
  • immunohistochemistry; human; 1:50; tbl 1
Dako Bcl 2 antibody (Dako, 124) was used in immunohistochemistry on human samples at 1:50 (tbl 1). Oral Surg Oral Med Oral Pathol Oral Radiol (2016) ncbi
mouse monoclonal (124)
  • immunohistochemistry; human; 1:25; fig s2
In order to analyze propagation of oestrogen-responsive and oestrogen receptor-positive normal human breast cells in culture, Dako Bcl 2 antibody (Dako, M0887) was used in immunohistochemistry on human samples at 1:25 (fig s2). Nat Commun (2015) ncbi
mouse monoclonal (124)
  • western blot; human; loading ...; fig 6b
Dako Bcl 2 antibody (Dako, M0887) was used in western blot on human samples (fig 6b). Oncotarget (2015) ncbi
mouse monoclonal (124)
  • immunohistochemistry; human; 1:50
Dako Bcl 2 antibody (Dako, 124) was used in immunohistochemistry on human samples at 1:50. Hum Pathol (2015) ncbi
mouse monoclonal (124)
  • immunohistochemistry - paraffin section; human; 1:10
Dako Bcl 2 antibody (DAKO, 124) was used in immunohistochemistry - paraffin section on human samples at 1:10. APMIS (2015) ncbi
mouse monoclonal (124)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 3
Dako Bcl 2 antibody (Dako, 124) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 3). Ann Diagn Pathol (2015) ncbi
mouse monoclonal (124)
  • immunohistochemistry; human
Dako Bcl 2 antibody (Dako, clone 124) was used in immunohistochemistry on human samples . Brain Tumor Pathol (2015) ncbi
mouse monoclonal (124)
  • immunohistochemistry - paraffin section; human; 1:75
In order to describe a case of marginal zone lymphoma with extensive emperipolesis, Dako Bcl 2 antibody (Dako, 124) was used in immunohistochemistry - paraffin section on human samples at 1:75. Cytopathology (2016) ncbi
mouse monoclonal (124)
  • western blot; human; fig 3
In order to use a cell culture model for aromatase inhibitor-resistant breast cancer to show how fulvestrant treatment and cross-resistance between exemestane and letrozole shows sensitivity, Dako Bcl 2 antibody (Dako, M0887) was used in western blot on human samples (fig 3). Int J Oncol (2015) ncbi
mouse monoclonal (124)
  • immunohistochemistry - paraffin section; human; 1:100
In order to analyze the significance biologically and clinically of PARP1 protein expression in breast cancer, Dako Bcl 2 antibody (Dako, 124) was used in immunohistochemistry - paraffin section on human samples at 1:100. Breast Cancer Res Treat (2015) ncbi
mouse monoclonal (124)
  • western blot; human; fig 3
Dako Bcl 2 antibody (Dako, M0887) was used in western blot on human samples (fig 3). Cancer Biol Ther (2015) ncbi
mouse monoclonal (124)
  • immunohistochemistry; human
In order to characterize first case of primary intraosseous hybrid nerve sheath tumor, Dako Bcl 2 antibody (Dako, 124) was used in immunohistochemistry on human samples . Pathol Res Pract (2015) ncbi
mouse monoclonal (124)
  • immunohistochemistry - paraffin section; human; 1:80
Dako Bcl 2 antibody (DAKO, 124) was used in immunohistochemistry - paraffin section on human samples at 1:80. Diagn Pathol (2014) ncbi
mouse monoclonal (124)
  • flow cytometry; human
In order to assess the efficacy of using flow cytometry immunophenotyping with fine-needle aspiration cytology for the diagnosis of thyroid lymphoma, Dako Bcl 2 antibody (Dako, 124) was used in flow cytometry on human samples . Cytometry B Clin Cytom (2015) ncbi
mouse monoclonal (124)
  • immunohistochemistry - paraffin section; human; 1:100
Dako Bcl 2 antibody (DAKO, 124) was used in immunohistochemistry - paraffin section on human samples at 1:100. Cancer Med (2015) ncbi
mouse monoclonal (124)
  • immunohistochemistry - paraffin section; human; 1:600
Dako Bcl 2 antibody (DAKOCytomation, M0887) was used in immunohistochemistry - paraffin section on human samples at 1:600. Anticancer Res (2014) ncbi
mouse monoclonal (124)
  • immunohistochemistry; human; 1:40
In order to describe the histological features canalicular adenoma, Dako Bcl 2 antibody (Dako, 124) was used in immunohistochemistry on human samples at 1:40. Head Neck Pathol (2015) ncbi
mouse monoclonal (124)
  • immunohistochemistry - paraffin section; human; 1:100; tbl 2
In order to study triple negative primary breast cancer biological characteristics and clinical outcome in older women in comparison to their younger counterparts, Dako Bcl 2 antibody (Dako, M0887) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 2). PLoS ONE (2014) ncbi
mouse monoclonal (124)
  • immunoprecipitation; human
  • western blot; human; 1:300
Dako Bcl 2 antibody (DAKO, 124) was used in immunoprecipitation on human samples and in western blot on human samples at 1:300. J Biol Chem (2014) ncbi
mouse monoclonal (124)
  • immunohistochemistry - paraffin section; human; 1:50
Dako Bcl 2 antibody (Dako, 124) was used in immunohistochemistry - paraffin section on human samples at 1:50. PLoS ONE (2014) ncbi
mouse monoclonal (124)
  • immunohistochemistry - paraffin section; human; 1:40
In order to reoprt on a case of an unusual primary gastric Merkel cell carcinoma, Dako Bcl 2 antibody (Dako, 124) was used in immunohistochemistry - paraffin section on human samples at 1:40. Hum Pathol (2014) ncbi
mouse monoclonal (124)
  • immunohistochemistry; human; 1:50
Dako Bcl 2 antibody (Dako, M0887) was used in immunohistochemistry on human samples at 1:50. Blood Cancer J (2013) ncbi
mouse monoclonal (124)
  • flow cytometry; human; tbl 1
In order to compare fine needle aspiration cytology with flow cytometry immunophenotyping for the diagnosis of lymphoproliferative processes in the salivary glands, Dako Bcl 2 antibody (Dako, clone 124) was used in flow cytometry on human samples (tbl 1). Cytopathology (2014) ncbi
mouse monoclonal (124)
  • immunohistochemistry - paraffin section; human
In order to study the predictive and prognostic value of a range of biomarkers in pre-treatment biopsies from patients with advanced cancer of the larynx, Dako Bcl 2 antibody (Dako, 124) was used in immunohistochemistry - paraffin section on human samples . Laryngoscope (2014) ncbi
mouse monoclonal (124)
  • immunohistochemistry - paraffin section; human; 1:600
Dako Bcl 2 antibody (DAKOCytomation, M0887) was used in immunohistochemistry - paraffin section on human samples at 1:600. Oncology (2013) ncbi
mouse monoclonal (124)
  • immunohistochemistry - paraffin section; human; 1:300
Dako Bcl 2 antibody (DAKO, 124) was used in immunohistochemistry - paraffin section on human samples at 1:300. Hum Pathol (2011) ncbi
mouse monoclonal (124)
  • immunohistochemistry - paraffin section; human; 1:30
Dako Bcl 2 antibody (DakoCytomation, clone 124) was used in immunohistochemistry - paraffin section on human samples at 1:30. J Neuropathol Exp Neurol (2008) ncbi
Bioworld
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 6g
Bioworld Bcl 2 antibody (Bioworld, bs1511) was used in western blot on mouse samples (fig 6g). Cell Death Dis (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 4
Bioworld Bcl 2 antibody (Bioworld Technology, BS1511) was used in western blot on human samples at 1:1000 (fig 4). Oncol Lett (2016) ncbi
domestic rabbit polyclonal
  • western blot; rat; 1:800; fig 6
Bioworld Bcl 2 antibody (Bio-World, bs1511) was used in western blot on rat samples at 1:800 (fig 6). Mol Med Rep (2016) ncbi
AmyJet Scientific
mouse monoclonal (6F11)
  • western blot; human; loading ...; fig 4d
AmyJet Scientific Bcl 2 antibody (AmyJet Scientific, ABM40273) was used in western blot on human samples (fig 4d). Biomed Pharmacother (2017) ncbi
Cell Marque
  • immunohistochemistry - paraffin section; human; 1:50; tbl 1
In order to discuss features of giant cell ependymoma of the filum terminale, Cell Marque Bcl 2 antibody (Cell Marque, 226R-16) was used in immunohistochemistry - paraffin section on human samples at 1:50 (tbl 1). Diagn Pathol (2017) ncbi
BD Biosciences
mouse monoclonal (7/Bcl-2)
  • western blot; human; 1:1000; loading ...; fig 4c, 4d, 4g
BD Biosciences Bcl 2 antibody (BD, 610538) was used in western blot on human samples at 1:1000 (fig 4c, 4d, 4g). Cell Death Dis (2020) ncbi
mouse monoclonal (Bcl-2/100)
  • flow cytometry; human; loading ...; fig 3d
BD Biosciences Bcl 2 antibody (BD Bioscience, Bcl-2/100) was used in flow cytometry on human samples (fig 3d). Methods Mol Biol (2019) ncbi
mouse monoclonal (4D7)
  • western blot; human; 1:1000; loading ...; fig 2a
BD Biosciences Bcl 2 antibody (BD, 551097) was used in western blot on human samples at 1:1000 (fig 2a). Cell Death Dis (2018) ncbi
mouse monoclonal (7/Bcl-2)
  • western blot; human; 1:500; loading ...; fig 4b
BD Biosciences Bcl 2 antibody (BD Pharmingen, 610539) was used in western blot on human samples at 1:500 (fig 4b). Mol Med Rep (2017) ncbi
mouse monoclonal (7/Bcl-2)
  • western blot; mouse; loading ...; fig 1b
BD Biosciences Bcl 2 antibody (BD Biosciences, 7) was used in western blot on mouse samples (fig 1b). Cell Death Differ (2017) ncbi
mouse monoclonal (7/Bcl-2)
  • immunohistochemistry - paraffin section; human; fig 6b
BD Biosciences Bcl 2 antibody (BD Biosciences, 610538) was used in immunohistochemistry - paraffin section on human samples (fig 6b). Oncotarget (2016) ncbi
hamsters monoclonal (6C8)
  • western blot; human; fig 5
BD Biosciences Bcl 2 antibody (BD-Transduction Laboratories, 551052) was used in western blot on human samples (fig 5). BMC Cancer (2016) ncbi
mouse monoclonal (7/Bcl-2)
  • western blot; human; fig 4a
In order to evaluate the therapeutic use of the dental pulp stem cell secretome to reduce cytotoxicity and apoptosis caused by the amyloid beta peptide, BD Biosciences Bcl 2 antibody (BD, 610538) was used in western blot on human samples (fig 4a). Stem Cells Int (2016) ncbi
  • flow cytometry; human; 1:10; tbl 2
BD Biosciences Bcl 2 antibody (BD PharMingen, 556535) was used in flow cytometry on human samples at 1:10 (tbl 2). Oncoimmunology (2016) ncbi
mouse monoclonal (7/Bcl-2)
  • western blot; human; 1:500; fig 6
BD Biosciences Bcl 2 antibody (BD, 610538) was used in western blot on human samples at 1:500 (fig 6). Cell Rep (2016) ncbi
hamsters monoclonal (6C8)
  • flow cytometry; human; fig 2
BD Biosciences Bcl 2 antibody (BD Biosciences, 6C8) was used in flow cytometry on human samples (fig 2). Int Immunol (2016) ncbi
mouse monoclonal (7/Bcl-2)
  • western blot; human; fig 4
BD Biosciences Bcl 2 antibody (BD Biosciences, 610539) was used in western blot on human samples (fig 4). Oncotarget (2016) ncbi
mouse monoclonal (Bcl-2/100)
  • western blot; human; 1:1000; fig 2
In order to elucidate mechanisms that regulate T cell glycolytic metabolism, BD Biosciences Bcl 2 antibody (BD Bioscience, 551107) was used in western blot on human samples at 1:1000 (fig 2). Nat Immunol (2016) ncbi
mouse monoclonal (7/Bcl-2)
  • western blot; mouse; 1:100; fig 6d, 6e
BD Biosciences Bcl 2 antibody (BD Transduction Laboratories, 610539) was used in western blot on mouse samples at 1:100 (fig 6d, 6e). FEBS Open Bio (2015) ncbi
mouse monoclonal (7/Bcl-2)
  • western blot; human; 1:1000; fig 3
BD Biosciences Bcl 2 antibody (BD Biosciences, 610539) was used in western blot on human samples at 1:1000 (fig 3). PLoS ONE (2015) ncbi
mouse monoclonal (Bcl-2/100)
  • flow cytometry; rhesus macaque
BD Biosciences Bcl 2 antibody (BD Biosciences, Bcl2/100) was used in flow cytometry on rhesus macaque samples . Vaccine (2015) ncbi
mouse monoclonal (7/Bcl-2)
  • western blot; human; loading ...; fig 5a,5c
BD Biosciences Bcl 2 antibody (BD Biosciences, 610538) was used in western blot on human samples (fig 5a,5c). Cell Death Dis (2015) ncbi
mouse monoclonal (4D7)
  • western blot; human; fig s2b
In order to elucidate the molecular mechanisms by which mitochondrial respiratory chain dysfunction results in cell death, BD Biosciences Bcl 2 antibody (BD, 4D7) was used in western blot on human samples (fig s2b). Cell Death Dis (2015) ncbi
mouse monoclonal (7/Bcl-2)
  • western blot; human; fig 5
BD Biosciences Bcl 2 antibody (BD Biosciences, 610538) was used in western blot on human samples (fig 5). Biomed Res Int (2015) ncbi
mouse monoclonal (Bcl-2/100)
  • flow cytometry; rhesus macaque
BD Biosciences Bcl 2 antibody (BD Biosciences, Bcl-2/100) was used in flow cytometry on rhesus macaque samples . J Immunol (2014) ncbi
mouse monoclonal (Bcl-2/100)
  • flow cytometry; human
BD Biosciences Bcl 2 antibody (BD, Bcl-2/100) was used in flow cytometry on human samples . Eur J Immunol (2014) ncbi
mouse monoclonal (Bcl-2/100)
  • flow cytometry; human
BD Biosciences Bcl 2 antibody (BD Biosciences, Bcl-2/100) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (7/Bcl-2)
  • immunoprecipitation; human
BD Biosciences Bcl 2 antibody (BD Transduction Laboratories, 7/Bcl-2) was used in immunoprecipitation on human samples . Biochem Biophys Res Commun (2014) ncbi
mouse monoclonal (7/Bcl-2)
  • western blot; human
BD Biosciences Bcl 2 antibody (BD Transduction Laboratories, 610539) was used in western blot on human samples . Mol Cell Biol (2014) ncbi
mouse monoclonal (7/Bcl-2)
  • western blot; human
In order to investigate the effect of antimesothelin immunotoxin SS1P and BH3-mimetic ABT-737 on SS1P-resistant pancreatic cancer cells, BD Biosciences Bcl 2 antibody (BD Transduction Laboratories, 610539) was used in western blot on human samples . J Immunother (2014) ncbi
mouse monoclonal (7/Bcl-2)
  • western blot; human; 1:500
BD Biosciences Bcl 2 antibody (BD Transduction Laboratories, 610538) was used in western blot on human samples at 1:500. PLoS ONE (2013) ncbi
mouse monoclonal (4D7)
  • western blot; human
BD Biosciences Bcl 2 antibody (BD Biosciences, 551097) was used in western blot on human samples . Int J Cancer (2011) ncbi
mouse monoclonal (Bcl-2/100)
  • flow cytometry; human; 1 ug
  • western blot; human
BD Biosciences Bcl 2 antibody (BD Biosciences, Bcl-2/100) was used in flow cytometry on human samples at 1 ug and in western blot on human samples . Cell Death Differ (2008) ncbi
Leica Biosystems
  • immunohistochemistry; human; fig 3a
Leica Biosystems Bcl 2 antibody (Novocastra, bcl-2/100/D5) was used in immunohistochemistry on human samples (fig 3a). Histopathology (2017) ncbi
  • immunohistochemistry - paraffin section; human; 1:500; fig 2c
In order to characterize ten cases of canine follicular lymphomas, Leica Biosystems Bcl 2 antibody (Leica Microsystems, BCL2-486) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 2c). Vet Comp Oncol (2017) ncbi
MilliporeSigma
mouse monoclonal (Bcl-2-100)
  • western blot; human; fig 8
MilliporeSigma Bcl 2 antibody (Sigma, B3170) was used in western blot on human samples (fig 8). BMC Complement Altern Med (2016) ncbi
Articles Reviewed
  1. Zang N, Cui C, Guo X, Song J, Hu H, Yang M, et al. cGAS-STING activation contributes to podocyte injury in diabetic kidney disease. iScience. 2022;25:105145 pubmed publisher
  2. Fei X, Wu X, Dou Y, Sun K, Guo Q, Zhang L, et al. TRIM22 orchestrates the proliferation of GBMs and the benefits of TMZ by coordinating the modification and degradation of RIG-I. Mol Ther Oncolytics. 2022;26:413-428 pubmed publisher
  3. Tao M, Ma H, Fu X, Wang C, Li Y, Hu X, et al. Semaphorin 3F induces colorectal cancer cell chemosensitivity by promoting P27 nuclear export. Front Oncol. 2022;12:899927 pubmed publisher
  4. Abousaad S, Ahmed F, Abouzeid A, Ongeri E. Meprin β expression modulates the interleukin-6 mediated JAK2-STAT3 signaling pathway in ischemia/reperfusion-induced kidney injury. Physiol Rep. 2022;10:e15468 pubmed publisher
  5. Zhang Z, Li P, Sun P. Expression of SAMHD1 and its mutation on prognosis of colon cancer. Oncol Lett. 2022;24:303 pubmed publisher
  6. Gao H, Sun H, Yan N, Zhao P, Xu H, Zheng W, et al. ATP13A2 Declines Zinc-Induced Accumulation of α-Synuclein in a Parkinson's Disease Model. Int J Mol Sci. 2022;23: pubmed publisher
  7. Amen A, Loughran R, Huang C, Lew R, Ravi A, Guan Y, et al. Endogenous spacing enables co-processing of microRNAs and efficient combinatorial RNAi. Cell Rep Methods. 2022;2:100239 pubmed publisher
  8. Narayan S, Raza A, Mahmud I, Koo N, Garrett T, LAW M, et al. Sensitization of FOLFOX-resistant colorectal cancer cells via the modulation of a novel pathway involving protein phosphatase 2A. iScience. 2022;25:104518 pubmed publisher
  9. Chen J, Chen K, Wang L, Luo J, Zheng Q, He Y. Decoy receptor 2 mediates the apoptosis-resistant phenotype of senescent renal tubular cells and accelerates renal fibrosis in diabetic nephropathy. Cell Death Dis. 2022;13:522 pubmed publisher
  10. Zhou W, Xu Y, Zhang J, Zhang P, Yao Z, Yan Z, et al. MiRNA-363-3p/DUSP10/JNK axis mediates chemoresistance by enhancing DNA damage repair in diffuse large B-cell lymphoma. Leukemia. 2022;36:1861-1869 pubmed publisher
  11. Luo H, Song Y, Zhang J, Liu Y, Chen F, Wang Z, et al. MAT2A facilitates PDCD6 methylation and promotes cell growth under glucose deprivation in cervical cancer. Cell Death Discov. 2022;8:176 pubmed publisher
  12. Hu Q, Liu X, Liu Z, Liu Z, Zhang H, Zhang Q, et al. Dexmedetomidine reduces enteric glial cell injury induced by intestinal ischaemia-reperfusion injury through mitochondrial localization of TERT. J Cell Mol Med. 2022;26:2594-2606 pubmed publisher
  13. Su Y, Xu J, Gao R, Liu X, Liu T, Li C, et al. The Circ-CYP24A1-miR-224-PRLR Axis Impairs Cell Proliferation and Apoptosis in Recurrent Miscarriage. Front Physiol. 2022;13:778116 pubmed publisher
  14. Muhammad A, Hao L, Al Kury L, Rehman N, Alvi A, Badshah H, et al. Carveol Promotes Nrf2 Contribution in Depressive Disorders through an Anti-inflammatory Mechanism. Oxid Med Cell Longev. 2022;2022:4509204 pubmed publisher
  15. He S, Gao Q, Wu X, Shi J, Zhang Y, Yang J, et al. NAD+ ameliorates endotoxin-induced acute kidney injury in a sirtuin1-dependent manner via GSK-3β/Nrf2 signalling pathway. J Cell Mol Med. 2022;26:1979-1993 pubmed publisher
  16. Xu Y, Chen X, Pan S, Wang Z, Zhu X. TM7SF2 regulates cell proliferation and apoptosis by activation of C-Raf/ERK pathway in cervical cancer. Cell Death Discov. 2021;7:299 pubmed publisher
  17. Liu W, Feng Q, Liao W, Li E, Wu L. TUG1 promotes the expression of IFITM3 in hepatocellular carcinoma by competitively binding to miR-29a. J Cancer. 2021;12:6905-6920 pubmed publisher
  18. Fang S, Sun S, Cai H, Zou X, Wang S, Hao X, et al. IRGM/Irgm1 facilitates macrophage apoptosis through ROS generation and MAPK signal transduction: Irgm1 +/- mice display increases atherosclerotic plaque stability. Theranostics. 2021;11:9358-9375 pubmed publisher
  19. Ali A, Kuo W, Kuo C, Lo J, Chen M, Daddam J, et al. E3 ligase activity of Carboxyl terminus of Hsc70 interacting protein (CHIP) in Wharton's jelly derived mesenchymal stem cells improves their persistence under hyperglycemic stress and promotes the prophylactic effects against diabetic cardiac damages. Bioeng Transl Med. 2021;6:e10234 pubmed publisher
  20. Li K, Wu R, Zhou M, Tong H, Luo K. Desmosomal proteins of DSC2 and PKP1 promote cancer cells survival and metastasis by increasing cluster formation in circulatory system. Sci Adv. 2021;7:eabg7265 pubmed publisher
  21. Lü Z, Liu H, Song N, Liang Y, Zhu J, Chen J, et al. METTL14 aggravates podocyte injury and glomerulopathy progression through N6-methyladenosine-dependent downregulating of Sirt1. Cell Death Dis. 2021;12:881 pubmed publisher
  22. Lee Y, Gil E, Jeong I, Kim H, Jang J, Choung Y. Heat Shock Factor 1 Prevents Age-Related Hearing Loss by Decreasing Endoplasmic Reticulum Stress. Cells. 2021;10: pubmed publisher
  23. Bhattarai K, Kim H, Chaudhary M, Ur Rashid M, Kim J, Kim H, et al. TMBIM6 regulates redox-associated posttranslational modifications of IRE1α and ER stress response failure in aging mice and humans. Redox Biol. 2021;47:102128 pubmed publisher
  24. Chiang C, Hong Y. In situ delivery of biobutyrate by probiotic Escherichia coli for cancer therapy. Sci Rep. 2021;11:18172 pubmed publisher
  25. Huang J, Xiao R, Wang X, Khadka B, Fang Z, Yu M, et al. MicroRNA‑93 knockdown inhibits acute myeloid leukemia cell growth via inactivating the PI3K/AKT pathway by upregulating DAB2. Int J Oncol. 2021;59: pubmed publisher
  26. Ji Z, Chen S, Cui J, Huang W, Zhang R, Wei J, et al. Oct4-dependent FoxC1 activation improves the survival and neovascularization of mesenchymal stem cells under myocardial ischemia. Stem Cell Res Ther. 2021;12:483 pubmed publisher
  27. Liu Y, Zhang Y. Hsa_circ_0134111 promotes osteoarthritis progression by regulating miR-224-5p/CCL1 interaction. Aging (Albany NY). 2021;13:20383-20394 pubmed publisher
  28. Yan D, Li X, Yang Q, Huang Q, Yao L, Zhang P, et al. Regulation of Bax-dependent apoptosis by mitochondrial deubiquitinase USP30. Cell Death Discov. 2021;7:211 pubmed publisher
  29. Zhao Z, Szczepanski A, Tsuboyama N, Abdala Valencia H, Goo Y, Singer B, et al. PAX9 Determines Epigenetic State Transition and Cell Fate in Cancer. Cancer Res. 2021;81:4696-4708 pubmed publisher
  30. Zheleznyak A, Mixdorf M, Marsala L, Prior J, Yang X, Cui G, et al. Orthogonal targeting of osteoclasts and myeloma cells for radionuclide stimulated dynamic therapy induces multidimensional cell death pathways. Theranostics. 2021;11:7735-7754 pubmed publisher
  31. Meng L, Zhang Y, Li D, Shang X, Hao X, Chen X, et al. TIMP3 attenuates cerebral ischemia/reperfusion-induced apoptosis and oxidative stress in neurocytes by regulating the AKT pathway. Exp Ther Med. 2021;22:973 pubmed publisher
  32. Oberhardt V, Luxenburger H, Kemming J, Schulien I, Ciminski K, Giese S, et al. Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine. Nature. 2021;597:268-273 pubmed publisher
  33. Lassiter R, Merchen T, Fang X, Wang Y. Protective Role of Kynurenine 3-Monooxygenase in Allograft Rejection and Tubular Injury in Kidney Transplantation. Front Immunol. 2021;12:671025 pubmed publisher
  34. Lee S, Jung J, Lee Y, Kim S, Kim J, Kim B, et al. Targeting HSF1 as a Therapeutic Strategy for Multiple Mechanisms of EGFR Inhibitor Resistance in EGFR Mutant Non-Small-Cell Lung Cancer. Cancers (Basel). 2021;13: pubmed publisher
  35. Cho J, Lee J, Kim H, Lee H, Fang Z, Kwon H, et al. Ethyl Acetate Fraction of Amomum villosum var. xanthioides Attenuates Hepatic Endoplasmic Reticulum Stress-Induced Non-Alcoholic Steatohepatitis via Improvement of Antioxidant Capacities. Antioxidants (Basel). 2021;10: pubmed publisher
  36. Zou S, Gao Y, Zhang S. lncRNA HCP5 acts as a ceRNA to regulate EZH2 by sponging miR‑138‑5p in cutaneous squamous cell carcinoma. Int J Oncol. 2021;59: pubmed publisher
  37. Li S, Jin H, Sun G, Zhang C, Wang J, Xu H, et al. Dietary Inorganic Nitrate Protects Hepatic Ischemia-Reperfusion Injury Through NRF2-Mediated Antioxidative Stress. Front Pharmacol. 2021;12:634115 pubmed publisher
  38. Bai Y, Pei W, Zhang X, Zheng H, Hua C, Min J, et al. ApoM is an important potential protective factor in the pathogenesis of primary liver cancer. J Cancer. 2021;12:4661-4671 pubmed publisher
  39. Hu F, Song D, Yan Y, Huang C, Shen C, Lan J, et al. IL-6 regulates autophagy and chemotherapy resistance by promoting BECN1 phosphorylation. Nat Commun. 2021;12:3651 pubmed publisher
  40. Ma X, Zhao T, Yan H, Guo K, Liu Z, Wei L, et al. Fatostatin reverses progesterone resistance by inhibiting the SREBP1-NF-κB pathway in endometrial carcinoma. Cell Death Dis. 2021;12:544 pubmed publisher
  41. Wang H, Xiong W, Hang S, Wang Y, Zhang S, Liu S. Depletion of SENP1-mediated PPARγ SUMOylation exaggerates intermittent hypoxia-induced cognitive decline by aggravating microglia-mediated neuroinflammation. Aging (Albany NY). 2021;13:15240-15254 pubmed publisher
  42. Hong H, Jin Z, Qian T, Xu X, Zhu X, Fei Q, et al. Falcarindiol Enhances Cisplatin Chemosensitivity of Hepatocellular Carcinoma via Down-Regulating the STAT3-Modulated PTTG1 Pathway. Front Pharmacol. 2021;12:656697 pubmed publisher
  43. Li Q, Liu M, Sun Y, Jin T, Zhu P, Wan X, et al. SLC6A8-mediated intracellular creatine accumulation enhances hypoxic breast cancer cell survival via ameliorating oxidative stress. J Exp Clin Cancer Res. 2021;40:168 pubmed publisher
  44. Yu F, Ma R, Liu C, Zhang L, Feng K, Wang M, et al. SQSTM1/p62 Promotes Cell Growth and Triggers Autophagy in Papillary Thyroid Cancer by Regulating the AKT/AMPK/mTOR Signaling Pathway. Front Oncol. 2021;11:638701 pubmed publisher
  45. Loureiro J, Raimundo L, Calheiros J, Carvalho C, Barcherini V, Lima N, et al. Targeting p53 for Melanoma Treatment: Counteracting Tumour Proliferation, Dissemination and Therapeutic Resistance. Cancers (Basel). 2021;13: pubmed publisher
  46. Park J, Kam T, Lee S, Park H, Oh Y, Kwon S, et al. Blocking microglial activation of reactive astrocytes is neuroprotective in models of Alzheimer's disease. Acta Neuropathol Commun. 2021;9:78 pubmed publisher
  47. Zhou H, Li G, Wang Y, Jiang R, Li Y, Wang H, et al. Microbial Metabolite Sodium Butyrate Attenuates Cartilage Degradation by Restoring Impaired Autophagy and Autophagic Flux in Osteoarthritis Development. Front Pharmacol. 2021;12:659597 pubmed publisher
  48. Guo J, Zhu H, Li Q, Dong J, Xiong W, Yu K. SPRY4 suppresses proliferation and induces apoptosis of colorectal cancer cells by repressing oncogene EZH2. Aging (Albany NY). 2021;13:11665-11677 pubmed publisher
  49. Tian F, Zhang Y. Overexpression of SERCA2a Alleviates Cardiac Microvascular Ischemic Injury by Suppressing Mfn2-Mediated ER/Mitochondrial Calcium Tethering. Front Cell Dev Biol. 2021;9:636553 pubmed publisher
  50. Zhou F, Zou X, Zhang J, Wang Z, Yang Y, Wang D. Jian-Pi-Yi-Shen Formula Ameliorates Oxidative Stress, Inflammation, and Apoptosis by Activating the Nrf2 Signaling in 5/6 Nephrectomized Rats. Front Pharmacol. 2021;12:630210 pubmed publisher
  51. Cao X, Ma Q, Wang B, Qian Q, Liu N, Liu T, et al. Silencing long non-coding RNA MIAT ameliorates myocardial dysfunction induced by myocardial infarction via MIAT/miR-10a-5p/EGR2 axis. Aging (Albany NY). 2021;13:11188-11206 pubmed publisher
  52. Gao S, Gao L, Wang S, Shi X, Yue C, Wei S, et al. ATF3 Suppresses Growth and Metastasis of Clear Cell Renal Cell Carcinoma by Deactivating EGFR/AKT/GSK3β/β-Catenin Signaling Pathway. Front Cell Dev Biol. 2021;9:618987 pubmed publisher
  53. Nishad R, Mukhi D, Singh A, Motrapu M, Chintala K, Tammineni P, et al. Growth hormone induces mitotic catastrophe of glomerular podocytes and contributes to proteinuria. Cell Death Dis. 2021;12:342 pubmed publisher
  54. Liu X, Zhang H, Zhou P, Yu Y, Zhang H, Chen L, et al. CREB1 acts via the miR‑922/ARID2 axis to enhance malignant behavior of liver cancer cells. Oncol Rep. 2021;45: pubmed publisher
  55. Yin S, Li L, Tao Y, Yu J, Wei S, Liu M, et al. The Inhibitory Effect of Artesunate on Excessive Endoplasmic Reticulum Stress Alleviates Experimental Colitis in Mice. Front Pharmacol. 2021;12:629798 pubmed publisher
  56. Kim D, Park J, Choi H, Kim C, Bae E, Ma S, et al. The critical role of FXR is associated with the regulation of autophagy and apoptosis in the progression of AKI to CKD. Cell Death Dis. 2021;12:320 pubmed publisher
  57. Jin X, Zhu L, Xiao S, Cui Z, Tang J, Yu J, et al. MST1 inhibits the progression of breast cancer by regulating the Hippo signaling pathway and may serve as a prognostic biomarker. Mol Med Rep. 2021;23: pubmed publisher
  58. Chen W, Wu C, Chen Y, Guo Y, Qiu L, Liu Z, et al. Downregulation of ceramide synthase 1 promotes oral cancer through endoplasmic reticulum stress. Int J Oral Sci. 2021;13:10 pubmed publisher
  59. Sewastianik T, Straubhaar J, Zhao J, Samur M, Adler K, Tanton H, et al. miR-15a/16-1 deletion in activated B cells promotes plasma cell and mature B-cell neoplasms. Blood. 2021;137:1905-1919 pubmed publisher
  60. An J, Yang J, Yao Y, Lu K, Zhao Z, Yu M, et al. Sirtuin 6 regulates the proliferation and survival of clear cell renal cell carcinoma cells via B-cell lymphoma 2. Oncol Lett. 2021;21:293 pubmed publisher
  61. Jiang X, Shao M, Liu X, Liu X, Zhang X, Wang Y, et al. Reversible Treatment of Pressure Overload-Induced Left Ventricular Hypertrophy through Drd5 Nucleic Acid Delivery Mediated by Functional Polyaminoglycoside. Adv Sci (Weinh). 2021;8:2003706 pubmed publisher
  62. Xu J, Ma L, Fu P. Eriocitrin attenuates ischemia reperfusion-induced oxidative stress and inflammation in rats with acute kidney injury by regulating the dual-specificity phosphatase 14 (DUSP14)-mediated Nrf2 and nuclear factor-κB (NF-κB) pathways. Ann Transl Med. 2021;9:350 pubmed publisher
  63. Shao N, Cheng J, Huang H, Gong X, Lu Y, Idris M, et al. GASC1 promotes hepatocellular carcinoma progression by inhibiting the degradation of ROCK2. Cell Death Dis. 2021;12:253 pubmed publisher
  64. Sripada A, Sirohi K, Michalec L, Guo L, McKay J, Yadav S, et al. Sprouty2 positively regulates T cell function and airway inflammation through regulation of CSK and LCK kinases. PLoS Biol. 2021;19:e3001063 pubmed publisher
  65. Wu N, Du X, Peng Z, Zhang Z, Cui L, Li D, et al. Silencing of peroxiredoxin 1 expression ameliorates ulcerative colitis in a rat model. J Int Med Res. 2021;49:300060520986313 pubmed publisher
  66. Luo Y, Niu G, Yi H, Li Q, Wu Z, Wang J, et al. Nanomedicine promotes ferroptosis to inhibit tumour proliferation in vivo. Redox Biol. 2021;42:101908 pubmed publisher
  67. Kitamura Y, Kanaya N, Moleirinho S, Du W, Reinshagen C, Attia N, et al. Anti-EGFR VHH-armed death receptor ligand-engineered allogeneic stem cells have therapeutic efficacy in diverse brain metastatic breast cancers. Sci Adv. 2021;7: pubmed publisher
  68. Cheng Y, Liu M, Tang H, Chen B, Yang G, Zhao W, et al. iTRAQ-Based Quantitative Proteomics Indicated Nrf2/OPTN-Mediated Mitophagy Inhibits NLRP3 Inflammasome Activation after Intracerebral Hemorrhage. Oxid Med Cell Longev. 2021;2021:6630281 pubmed publisher
  69. Diao L, Zhang Q. Transfer of lncRNA UCA1 by hUCMSCs-derived exosomes protects against hypoxia/reoxygenation injury through impairing miR-143-targeted degradation of Bcl-2. Aging (Albany NY). 2021;13:5967-5985 pubmed publisher
  70. Chen F, Xu B, Li J, Yang X, Gu J, Yao X, et al. Hypoxic tumour cell-derived exosomal miR-340-5p promotes radioresistance of oesophageal squamous cell carcinoma via KLF10. J Exp Clin Cancer Res. 2021;40:38 pubmed publisher
  71. Li S, Zhu Z, Xue M, Pan X, Tong G, Yi X, et al. The protective effects of fibroblast growth factor 10 against hepatic ischemia-reperfusion injury in mice. Redox Biol. 2021;40:101859 pubmed publisher
  72. Zhang K, Wang D, Cai H, Cao M, Zhang Y, Zhuang P, et al. IL‑6 plays a crucial role in epithelial‑mesenchymal transition and pro‑metastasis induced by sorafenib in liver cancer. Oncol Rep. 2021;45:1105-1117 pubmed publisher
  73. Deng X, He Y, Miao X, Yu B. ATF4-mediated histone deacetylase HDAC1 promotes the progression of acute pancreatitis. Cell Death Dis. 2021;12:5 pubmed publisher
  74. Xiao L, Sharma V, Toulabi L, Yang X, Lee C, Abebe D, et al. Neurotrophic factor-α1, a novel tropin is critical for the prevention of stress-induced hippocampal CA3 cell death and cognitive dysfunction in mice: comparison to BDNF. Transl Psychiatry. 2021;11:24 pubmed publisher
  75. Ao H, Li H, Zhao X, Liu B, Lu L. TXNIP positively regulates the autophagy and apoptosis in the rat müller cell of diabetic retinopathy. Life Sci. 2021;267:118988 pubmed publisher
  76. Wen Y, Hou Y, Yi X, Sun S, Guo J, He X, et al. EZH2 activates CHK1 signaling to promote ovarian cancer chemoresistance by maintaining the properties of cancer stem cells. Theranostics. 2021;11:1795-1813 pubmed publisher
  77. Li Z, Meng Y, Liu C, Liu H, Cao W, Tong C, et al. Kcnh2 mediates FAK/AKT-FOXO3A pathway to attenuate sepsis-induced cardiac dysfunction. Cell Prolif. 2021;54:e12962 pubmed publisher
  78. Omairi I, Kobeissy F, Nasreddine S. Anti-Oxidant, Anti-Hemolytic Effects of Crataegus aronia Leaves and Its Anti- Proliferative Effect Enhance Cisplatin Cytotoxicity in A549 Human Lung Cancer Cell Line. Asian Pac J Cancer Prev. 2020;21:2993-3003 pubmed publisher
  79. Tang S, Wu W, Wan H, Wu X, Chen H. Knockdown of NHP2 inhibits hepatitis B virus X protein-induced hepatocarcinogenesis via repressing TERT expression and disrupting the stability of telomerase complex. Aging (Albany NY). 2020;12:19365-19374 pubmed publisher
  80. Wang T, Gao X, Zhou K, Jiang T, Gao S, Liu P, et al. Role of ARID1A in epithelial‑mesenchymal transition in breast cancer and its effect on cell sensitivity to 5‑FU. Int J Mol Med. 2020;46:1683-1694 pubmed publisher
  81. Chen J, Liu X, Ke K, Zou J, Gao Z, Habuchi T, et al. LINC00992 contributes to the oncogenic phenotypes in prostate cancer via targeting miR-3935 and augmenting GOLM1 expression. BMC Cancer. 2020;20:749 pubmed publisher
  82. Meng L, Teng X, Liu Y, Yang C, Wang S, Yuan W, et al. Vital Roles of Gremlin-1 in Pulmonary Arterial Hypertension Induced by Systemic-to-Pulmonary Shunts. J Am Heart Assoc. 2020;9:e016586 pubmed publisher
  83. Au C, Furness J, Britt K, Oshchepkova S, Ladumor H, Soo K, et al. Three-dimensional growth of breast cancer cells potentiates the anti-tumor effects of unacylated ghrelin and AZP-531. elife. 2020;9: pubmed publisher
  84. Gu J, Zhang Y, Wang X, Xiang J, Deng S, Wu D, et al. Matrine inhibits the growth of natural killer/T-cell lymphoma cells by modulating CaMKIIγ-c-Myc signaling pathway. BMC Complement Med Ther. 2020;20:214 pubmed publisher
  85. Mamriev D, Abbas R, Klingler F, Kagan J, Kfir N, Donald A, et al. A small-molecule ARTS mimetic promotes apoptosis through degradation of both XIAP and Bcl-2. Cell Death Dis. 2020;11:483 pubmed publisher
  86. Christgen M, Bartels S, van Luttikhuizen J, Bublitz J, Rieger L, Christgen H, et al. E-cadherin to P-cadherin switching in lobular breast cancer with tubular elements. Mod Pathol. 2020;33:2483-2498 pubmed publisher
  87. Yin S, Song M, Zhao R, Liu X, Kang W, Lee J, et al. Xanthohumol Inhibits the Growth of Keratin 18-Overexpressed Esophageal Squamous Cell Carcinoma in vitro and in vivo. Front Cell Dev Biol. 2020;8:366 pubmed publisher
  88. Wang X, Tong J, Han X, Qi X, Zhang J, Wu E, et al. Acute effects of human protein S administration after traumatic brain injury in mice. Neural Regen Res. 2020;15:2073-2081 pubmed publisher
  89. Vu M, Kassouf N, Ofili R, Lund T, Bell C, Appiah S. Doxorubicin selectively induces apoptosis through the inhibition of a novel isoform of Bcl‑2 in acute myeloid leukaemia MOLM‑13 cells with reduced Beclin 1 expression. Int J Oncol. 2020;57:113-121 pubmed publisher
  90. Simula L, Corrado M, Accordi B, Di Rita A, Nazio F, Antonucci Y, et al. JNK1 and ERK1/2 modulate lymphocyte homeostasis via BIM and DRP1 upon AICD induction. Cell Death Differ. 2020;: pubmed publisher
  91. Chen S, Zhang H, Li J, Shi J, Tang H, Zhang Y, et al. Tripartite Motif-Containing 27 Attenuates Liver Ischemia/Reperfusion Injury by Suppressing Transforming Growth Factor β-Activated Kinase 1 (TAK1) by TAK1 Binding Protein 2/3 Degradation. Hepatology. 2021;73:738-758 pubmed publisher
  92. Wu X, Gardashova G, Lan L, Han S, Zhong C, Marquez R, et al. Targeting the interaction between RNA-binding protein HuR and FOXQ1 suppresses breast cancer invasion and metastasis. Commun Biol. 2020;3:193 pubmed publisher
  93. Zhao J, Li G, Zhao X, Lin X, Gao Y, Raimundo N, et al. Down-regulation of AMPK signaling pathway rescues hearing loss in TFB1 transgenic mice and delays age-related hearing loss. Aging (Albany NY). 2020;12:5590-5611 pubmed publisher
  94. Han B, Meng X, Wu P, Li Z, Li S, Zhang Y, et al. ATRX/EZH2 complex epigenetically regulates FADD/PARP1 axis, contributing to TMZ resistance in glioma. Theranostics. 2020;10:3351-3365 pubmed publisher
  95. Feng C, Zhang H, Zeng A, Bai M, Wang X. Tumor-Suppressive MicroRNA-216b Binds to TPX2, Activating the p53 Signaling in Human Cutaneous Squamous Cell Carcinoma. Mol Ther Nucleic Acids. 2020;20:186-195 pubmed publisher
  96. Zhao J, He L, Yin L. lncRNA NEAT1 Binds to MiR-339-5p to Increase HOXA1 and Alleviate Ischemic Brain Damage in Neonatal Mice. Mol Ther Nucleic Acids. 2020;20:117-127 pubmed publisher
  97. Bajpai R, Sharma A, Achreja A, Edgar C, Wei C, Siddiqa A, et al. Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myeloma. Nat Commun. 2020;11:1228 pubmed publisher
  98. Gao Y, Dai X, Li Y, Li G, Lin X, Ai C, et al. Role of Parkin-mediated mitophagy in the protective effect of polydatin in sepsis-induced acute kidney injury. J Transl Med. 2020;18:114 pubmed publisher
  99. Xiang Q, Kang L, Wang J, Liao Z, Song Y, Zhao K, et al. CircRNA-CIDN mitigated compression loading-induced damage in human nucleus pulposus cells via miR-34a-5p/SIRT1 axis. EBioMedicine. 2020;53:102679 pubmed publisher
  100. Chen Y, Liu Z, Wang Y, Zhuang J, Peng Y, Mo X, et al. FKBP51 induces p53-dependent apoptosis and enhances drug sensitivity of human non-small-cell lung cancer cells. Exp Ther Med. 2020;19:2236-2242 pubmed publisher
  101. Castro Gonzalez S, Shi Y, Colomer Lluch M, Song Y, Mowery K, Almodovar S, et al. HIV-1 Nef counteracts autophagy restriction by enhancing the association between BECN1 and its inhibitor BCL2 in a PRKN-dependent manner. Autophagy. 2020;:1-25 pubmed publisher
  102. Wan G, An Y, Tao J, Wang Y, Zhou Q, Yang R, et al. MicroRNA-129-5p alleviates spinal cord injury in mice via suppressing the apoptosis and inflammatory response through HMGB1/TLR4/NF-κB pathway. Biosci Rep. 2020;40: pubmed publisher
  103. Chandrasekaran B, Dahiya N, Tyagi A, Kolluru V, Saran U, Baby B, et al. Chronic exposure to cadmium induces a malignant transformation of benign prostate epithelial cells. Oncogenesis. 2020;9:23 pubmed publisher
  104. Guttà C, Rahman A, Aura C, Dynoodt P, Charles E, Hirschenhahn E, et al. Low expression of pro-apoptotic proteins Bax, Bak and Smac indicates prolonged progression-free survival in chemotherapy-treated metastatic melanoma. Cell Death Dis. 2020;11:124 pubmed publisher
  105. Huang S, Zhang C, Sun C, Hou Y, Zhang Y, Tam N, et al. Obg-like ATPase 1 (OLA1) overexpression predicts poor prognosis and promotes tumor progression by regulating P21/CDK2 in hepatocellular carcinoma. Aging (Albany NY). 2020;12:3025-3041 pubmed publisher
  106. Zhuang K, Zuo Y, Sherchan P, Wang J, Yan X, Liu F. Hydrogen Inhalation Attenuates Oxidative Stress Related Endothelial Cells Injury After Subarachnoid Hemorrhage in Rats. Front Neurosci. 2019;13:1441 pubmed publisher
  107. Xiang S, Chen K, Xu L, Wang T, Guo C. Bergenin Exerts Hepatoprotective Effects by Inhibiting the Release of Inflammatory Factors, Apoptosis and Autophagy via the PPAR-γ Pathway. Drug Des Devel Ther. 2020;14:129-143 pubmed publisher
  108. Hou K, Li G, Zhao J, Xu B, Zhang Y, Yu J, et al. Bone mesenchymal stem cell-derived exosomal microRNA-29b-3p prevents hypoxic-ischemic injury in rat brain by activating the PTEN-mediated Akt signaling pathway. J Neuroinflammation. 2020;17:46 pubmed publisher
  109. Cui J, Duan J, Chu J, Guo C, Xi M, Li Y, et al. Chikusetsu saponin IVa protects pancreatic β cell against intermittent high glucose-induced injury by activating Wnt/β-catenin/TCF7L2 pathway. Aging (Albany NY). 2020;12:1591-1609 pubmed publisher
  110. Li C, Liu W, Li X, Zhang Z, Qi H, Liu S, et al. The novel GLP-1/GIP analogue DA5-CH reduces tau phosphorylation and normalizes theta rhythm in the icv. STZ rat model of AD. Brain Behav. 2020;10:e01505 pubmed publisher
  111. Molagoda I, Lee K, Choi Y, Kim G. Anthocyanins from Hibiscus syriacus L. Inhibit Oxidative Stress-Mediated Apoptosis by Activating the Nrf2/HO-1 Signaling Pathway. Antioxidants (Basel). 2020;9: pubmed publisher
  112. Tang X, Yan K, Wang Y, Wang Y, Chen H, Xu J, et al. Activation of PPAR-β/δ Attenuates Brain Injury by Suppressing Inflammation and Apoptosis in a Collagenase-Induced Intracerebral Hemorrhage Mouse Model. Neurochem Res. 2020;45:837-850 pubmed publisher
  113. Lohard S, Bourgeois N, Maillet L, Gautier F, Fétiveau A, Lasla H, et al. STING-dependent paracriny shapes apoptotic priming of breast tumors in response to anti-mitotic treatment. Nat Commun. 2020;11:259 pubmed publisher
  114. Sheng L, Zhang J, Li L, Xie X, Wen X, Cheng K. Design, Synthesis, and Evaluation of Novel 2-Methoxyestradiol Derivatives as Apoptotic Inducers Through an Intrinsic Apoptosis Pathway. Biomolecules. 2020;10: pubmed publisher
  115. Chen X, Zhao Y, Xu J, Bao J, Zhao J, Chen J, et al. The Nephroprotective Effect of TNF Receptor-Associated Factor 6 (TRAF6) Blockade on LPS-Induced Acute Renal Injury Through the Inhibition if Inflammation and Oxidative Stress. Med Sci Monit. 2020;26:e919698 pubmed publisher
  116. Zhou Z, Zhou Q, Wu X, Xu S, Hu X, Tao X, et al. VCAM-1 secreted from cancer-associated fibroblasts enhances the growth and invasion of lung cancer cells through AKT and MAPK signaling. Cancer Lett. 2020;473:62-73 pubmed publisher
  117. Tang L, Li J, Fu W, Wu W, Xu J. Suppression of FADS1 induces ROS generation, cell cycle arrest, and apoptosis in melanocytes: implications for vitiligo. Aging (Albany NY). 2019;11:11829-11843 pubmed publisher
  118. Hu Y, Ma Y, Liu J, Cai Y, Zhang M, Fang X. LINC01128 expedites cervical cancer progression by regulating miR-383-5p/SFN axis. BMC Cancer. 2019;19:1157 pubmed publisher
  119. Moya I, Castaldo S, Van den Mooter L, Soheily S, Sansores Garcia L, Jacobs J, et al. Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in mice. Science. 2019;366:1029-1034 pubmed publisher
  120. Leone R, Zhao L, Englert J, Sun I, Oh M, Sun I, et al. Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion. Science. 2019;366:1013-1021 pubmed publisher
  121. Jiao W, Ji J, Xu W, Bu W, Zheng Y, Ma A, et al. Distinct downstream signaling and the roles of VEGF and PlGF in high glucose-mediated injuries of human retinal endothelial cells in culture. Sci Rep. 2019;9:15339 pubmed publisher
  122. Li J, Liu Z, Wang L, Xu H, Wang Y. Thousand and one kinase 1 protects MCAO-induced cerebral ischemic stroke in rats by decreasing apoptosis and pro-inflammatory factors. Biosci Rep. 2019;39: pubmed publisher
  123. Tian M, Gong W, Guo J. Long non-coding RNA SNHG1 indicates poor prognosis and facilitates disease progression in acute myeloid leukemia. Biol Open. 2019;8: pubmed publisher
  124. Garc a Arroyo F, Monroy S nchez F, Mu oz Jim nez I, Gonzaga G, Andr s Hernando A, Zazueta C, et al. Allopurinol Prevents the Lipogenic Response Induced by an Acute Oral Fructose Challenge in Short-Term Fructose Fed Rats. Biomolecules. 2019;9: pubmed publisher
  125. Veschi V, Mangiapane L, Nicotra A, Di Franco S, Scavo E, Apuzzo T, et al. Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant. Oncogene. 2020;39:987-1003 pubmed publisher
  126. Liu J, Yao L, Zhang M, Jiang J, Yang M, Wang Y. Downregulation of LncRNA-XIST inhibited development of non-small cell lung cancer by activating miR-335/SOD2/ROS signal pathway mediated pyroptotic cell death. Aging (Albany NY). 2019;11:7830-7846 pubmed publisher
  127. Shan L, Liu W, Zhan Y. Sulfated polysaccharide of Sepiella maindroni ink targets Akt and overcomes resistance to the FGFR inhibitor AZD4547 in bladder cancer. Aging (Albany NY). 2019;11:7780-7795 pubmed publisher
  128. Chollat Namy M, Ben Safta Saadoun T, Haferssas D, Meurice G, Chouaib S, Thiery J. The pharmalogical reactivation of p53 function improves breast tumor cell lysis by granzyme B and NK cells through induction of autophagy. Cell Death Dis. 2019;10:695 pubmed publisher
  129. Barbero G, Castro M, Villanueva M, Quezada M, Fernández N, Demorrow S, et al. An Autocrine Wnt5a Loop Promotes NF-κB Pathway Activation and Cytokine/Chemokine Secretion in Melanoma. Cells. 2019;8: pubmed publisher
  130. Yan P, Su Z, Zhang Z, Gao T. LncRNA NEAT1 enhances the resistance of anaplastic thyroid carcinoma cells to cisplatin by sponging miR‑9‑5p and regulating SPAG9 expression. Int J Oncol. 2019;55:988-1002 pubmed publisher
  131. Thangaraj K, Balasubramanian B, Park S, Natesan K, Liu W, Manju V. Orientin Induces G0/G1 Cell Cycle Arrest and Mitochondria Mediated Intrinsic Apoptosis in Human Colorectal Carcinoma HT29 Cells. Biomolecules. 2019;9: pubmed publisher
  132. Gao L, Wang Z, Lu D, Huang J, Liu J, Hong L. Paeonol induces cytoprotective autophagy via blocking the Akt/mTOR pathway in ovarian cancer cells. Cell Death Dis. 2019;10:609 pubmed publisher
  133. Wang X, Peng P, Pan Z, Fang Z, Lu W, Liu X. Psoralen inhibits malignant proliferation and induces apoptosis through triggering endoplasmic reticulum stress in human SMMC7721 hepatoma cells. Biol Res. 2019;52:34 pubmed publisher
  134. Kaur S, Nag A, Gangenahalli G, Sharma K. Peroxisome Proliferator Activated Receptor Gamma Sensitizes Non-small Cell Lung Carcinoma to Gamma Irradiation Induced Apoptosis. Front Genet. 2019;10:554 pubmed publisher
  135. Zhang L, Feng Q, Wang Z, Liu P, Cui S. Progesterone receptor antagonist provides palliative effects for uterine leiomyoma through a Bcl-2/Beclin1-dependent mechanism. Biosci Rep. 2019;39: pubmed publisher
  136. Roy N, Monisha J, Padmavathi G, Lalhruaitluanga H, Kumar N, Singh A, et al. Isoform-Specific Role of Akt in Oral Squamous Cell Carcinoma. Biomolecules. 2019;9: pubmed publisher
  137. Liu F, Fan D, Yang Z, Tang N, Guo Z, Ma S, et al. TLR9 is essential for HMGB1-mediated post-myocardial infarction tissue repair through affecting apoptosis, cardiac healing, and angiogenesis. Cell Death Dis. 2019;10:480 pubmed publisher
  138. Hou N, He X, Yang Y, Fu J, Zhang W, Guo Z, et al. TRPV1 Induced Apoptosis of Colorectal Cancer Cells by Activating Calcineurin-NFAT2-p53 Signaling Pathway. Biomed Res Int. 2019;2019:6712536 pubmed publisher
  139. Donadoni M, Cicalese S, Sarkar D, Chang S, Sariyer I. Alcohol exposure alters pre-mRNA splicing of antiapoptotic Mcl-1L isoform and induces apoptosis in neural progenitors and immature neurons. Cell Death Dis. 2019;10:447 pubmed publisher
  140. Wu K, Zou J, Lin C, Jie Z. MicroRNA-140-5p inhibits cell proliferation, migration and promotes cell apoptosis in gastric cancer through the negative regulation of THY1-mediated Notch signaling. Biosci Rep. 2019;: pubmed publisher
  141. Sul O, Rajasekaran M, Park H, Suh J, Choi H. MicroRNA-29b Enhances Osteoclast Survival by Targeting BCL-2-Modifying Factor after Lipopolysaccharide Stimulation. Oxid Med Cell Longev. 2019;2019:6018180 pubmed publisher
  142. Pan C, Jin L, Wang X, Li Y, Chun J, Boese A, et al. Inositol-triphosphate 3-kinase B confers cisplatin resistance by regulating NOX4-dependent redox balance. J Clin Invest. 2019;129:2431-2445 pubmed publisher
  143. Zhao J, Sun H, Zhang J, Wang M, Du X, Zhang J. Long non-coding RNA ANRIL down-regulates microRNA-7 to protect human trabecular meshwork cells in an experimental model for glaucoma. Eur Rev Med Pharmacol Sci. 2019;23:3173-3182 pubmed publisher
  144. Zhang C, Zhu Q, Gu J, Chen S, Li Q, Ying L. Down-regulation of CCNE1 expression suppresses cell proliferation and sensitizes gastric carcinoma cells to Cisplatin. Biosci Rep. 2019;39: pubmed publisher
  145. He M, Chaurushiya M, Webster J, Kummerfeld S, Reja R, Chaudhuri S, et al. Intrinsic apoptosis shapes the tumor spectrum linked to inactivation of the deubiquitinase BAP1. Science. 2019;364:283-285 pubmed publisher
  146. Wagner J, Rapsomaniki M, Chevrier S, Anzeneder T, Langwieder C, Dykgers A, et al. A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer. Cell. 2019;177:1330-1345.e18 pubmed publisher
  147. You Y, Qin Z, Zhang H, Yuan Z, Yu X. MicroRNA-153 promotes brain-derived neurotrophic factor and hippocampal neuron proliferation to alleviate autism symptoms through inhibition of JAK-STAT pathway by LEPR. Biosci Rep. 2019;: pubmed publisher
  148. Rong X, Rao J, Li D, Jing Q, Lu Y, Ji Y. TRIM69 inhibits cataractogenesis by negatively regulating p53. Redox Biol. 2019;22:101157 pubmed publisher
  149. Liu Y, Wang X, Deng L, Ping L, Shi Y, Zheng W, et al. ITK inhibition induced in vitro and in vivo anti-tumor activity through downregulating TCR signaling pathway in malignant T cell lymphoma. Cancer Cell Int. 2019;19:32 pubmed publisher
  150. Thompson P, Shah A, Ntranos V, Van Gool F, Atkinson M, Bhushan A. Targeted Elimination of Senescent Beta Cells Prevents Type 1 Diabetes. Cell Metab. 2019;29:1045-1060.e10 pubmed publisher
  151. Dong H, Ye X, Zhong L, Xu J, Qiu J, Wang J, et al. Role of FOXO3 Activated by HIV-1 Tat in HIV-Associated Neurocognitive Disorder Neuronal Apoptosis. Front Neurosci. 2019;13:44 pubmed publisher
  152. Li J, Liu X, Chen H, Sun Z, Chen H, Wang L, et al. Multi-targeting chemoprevention of Chinese herb formula Yanghe Huayan decoction on experimentally induced mammary tumorigenesis. BMC Complement Altern Med. 2019;19:48 pubmed publisher
  153. Wang Y, Qi Z, Zhou M, Yang W, Hu R, Li G, et al. Stanniocalcin‑1 promotes cell proliferation, chemoresistance and metastasis in hypoxic gastric cancer cells via Bcl‑2. Oncol Rep. 2019;41:1998-2008 pubmed publisher
  154. Su W, Wang Y, Wang F, Zhang B, Zhang H, Shen Y, et al. Circular RNA hsa_circ_0007059 indicates prognosis and influences malignant behavior via AKT/mTOR in oral squamous cell carcinoma. J Cell Physiol. 2019;: pubmed publisher
  155. Li Z, Mbah N, Overmeyer J, Sarver J, George S, Trabbic C, et al. The JNK signaling pathway plays a key role in methuosis (non-apoptotic cell death) induced by MOMIPP in glioblastoma. BMC Cancer. 2019;19:77 pubmed publisher
  156. Huang X, Zhao Y, Pu Q, Liu G, Peng Y, Wang F, et al. Intracellular selection of trans-cleaving hammerhead ribozymes. Nucleic Acids Res. 2019;47:2514-2522 pubmed publisher
  157. Wysokińska E, Cichos J, Kowalczyk A, Karbowiak M, Strzadała L, Bednarkiewicz A, et al. Toxicity Mechanism of Low Doses of NaGdF₄:Yb3+,Er3+ Upconverting Nanoparticles in Activated Macrophage Cell Lines. Biomolecules. 2019;9: pubmed publisher
  158. Zhang J, Sheng J, Dong L, Xu Y, Yu L, Liu Y, et al. Cardiomyocyte-specific loss of RMP causes myocardial dysfunction and heart failure. Cardiovasc Res. 2018;: pubmed publisher
  159. LeBlanc L, Lee B, Yu A, Kim M, Kambhampati A, Dupont S, et al. Yap1 safeguards mouse embryonic stem cells from excessive apoptosis during differentiation. elife. 2018;7: pubmed publisher
  160. Smith M, Tahir S. Quantification of BCL-2 Family Members by Flow Cytometry. Methods Mol Biol. 2019;1877:163-172 pubmed publisher
  161. Liang C, Ma Y, Yong L, Yang C, Wang P, Liu X, et al. Y-box binding protein-1 promotes tumorigenesis and progression via the epidermal growth factor receptor/AKT pathway in spinal chordoma. Cancer Sci. 2019;110:166-179 pubmed publisher
  162. Li H, Feng J, Zhang Y, Feng J, Wang Q, Zhao S, et al. Mst1 deletion attenuates renal ischaemia-reperfusion injury: The role of microtubule cytoskeleton dynamics, mitochondrial fission and the GSK3β-p53 signalling pathway. Redox Biol. 2019;20:261-274 pubmed publisher
  163. De R, Sarkar S, Mazumder S, Debsharma S, Siddiqui A, Saha S, et al. Macrophage migration inhibitory factor regulates mitochondrial dynamics and cell growth of human cancer cell lines through CD74-NF-κB signaling. J Biol Chem. 2018;293:19740-19760 pubmed publisher
  164. Wu R, Yang H, Wan J, Deng X, Chen L, Hao S, et al. Knockdown of the Hippo transducer YAP reduces proliferation and promotes apoptosis in the Jurkat leukemia cell. Mol Med Rep. 2018;18:5379-5388 pubmed publisher
  165. Li W, Yue F, Dai Y, Shi B, Xu G, Jiang X, et al. Suppressor of hepatocellular carcinoma RASSF1A activates autophagy initiation and maturation. Cell Death Differ. 2018;: pubmed publisher
  166. Zhao H, Pan W, Chen L, Luo Y, Xu R. Nur77 promotes cerebral ischemia-reperfusion injury via activating INF2-mediated mitochondrial fragmentation. J Mol Histol. 2018;49:599-613 pubmed publisher
  167. Park J, Lee J, Sheu K, Wang L, Balanis N, Nguyen K, et al. Reprogramming normal human epithelial tissues to a common, lethal neuroendocrine cancer lineage. Science. 2018;362:91-95 pubmed publisher
  168. Yue D, Sun X. Idelalisib promotes Bim-dependent apoptosis through AKT/FoxO3a in hepatocellular carcinoma. Cell Death Dis. 2018;9:935 pubmed publisher
  169. Greenhough A, Bagley C, Heesom K, Gurevich D, Gay D, Bond M, et al. Cancer cell adaptation to hypoxia involves a HIF-GPRC5A-YAP axis. EMBO Mol Med. 2018;10: pubmed publisher
  170. Pearce M, Gamble J, Kopparapu P, O Donnell E, Mueller M, Jang H, et al. Induction of apoptosis and suppression of tumor growth by Nur77-derived Bcl-2 converting peptide in chemoresistant lung cancer cells. Oncotarget. 2018;9:26072-26085 pubmed publisher
  171. LI Y, Du L, Aldana Masangkay G, Wang X, Urak R, Forman S, et al. Regulation of miR-34b/c-targeted gene expression program by SUMOylation. Nucleic Acids Res. 2018;: pubmed publisher
  172. Li R, Sahu S, Schachner M. Phenelzine, a small organic compound mimicking the functions of cell adhesion molecule L1, promotes functional recovery after mouse spinal cord injury. Restor Neurol Neurosci. 2018;36:469-483 pubmed publisher
  173. Yang M, Li C, Zhu S, Cao L, Kroemer G, Zeh H, et al. TFAM is a novel mediator of immunogenic cancer cell death. Oncoimmunology. 2018;7:e1431086 pubmed publisher
  174. Pan B, Wu L, Pan L, Yang Y, Li H, Dai Y, et al. Up-regulation of microRNA-340 promotes osteosarcoma cell apoptosis while suppressing proliferation, migration, and invasion by inactivating the CTNNB1-mediated Notch signaling pathway. Biosci Rep. 2018;38: pubmed publisher
  175. Wang J, Wang F, Zhu J, Song M, An J, Li W. Transcriptome Profiling Reveals PHLDA1 as a Novel Molecular Marker for Ischemic Cardiomyopathy. J Mol Neurosci. 2018;65:102-109 pubmed publisher
  176. Han F, Xia X, Dou M, Wang Y, Xue W, Ding X, et al. Arctigenin: A two-edged sword in ischemia/reperfusion induced acute kidney injury. Biomed Pharmacother. 2018;103:1127-1136 pubmed publisher
  177. Xiao G, Chan L, Klemm L, Braas D, Chen Z, Geng H, et al. B-Cell-Specific Diversion of Glucose Carbon Utilization Reveals a Unique Vulnerability in B Cell Malignancies. Cell. 2018;173:470-484.e18 pubmed publisher
  178. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed publisher
  179. Yang R, Tao Z, Huang M, Zheng Y, Dai M, Zou Y, et al. Knockout of the placenta specific 8 gene radiosensitizes nasopharyngeal carcinoma cells by activating the PI3K/AKT/GSK3β pathway. Am J Transl Res. 2018;10:455-464 pubmed
  180. Hou Y, Lautrup S, Cordonnier S, Wang Y, Croteau D, Zavala E, et al. NAD+ supplementation normalizes key Alzheimer's features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency. Proc Natl Acad Sci U S A. 2018;115:E1876-E1885 pubmed publisher
  181. Tan X, Banerjee P, Liu X, Yu J, Gibbons D, Wu P, et al. The epithelial-to-mesenchymal transition activator ZEB1 initiates a prometastatic competing endogenous RNA network. J Clin Invest. 2018;128:1267-1282 pubmed publisher
  182. Bogenberger J, Whatcott C, Hansen N, Delman D, Shi C, Kim W, et al. Combined venetoclax and alvocidib in acute myeloid leukemia. Oncotarget. 2017;8:107206-107222 pubmed publisher
  183. Zhao X, Huang L, Xu W, Chen X, Shen Y, Zeng W, et al. Physapubescin B inhibits tumorgenesis and circumvents taxol resistance of ovarian cancer cells through STAT3 signaling. Oncotarget. 2017;8:70130-70141 pubmed publisher
  184. Xie Z, Enkhjargal B, Wu L, Zhou K, Sun C, Hu X, et al. Exendin-4 attenuates neuronal death via GLP-1R/PI3K/Akt pathway in early brain injury after subarachnoid hemorrhage in rats. Neuropharmacology. 2018;128:142-151 pubmed publisher
  185. Shimono J, Miyoshi H, Kamimura T, Eto T, Miyagishima T, Sasaki Y, et al. Clinicopathological features of primary splenic follicular lymphoma. Ann Hematol. 2017;96:2063-2070 pubmed publisher
  186. Zou Y, Qiu G, Jiang L, Cai Z, Sun W, Hu H, et al. Overexpression of ubiquitin specific proteases 44 promotes the malignancy of glioma by stabilizing tumor-promoter securin. Oncotarget. 2017;8:58231-58246 pubmed publisher
  187. Vu L, Pickering B, Cheng Y, Zaccara S, Nguyen D, Minuesa G, et al. The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells. Nat Med. 2017;23:1369-1376 pubmed publisher
  188. Yu J, Wu H, Liu Z, Zhu Q, Shan C, Zhang K. Advanced glycation end products induce the apoptosis of and inflammation in mouse podocytes through CXCL9-mediated JAK2/STAT3 pathway activation. Int J Mol Med. 2017;40:1185-1193 pubmed publisher
  189. Rocchi A, Yamamoto S, Ting T, Fan Y, SADLEIR K, Wang Y, et al. A Becn1 mutation mediates hyperactive autophagic sequestration of amyloid oligomers and improved cognition in Alzheimer's disease. PLoS Genet. 2017;13:e1006962 pubmed publisher
  190. Zhang Y, Chen P, Hong H, Wang L, Zhou Y, Lang Y. JNK pathway mediates curcumin-induced apoptosis and autophagy in osteosarcoma MG63 cells. Exp Ther Med. 2017;14:593-599 pubmed publisher
  191. Patel N, Garikapati K, Pandita R, Singh D, Pandita T, Bhadra U, et al. miR-15a/miR-16 down-regulates BMI1, impacting Ub-H2A mediated DNA repair and breast cancer cell sensitivity to doxorubicin. Sci Rep. 2017;7:4263 pubmed publisher
  192. Verdanet E, Dereure O, René C, Tempier A, Benammar Hafidi A, Gallo M, et al. Diagnostic value of STMN1, LMO2, HGAL, AID expression and 1p36 chromosomal abnormalities in primary cutaneous B cell lymphomas. Histopathology. 2017;71:648-660 pubmed publisher
  193. Angori S, Capanni C, Faulkner G, Bean C, Boriani G, Lattanzi G, et al. Emery-Dreifuss Muscular Dystrophy-Associated Mutant Forms of Lamin A Recruit the Stress Responsive Protein Ankrd2 into the Nucleus, Affecting the Cellular Response to Oxidative Stress. Cell Physiol Biochem. 2017;42:169-184 pubmed publisher
  194. Zhang Z, Huang A, Zhang A, Zhou C. HuR promotes breast cancer cell proliferation and survival via binding to CDK3 mRNA. Biomed Pharmacother. 2017;91:788-795 pubmed publisher
  195. Yue X, Zuo Y, Ke H, Luo J, Lou L, Qin W, et al. Identification of 4-arylidene curcumin analogues as novel proteasome inhibitors for potential anticancer agents targeting 19S regulatory particle associated deubiquitinase. Biochem Pharmacol. 2017;137:29-50 pubmed publisher
  196. Xie Y, Ma W, Meng J, Ren X. Knockdown of ZFPL1 results in increased autophagy and autophagy‑related cell death in NCI‑N87 and BGC‑823 human gastric carcinoma cell lines. Mol Med Rep. 2017;15:2633-2642 pubmed publisher
  197. Liu Y, Chen X, Li J. Resveratrol protects against oxidized low‑density lipoprotein‑induced human umbilical vein endothelial cell apoptosis via inhibition of mitochondrial‑derived oxidative stress. Mol Med Rep. 2017;15:2457-2464 pubmed publisher
  198. Lian W, Zhang L, Yang L, Chen W. AP-2α reverses vincristine-induced multidrug resistance of SGC7901 gastric cancer cells by inhibiting the Notch pathway. Apoptosis. 2017;22:933-941 pubmed publisher
  199. Lee T, Pelletier J. Dependence of p53-deficient cells on the DHX9 DExH-box helicase. Oncotarget. 2017;8:30908-30921 pubmed publisher
  200. Sun J, Zhang X, Sun Y, Tang Z, Guo D. Effects of Hylomecon vernalis ethanol extracts on cell cycle and apoptosis of colon cancer cells. Mol Med Rep. 2017;15:3485-3492 pubmed publisher
  201. Gao Y, Zhuang Z, Gao S, Li X, Zhang Z, Ye Z, et al. Tetrahydrocurcumin reduces oxidative stress-induced apoptosis via the mitochondrial apoptotic pathway by modulating autophagy in rats after traumatic brain injury. Am J Transl Res. 2017;9:887-899 pubmed
  202. Jelinek M, Kabelova A, Srámek J, Seitz J, Ojima I, Kovar J. Differing Mechanisms of Death Induction by Fluorinated Taxane SB-T-12854 in Breast Cancer Cells. Anticancer Res. 2017;37:1581-1590 pubmed
  203. Paterniti I, Campolo M, Siracusa R, Cordaro M, Di Paola R, Calabrese V, et al. Liver X receptors activation, through TO901317 binding, reduces neuroinflammation in Parkinson's disease. PLoS ONE. 2017;12:e0174470 pubmed publisher
  204. Ji X, Pan C, Li X, Gao Y, Xia L, Quan X, et al. Trametes robiniophila may induce apoptosis and inhibit MMPs expression in the human gastric carcinoma cell line MKN-45. Oncol Lett. 2017;13:841-846 pubmed publisher
  205. Yokoyama T, Kohn E, Brill E, Lee J. Apoptosis is augmented in high-grade serous ovarian cancer by the combined inhibition of Bcl-2/Bcl-xL and PARP. Int J Oncol. 2017;: pubmed publisher
  206. Mytych J, Romerowicz Misielak M, Koziorowski M. Long-term culture with lipopolysaccharide induces dose-dependent cytostatic and cytotoxic effects in THP-1 monocytes. Toxicol In Vitro. 2017;42:1-9 pubmed publisher
  207. Cherniack A, Shen H, Walter V, Stewart C, Murray B, Bowlby R, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31:411-423 pubmed publisher
  208. Tian Y, Wu X, Guo S, Ma L, Huang W, Zhao X. Minocycline attenuates sevoflurane-induced cell injury via activation of Nrf2. Int J Mol Med. 2017;39:869-878 pubmed publisher
  209. Fu S, Xu H, Gu M, Liu C, Wang Q, Wan X, et al. Adiponectin deficiency contributes to the development and progression of benign prostatic hyperplasia in obesity. Sci Rep. 2017;7:43771 pubmed publisher
  210. Zhang H, Wang Y, Liu Z, Yao B, Dou C, Xu M, et al. Lymphocyte-specific protein 1 inhibits the growth of hepatocellular carcinoma by suppressing ERK1/2 phosphorylation. FEBS Open Bio. 2016;6:1227-1237 pubmed publisher
  211. Cen M, Hu P, Cai Z, Fang T, Zhang J, Lu M. TIEG1 deficiency confers enhanced myocardial protection in the infarcted heart by mediating the Pten/Akt signalling pathway. Int J Mol Med. 2017;39:569-578 pubmed publisher
  212. Furukawa S, Nagaike M, Ozaki K. Databases for technical aspects of immunohistochemistry. J Toxicol Pathol. 2017;30:79-107 pubmed publisher
  213. Wu Q, Yan H, Tao S, Wang X, Mou L, Chen P, et al. XIAP 3'-untranslated region as a ceRNA promotes FSCN1 function in inducing the progression of breast cancer by binding endogenous miR-29a-5p. Oncotarget. 2017;8:16784-16800 pubmed publisher
  214. Dong Q, Fu L, Zhao Y, Tan S, Wang E. Derlin-1 overexpression confers poor prognosis in muscle invasive bladder cancer and contributes to chemoresistance and invasion through PI3K/AKT and ERK/MMP signaling. Oncotarget. 2017;8:17059-17069 pubmed publisher
  215. Jeffery H, Jeffery L, Lutz P, Corrigan M, Webb G, Hirschfield G, et al. Low-dose interleukin-2 promotes STAT-5 phosphorylation, Treg survival and CTLA-4-dependent function in autoimmune liver diseases. Clin Exp Immunol. 2017;188:394-411 pubmed publisher
  216. Cayrol F, Praditsuktavorn P, Fernando T, Kwiatkowski N, Marullo R, Calvo Vidal M, et al. THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors. Nat Commun. 2017;8:14290 pubmed publisher
  217. Li M, Yuan Y, Hu B, Wu L. Study on Lentivirus-Mediated ABCA7 Improves Neurocognitive Function and Related Mechanisms in the C57BL/6 Mouse Model of Alzheimer's Disease. J Mol Neurosci. 2017;61:489-497 pubmed publisher
  218. Cai L, Wang H, Yang Q. CRKL overexpression promotes cell proliferation and inhibits apoptosis in endometrial carcinoma. Oncol Lett. 2017;13:51-56 pubmed publisher
  219. Choi I, Hwang L, Jin J, Ko I, Kim S, Shin M, et al. Dexmedetomidine alleviates cerebral ischemia-induced short-term memory impairment by inhibiting the expression of apoptosis-related molecules in the hippocampus of gerbils. Exp Ther Med. 2017;13:107-116 pubmed publisher
  220. . Integrated genomic and molecular characterization of cervical cancer. Nature. 2017;543:378-384 pubmed publisher
  221. Huang Y, Chen N, Miao D. Radioprotective effects of pyrroloquinoline quinone on parotid glands in C57BL/6J mice. Exp Ther Med. 2016;12:3685-3693 pubmed publisher
  222. Peng Y, Shi X, Li Z, He X, Sun Y. Particularly interesting Cys-His-rich protein is highly expressed in human intracranial aneurysms and resists aneurysmal rupture. Exp Ther Med. 2016;12:3905-3912 pubmed publisher
  223. Candanedo Gonzalez F, Ortiz Arce C, Rosales Perez S, Remirez Castellanos A, Cordova Uscanga C, Gamboa Dominguez A. Immunohistochemical features of giant cell ependymoma of the filum terminale with unusual clinical and radiological presentation. Diagn Pathol. 2017;12:7 pubmed publisher
  224. Schenk R, Tuzlak S, Carrington E, Zhan Y, Heinzel S, Teh C, et al. Characterisation of mice lacking all functional isoforms of the pro-survival BCL-2 family member A1 reveals minor defects in the haematopoietic compartment. Cell Death Differ. 2017;24:534-545 pubmed publisher
  225. Silva B, Barbosa M, Andrade P, Ferreira H, Nery J, Corte Real S, et al. Autophagy Is an Innate Mechanism Associated with Leprosy Polarization. PLoS Pathog. 2017;13:e1006103 pubmed publisher
  226. Hill S, Nesser N, Johnson Camacho K, Jeffress M, Johnson A, Boniface C, et al. Context Specificity in Causal Signaling Networks Revealed by Phosphoprotein Profiling. Cell Syst. 2017;4:73-83.e10 pubmed publisher
  227. Mytych J, Wos I, Solek P, Koziorowski M. Protective role of klotho protein on epithelial cells upon co-culture with activated or senescent monocytes. Exp Cell Res. 2017;350:358-367 pubmed publisher
  228. Ren Z, Aerts J, Vandenplas H, Wang J, Gorbenko O, Chen J, et al. Phosphorylated STAT5 regulates p53 expression via BRCA1/BARD1-NPM1 and MDM2. Cell Death Dis. 2016;7:e2560 pubmed publisher
  229. Li Y, Buijs Gladdines J, Cant Barrett K, Stubbs A, Vroegindeweij E, Smits W, et al. IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study. PLoS Med. 2016;13:e1002200 pubmed publisher
  230. Xiao F, Zhang J, Zhang C, An W. Hepatic stimulator substance inhibits calcium overflow through the mitochondria-associated membrane compartment during nonalcoholic steatohepatitis. Lab Invest. 2017;97:289-301 pubmed publisher
  231. Ohs I, Van Den Broek M, Nussbaum K, MUNZ C, Arnold S, Quezada S, et al. Interleukin-12 bypasses common gamma-chain signalling in emergency natural killer cell lymphopoiesis. Nat Commun. 2016;7:13708 pubmed publisher
  232. Sasaki C, Toman J, Vageli D. The In Vitro Effect of Acidic-Pepsin on Nuclear Factor KappaB Activation and Its Related Oncogenic Effect on Normal Human Hypopharyngeal Cells. PLoS ONE. 2016;11:e0168269 pubmed publisher
  233. Kattaia A, Abd El Baset S, Mohamed E, Abdul Maksou R, Elfakharany Y. Molecular mechanisms underlying histological and biochemical changes induced by nitrate in rat liver and the efficacy of S-Allylcysteine. Ultrastruct Pathol. 2017;41:10-22 pubmed publisher
  234. Suzuki J, Nakajima W, Suzuki H, Asano Y, Tanaka N. Chaperone-mediated autophagy promotes lung cancer cell survival through selective stabilization of the pro-survival protein, MCL1. Biochem Biophys Res Commun. 2017;482:1334-1340 pubmed publisher
  235. Yu G, Dou Z, Jia Z. 5?bromo?3?(3?hydroxyprop?1?ynyl)?2H?pyran?2?one induces apoptosis in T24 human bladder cancer cells through mitochondria-dependent signaling pathways. Mol Med Rep. 2017;15:153-159 pubmed publisher
  236. He X, Liu Z, Xia Y, Xu J, Lv G, Wang L, et al. HOXB7 overexpression promotes cell proliferation and correlates with poor prognosis in gastric cancer patients by inducing expression of both AKT and MARKs. Oncotarget. 2017;8:1247-1261 pubmed publisher
  237. Liu Z, Gan L, Wu T, Feng F, Luo D, Gu H, et al. Adiponectin reduces ER stress-induced apoptosis through PPARα transcriptional regulation of ATF2 in mouse adipose. Cell Death Dis. 2016;7:e2487 pubmed publisher
  238. Su F, Myers V, Knezevic T, Wang J, Gao E, Madesh M, et al. Bcl-2-associated athanogene 3 protects the heart from ischemia/reperfusion injury. JCI Insight. 2016;1:e90931 pubmed publisher
  239. Zhu X, Wang K, Zhang K, Zhang T, Yin Y, Xu F. Ziyuglycoside I Inhibits the Proliferation of MDA-MB-231 Breast Carcinoma Cells through Inducing p53-Mediated G2/M Cell Cycle Arrest and Intrinsic/Extrinsic Apoptosis. Int J Mol Sci. 2016;17: pubmed
  240. Singh A, Agrahari A, Singh R, Yadav S, Srivastava V, Parmar D. Imprinting of cerebral cytochrome P450s in offsprings prenatally exposed to cypermethrin augments toxicity on rechallenge. Sci Rep. 2016;6:37426 pubmed publisher
  241. Martínez Castillo M, Bonilla Moreno R, Alemán Lazarini L, Meraz Rios M, Orozco L, Cedillo Barron L, et al. A Subpopulation of the K562 Cells Are Killed by Curcumin Treatment after G2/M Arrest and Mitotic Catastrophe. PLoS ONE. 2016;11:e0165971 pubmed publisher
  242. Carreras J, Kikuti Y, Bea S, Miyaoka M, Hiraiwa S, Ikoma H, et al. Clinicopathological characteristics and genomic profile of primary sinonasal tract diffuse large B cell lymphoma (DLBCL) reveals gain at 1q31 and RGS1 encoding protein; high RGS1 immunohistochemical expression associates with poor overall survival in. Histopathology. 2017;70:595-621 pubmed publisher
  243. Dey K, Bharti R, Dey G, Pal I, Rajesh Y, Chavan S, et al. S100A7 has an oncogenic role in oral squamous cell carcinoma by activating p38/MAPK and RAB2A signaling pathway. Cancer Gene Ther. 2016;23:382-391 pubmed publisher
  244. Huang M, Garcia J, Thomas D, Zhu L, Nguyen L, Chan S, et al. Autophagy mediates proteolysis of NPM1 and HEXIM1 and sensitivity to BET inhibition in AML cells. Oncotarget. 2016;7:74917-74930 pubmed publisher
  245. Alexander Savino C, Hayden M, Richardson C, Zhao J, Poligone B. Doxycycline is an NF-κB inhibitor that induces apoptotic cell death in malignant T-cells. Oncotarget. 2016;7:75954-75967 pubmed publisher
  246. Rodina A, Wang T, Yan P, Gomes E, Dunphy M, Pillarsetty N, et al. The epichaperome is an integrated chaperome network that facilitates tumour survival. Nature. 2016;538:397-401 pubmed publisher
  247. Zhan Y, Mou L, Cheng K, Wang C, Deng X, Chen J, et al. Hepatocellular carcinoma stem cell-like cells are enriched following low-dose 5-fluorouracil chemotherapy. Oncol Lett. 2016;12:2511-2516 pubmed
  248. Xu Y, Ding G, Huang J, Xiong Y. Tanshinone IIA pretreatment attenuates ischemia/reperfusion-induced renal injury. Exp Ther Med. 2016;12:2741-2746 pubmed
  249. Schubert C, Raparelli V, Westphal C, Dworatzek E, Petrov G, Kararigas G, et al. Reduction of apoptosis and preservation of mitochondrial integrity under ischemia/reperfusion injury is mediated by estrogen receptor ?. Biol Sex Differ. 2016;7:53 pubmed publisher
  250. Cao R, Meng Z, Liu T, Wang G, Qian G, Cao T, et al. Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway. Oncotarget. 2016;7:72941-72960 pubmed publisher
  251. Soon G, Ow G, Chan H, Ng S, Wang S. Primary cardiac diffuse large B-cell lymphoma in immunocompetent patients: clinical, histologic, immunophenotypic, and genotypic features of 3 cases. Ann Diagn Pathol. 2016;24:40-6 pubmed publisher
  252. Torres A, Vargas Y, Uribe D, Jaramillo C, Gleisner A, Salazar Onfray F, et al. Adenosine A3 receptor elicits chemoresistance mediated by multiple resistance-associated protein-1 in human glioblastoma stem-like cells. Oncotarget. 2016;7:67373-67386 pubmed publisher
  253. Ranjan K, Pathak C. Expression of FADD and cFLIPL balances mitochondrial integrity and redox signaling to substantiate apoptotic cell death. Mol Cell Biochem. 2016;422:135-150 pubmed
  254. Gallo M, Cacheux V, Vincent L, Bret C, Tempier A, Guittard C, et al. Leukemic non-nodal mantle cell lymphomas have a distinct phenotype and are associated with deletion of PARP1 and 13q14. Virchows Arch. 2016;469:697-706 pubmed
  255. Lee J, Jung H, Han Y, Yoon Y, Yun C, Sun H, et al. Antioxidant effects of Cirsium setidens extract on oxidative stress in human mesenchymal stem cells. Mol Med Rep. 2016;14:3777-84 pubmed publisher
  256. Peng Y, Miao H, Wu S, Yang W, Zhang Y, Xie G, et al. ABHD5 interacts with BECN1 to regulate autophagy and tumorigenesis of colon cancer independent of PNPLA2. Autophagy. 2016;12:2167-2182 pubmed
  257. Cheng S, Jiang X, Ding C, Du C, Owusu Ansah K, Weng X, et al. Expression and Critical Role of Interleukin Enhancer Binding Factor 2 in Hepatocellular Carcinoma. Int J Mol Sci. 2016;17: pubmed publisher
  258. Jinesh G, Molina J, Huang L, Laing N, Mills G, Bar Eli M, et al. Mitochondrial oligomers boost glycolysis in cancer stem cells to facilitate blebbishield-mediated transformation after apoptosis. Cell Death Discov. 2016;2:16003 pubmed publisher
  259. Pomares H, Palmeri C, Iglesias Serret D, Moncunill Massaguer C, Saura Esteller J, Núñez Vázquez S, et al. Targeting prohibitins induces apoptosis in acute myeloid leukemia cells. Oncotarget. 2016;7:64987-65000 pubmed publisher
  260. Wang H, Li M, Hung C, Sinha M, Lee L, Wiesner D, et al. MyD88 Shapes Vaccine Immunity by Extrinsically Regulating Survival of CD4+ T Cells during the Contraction Phase. PLoS Pathog. 2016;12:e1005787 pubmed publisher
  261. Liu Y, Wang Y, Ding G, Yang T, Yao L, Hua J, et al. JAK2 inhibitor combined with DC-activated AFP-specific T-cells enhances antitumor function in a Fas/FasL signal-independent pathway. Onco Targets Ther. 2016;9:4425-33 pubmed publisher
  262. Weyhenmeyer B, Noonan J, Würstle M, Lincoln F, Johnston G, Rehm M, et al. Predicting the cell death responsiveness and sensitization of glioma cells to TRAIL and temozolomide. Oncotarget. 2016;7:61295-61311 pubmed publisher
  263. Shen H, Zhao L, Feng X, Xu C, Li C, Niu Y. Lin28A activates androgen receptor via regulation of c-myc and promotes malignancy of ER-/Her2+ breast cancer. Oncotarget. 2016;7:60407-60418 pubmed publisher
  264. Li C, Li Q, Cai Y, He Y, Lan X, Wang W, et al. Overexpression of angiopoietin 2 promotes the formation of oral squamous cell carcinoma by increasing epithelial-mesenchymal transition-induced angiogenesis. Cancer Gene Ther. 2016;23:295-302 pubmed publisher
  265. Tang Y, Bao W, Yang J, Ma L, Yang J, Xu Y, et al. Umbilical cord-derived mesenchymal stem cells inhibit growth and promote apoptosis of HepG2 cells. Mol Med Rep. 2016;14:2717-24 pubmed publisher
  266. Debliquis A, Voirin J, Harzallah I, Maurer M, Lerintiu F, Drenou B, et al. Cytomorphology and flow cytometry of brain biopsy rinse fluid enables faster and multidisciplinary diagnosis of large B-cell lymphoma of the central nervous system. Cytometry B Clin Cytom. 2018;94:182-188 pubmed publisher
  267. Martinez L, Thames E, Kim J, Chaudhuri G, Singh R, Pervin S. Increased sensitivity of African American triple negative breast cancer cells to nitric oxide-induced mitochondria-mediated apoptosis. BMC Cancer. 2016;16:559 pubmed publisher
  268. Wang Y, Wang Y, Li G. TRPC1/TRPC3 channels mediate lysophosphatidylcholine-induced apoptosis in cultured human coronary artery smooth muscles cells. Oncotarget. 2016;7:50937-50951 pubmed publisher
  269. Engel N, Ali I, Adamus A, Frank M, Dad A, Ali S, et al. Antitumor evaluation of two selected Pakistani plant extracts on human bone and breast cancer cell lines. BMC Complement Altern Med. 2016;16:244 pubmed publisher
  270. Jeong H, Cho Y, Kim K, Kim Y, Kim K, Na Y, et al. Anti-lipoapoptotic effects of Alisma orientalis extract on non-esterified fatty acid-induced HepG2 cells. BMC Complement Altern Med. 2016;16:239 pubmed publisher
  271. Yu X, Sun K, Tang X, Zhou C, Sun H, Yan Z, et al. Harmine combined with paclitaxel inhibits tumor proliferation and induces apoptosis through down-regulation of cyclooxygenase-2 expression in gastric cancer. Oncol Lett. 2016;12:983-988 pubmed
  272. Geng J, Li J, Huang T, Zhao K, Chen Q, Guo W, et al. A novel manganese complex selectively induces malignant glioma cell death by targeting mitochondria. Mol Med Rep. 2016;14:1970-8 pubmed publisher
  273. Ma T, Fan B, Zhang C, Zhao H, Han C, Gao C, et al. Metabonomics applied in exploring the antitumour mechanism of physapubenolide on hepatocellular carcinoma cells by targeting glycolysis through the Akt-p53 pathway. Sci Rep. 2016;6:29926 pubmed publisher
  274. Ahmed N, Murakami M, Hirose Y, Nakashima M. Therapeutic Potential of Dental Pulp Stem Cell Secretome for Alzheimer's Disease Treatment: An In Vitro Study. Stem Cells Int. 2016;2016:8102478 pubmed publisher
  275. Yang W, Ng F, Chan K, Pu X, Poston R, Ren M, et al. Coronary-Heart-Disease-Associated Genetic Variant at the COL4A1/COL4A2 Locus Affects COL4A1/COL4A2 Expression, Vascular Cell Survival, Atherosclerotic Plaque Stability and Risk of Myocardial Infarction. PLoS Genet. 2016;12:e1006127 pubmed publisher
  276. Peng H, Cheng Y, Hsu Y, Wu G, Kuo C, Liou J, et al. MPT0B098, a Microtubule Inhibitor, Suppresses JAK2/STAT3 Signaling Pathway through Modulation of SOCS3 Stability in Oral Squamous Cell Carcinoma. PLoS ONE. 2016;11:e0158440 pubmed publisher
  277. Takagi Y, Shimada K, Shimada S, Sakamoto A, Naoe T, Nakamura S, et al. SPIB is a novel prognostic factor in diffuse large B-cell lymphoma that mediates apoptosis via the PI3K-AKT pathway. Cancer Sci. 2016;107:1270-80 pubmed publisher
  278. Zhou X, Wei Y, Qiu S, Xu Y, Zhang T, Zhang S. Propofol Decreases Endoplasmic Reticulum Stress-Mediated Apoptosis in Retinal Pigment Epithelial Cells. PLoS ONE. 2016;11:e0157590 pubmed publisher
  279. Tagscherer K, Fassl A, Sinkovic T, Richter J, Schecher S, Macher Goeppinger S, et al. MicroRNA-210 induces apoptosis in colorectal cancer via induction of reactive oxygen. Cancer Cell Int. 2016;16:42 pubmed publisher
  280. Qi L, Lv X, Zhang T, Jia P, Yan R, Li S, et al. Cytotoxicity and genotoxicity of bacterial magnetosomes against human retinal pigment epithelium cells. Sci Rep. 2016;6:26961 pubmed publisher
  281. Amara S, Zheng M, Tiriveedhi V. Oleanolic Acid Inhibits High Salt-Induced Exaggeration of Warburg-like Metabolism in Breast Cancer Cells. Cell Biochem Biophys. 2016;74:427-34 pubmed publisher
  282. Kawamura T, Kawatani M, Muroi M, Kondoh Y, Futamura Y, Aono H, et al. Proteomic profiling of small-molecule inhibitors reveals dispensability of MTH1 for cancer cell survival. Sci Rep. 2016;6:26521 pubmed publisher
  283. Dar A, Majid S, Bezrookove V, Phan B, Ursu S, Nosrati M, et al. BPTF transduces MITF-driven prosurvival signals in melanoma cells. Proc Natl Acad Sci U S A. 2016;113:6254-8 pubmed publisher
  284. Hein A, Post C, Sheinin Y, Lakshmanan I, Natarajan A, Enke C, et al. RAC1 GTPase promotes the survival of breast cancer cells in response to hyper-fractionated radiation treatment. Oncogene. 2016;35:6319-6329 pubmed publisher
  285. Gao Z, Liu Z, Bi M, Zhang J, Han Z, Han X, et al. Metformin induces apoptosis via a mitochondria-mediated pathway in human breast cancer cells in vitro. Exp Ther Med. 2016;11:1700-1706 pubmed
  286. Tuşaliu M, Zainea V, Mogoantă C, Dragu A, GoanŢă C, Niţescu M, et al. Diagnostic and therapeutic aspects in malignant sinonasal lymphoma. Rom J Morphol Embryol. 2016;57:233-6 pubmed
  287. Wang Y, Li Y, Song L, Li Y, Jiang S, Zhang S. The transplantation of Akt-overexpressing amniotic fluid-derived mesenchymal stem cells protects the heart against ischemia-reperfusion injury in rabbits. Mol Med Rep. 2016;14:234-42 pubmed publisher
  288. Cook A, McDonnell A, Lake R, Nowak A. Dexamethasone co-medication in cancer patients undergoing chemotherapy causes substantial immunomodulatory effects with implications for chemo-immunotherapy strategies. Oncoimmunology. 2016;5:e1066062 pubmed
  289. Thomas R, Demeter Z, Kennedy K, Borst L, Singh K, Valli V, et al. Integrated immunohistochemical and DNA copy number profiling analysis provides insight into the molecular pathogenesis of canine follicular lymphoma. Vet Comp Oncol. 2017;15:852-867 pubmed publisher
  290. Huang Q, Zhan L, Cao H, Li J, Lyu Y, Guo X, et al. Increased mitochondrial fission promotes autophagy and hepatocellular carcinoma cell survival through the ROS-modulated coordinated regulation of the NFKB and TP53 pathways. Autophagy. 2016;12:999-1014 pubmed publisher
  291. Strappazzon F, Di Rita A, Cianfanelli V, D Orazio M, Nazio F, Fimia G, et al. Prosurvival AMBRA1 turns into a proapoptotic BH3-like protein during mitochondrial apoptosis. Autophagy. 2016;12:963-75 pubmed publisher
  292. Yao J, Wang Y, Fang B, Zhang S, Cheng B. piR-651 and its function in 95-D lung cancer cells. Biomed Rep. 2016;4:546-550 pubmed
  293. Pallis M, Burrows F, Ryan J, Grundy M, Seedhouse C, Abdul Aziz A, et al. Complementary dynamic BH3 profiles predict co-operativity between the multi-kinase inhibitor TG02 and the BH3 mimetic ABT-199 in acute myeloid leukaemia cells. Oncotarget. 2017;8:16220-16232 pubmed publisher
  294. Pires A, Marques C, Encarnação J, Abrantes A, Mamede A, Laranjo M, et al. Ascorbic acid and colon cancer: an oxidative stimulus to cell death depending on cell profile. Eur J Cell Biol. 2016;95:208-18 pubmed publisher
  295. Zeng W, Liu Q, Chen Z, Wu X, Zhong Y, Wu J. Silencing of hERG1 Gene Inhibits Proliferation and Invasion, and Induces Apoptosis in Human Osteosarcoma Cells by Targeting the NF-?B Pathway. J Cancer. 2016;7:746-57 pubmed publisher
  296. Conway A, Van Nostrand E, Pratt G, Aigner S, Wilbert M, Sundararaman B, et al. Enhanced CLIP Uncovers IMP Protein-RNA Targets in Human Pluripotent Stem Cells Important for Cell Adhesion and Survival. Cell Rep. 2016;15:666-679 pubmed publisher
  297. O Neill K, Huang K, Zhang J, Chen Y, Luo X. Inactivation of prosurvival Bcl-2 proteins activates Bax/Bak through the outer mitochondrial membrane. Genes Dev. 2016;30:973-88 pubmed publisher
  298. Zheng G, Li N, Jia X, Peng C, Luo L, Deng Y, et al. MYCN-mediated miR-21 overexpression enhances chemo-resistance via targeting CADM1 in tongue cancer. J Mol Med (Berl). 2016;94:1129-1141 pubmed
  299. Takeuchi H, Taoka R, Mmeje C, Jinesh G, Safe S, Kamat A. CDODA-Me decreases specificity protein transcription factors and induces apoptosis in bladder cancer cells through induction of reactive oxygen species. Urol Oncol. 2016;34:337.e11-8 pubmed publisher
  300. Wang H, Zhang H, Chen X, Zhao T, Kong Q, Yan M, et al. The decreased expression of electron transfer flavoprotein ? is associated with tubular cell apoptosis in diabetic nephropathy. Int J Mol Med. 2016;37:1290-8 pubmed publisher
  301. Li J, Chen K, Li S, Liu T, Wang F, Xia Y, et al. Pretreatment with Fucoidan from Fucus vesiculosus Protected against ConA-Induced Acute Liver Injury by Inhibiting Both Intrinsic and Extrinsic Apoptosis. PLoS ONE. 2016;11:e0152570 pubmed publisher
  302. Garcia C, Videla Richardson G, Dimopoulos N, Fernandez Espinosa D, Miriuka S, Sevlever G, et al. Human Pluripotent Stem Cells and Derived Neuroprogenitors Display Differential Degrees of Susceptibility to BH3 Mimetics ABT-263, WEHI-539 and ABT-199. PLoS ONE. 2016;11:e0152607 pubmed publisher
  303. Huang J, Yao C, Chuang S, Yeh C, Lee L, Chen R, et al. Honokiol inhibits sphere formation and xenograft growth of oral cancer side population cells accompanied with JAK/STAT signaling pathway suppression and apoptosis induction. BMC Cancer. 2016;16:245 pubmed publisher
  304. Li B, Chen D, Li W, Xiao D. 20(S)-Protopanaxadiol saponins inhibit SKOV3 cell migration. Oncol Lett. 2016;11:1693-1698 pubmed
  305. Salzman D, Nakamura K, Nallur S, Dookwah M, Metheetrairut C, Slack F, et al. miR-34 activity is modulated through 5'-end phosphorylation in response to DNA damage. Nat Commun. 2016;7:10954 pubmed publisher
  306. Li Y, Ma H, Lu Y, Tan B, Xu L, Lawal T, et al. Menoprogen, a TCM Herbal Formula for Menopause, Increases Endogenous E2 in an Aged Rat Model of Menopause by Reducing Ovarian Granulosa Cell Apoptosis. Biomed Res Int. 2016;2016:2574637 pubmed publisher
  307. Ranjan K, Pathak C. FADD regulates NF-κB activation and promotes ubiquitination of cFLIPL to induce apoptosis. Sci Rep. 2016;6:22787 pubmed publisher
  308. Bozkurt K, Yalçın Y, Erdemoğlu E, Tatar B, Erdemoğlu E, Çerçi S, et al. The role of immunohistochemical adrenomedullin and Bcl-2 expression in development of type-1 endometrial adenocarcinoma: Adrenomedullin expression in endometrium. Pathol Res Pract. 2016;212:450-5 pubmed publisher
  309. Qiao C, Lu N, Zhou Y, Ni T, Dai Y, Li Z, et al. Oroxylin A modulates mitochondrial function and apoptosis in human colon cancer cells by inducing mitochondrial translocation of wild-type p53. Oncotarget. 2016;7:17009-20 pubmed publisher
  310. van der Heijden M, Zimberlin C, Nicholson A, Colak S, Kemp R, Meijer S, et al. Bcl-2 is a critical mediator of intestinal transformation. Nat Commun. 2016;7:10916 pubmed publisher
  311. van den Brand M, Balagué O, van Cleef P, Groenen P, Hebeda K, de Jong D, et al. A subset of low-grade B cell lymphomas with a follicular growth pattern but without a BCL2 translocation shows features suggestive of nodal marginal zone lymphoma. J Hematop. 2016;9:3-8 pubmed
  312. Brito A, Ribeiro M, Abrantes A, Mamede A, Laranjo M, Casalta Lopes J, et al. New Approach for Treatment of Primary Liver Tumors: The Role of Quercetin. Nutr Cancer. 2016;68:250-66 pubmed publisher
  313. Barroso González J, Auclair S, Luan S, Thomas L, Atkins K, Aslan J, et al. PACS-2 mediates the ATM and NF-κB-dependent induction of anti-apoptotic Bcl-xL in response to DNA damage. Cell Death Differ. 2016;23:1448-57 pubmed publisher
  314. Kemp M, Sancar A. ATR Kinase Inhibition Protects Non-cycling Cells from the Lethal Effects of DNA Damage and Transcription Stress. J Biol Chem. 2016;291:9330-42 pubmed publisher
  315. Gilormini M, Malesys C, Armandy E, Manas P, Guy J, Magne N, et al. Preferential targeting of cancer stem cells in the radiosensitizing effect of ABT-737 on HNSCC. Oncotarget. 2016;7:16731-44 pubmed publisher
  316. Yang C, Cui X, Dai X, Liao W. Downregulation of Foxc2 enhances apoptosis induced by 5-fluorouracil through activation of MAPK and AKT pathways in colorectal cancer. Oncol Lett. 2016;11:1549-1554 pubmed
  317. Adighibe O, Leek R, Fernandez Mercado M, Hu J, Snell C, Gatter K, et al. Why some tumours trigger neovascularisation and others don't: the story thus far. Chin J Cancer. 2016;35:18 pubmed publisher
  318. Lamba Saini M, Bouzin C, Weynand B, Marbaix E. An Appraisal of Proliferation and Apoptotic Markers in Papillary Thyroid Carcinoma: An Automated Analysis. PLoS ONE. 2016;11:e0148656 pubmed publisher
  319. Setoguchi R. IL-15 boosts the function and migration of human terminally differentiated CD8+ T cells by inducing a unique gene signature. Int Immunol. 2016;28:293-305 pubmed publisher
  320. Zhang Y, Zou C, Yang S, Fu J. P120 catenin attenuates the angiotensin II-induced apoptosis of human umbilical vein endothelial cells by suppressing the mitochondrial pathway. Int J Mol Med. 2016;37:623-30 pubmed publisher
  321. Chen B, Song G, Liu M, Qian L, Wang L, Gu H, et al. Inhibition of miR-29c promotes proliferation, and inhibits apoptosis and differentiation in P19 embryonic carcinoma cells. Mol Med Rep. 2016;13:2527-35 pubmed publisher
  322. Li Y, Liu J, Gao D, Wei J, Yuan H, Niu X, et al. Age-related changes in hypertensive brain damage in the hippocampi of spontaneously hypertensive rats. Mol Med Rep. 2016;13:2552-60 pubmed publisher
  323. De Toni E, Ziesch A, Rizzani A, Török H, Hocke S, Lü S, et al. Inactivation of BRCA2 in human cancer cells identifies a subset of tumors with enhanced sensitivity towards death receptor-mediated apoptosis. Oncotarget. 2016;7:9477-90 pubmed publisher
  324. Klumpp D, Misovic M, Szteyn K, Shumilina E, Rudner J, Huber S. Targeting TRPM2 Channels Impairs Radiation-Induced Cell Cycle Arrest and Fosters Cell Death of T Cell Leukemia Cells in a Bcl-2-Dependent Manner. Oxid Med Cell Longev. 2016;2016:8026702 pubmed publisher
  325. Soriano A, París Coderch L, Jubierre L, Martínez A, Zhou X, Piskareva O, et al. MicroRNA-497 impairs the growth of chemoresistant neuroblastoma cells by targeting cell cycle, survival and vascular permeability genes. Oncotarget. 2016;7:9271-87 pubmed publisher
  326. Chandrasekaran U, Yi W, Gupta S, Weng C, Giannopoulou E, Chinenov Y, et al. Regulation of Effector Treg Cells in Murine Lupus. Arthritis Rheumatol. 2016;68:1454-66 pubmed publisher
  327. Wojtuszkiewicz A, Schuurhuis G, Kessler F, Piersma S, Knol J, Pham T, et al. Exosomes Secreted by Apoptosis-Resistant Acute Myeloid Leukemia (AML) Blasts Harbor Regulatory Network Proteins Potentially Involved in Antagonism of Apoptosis. Mol Cell Proteomics. 2016;15:1281-98 pubmed publisher
  328. Kanderová V, Kuzilkova D, Stuchly J, Vaskova M, Brdicka T, Fiser K, et al. High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells. Mol Cell Proteomics. 2016;15:1246-61 pubmed publisher
  329. Wu M, Ai W, Chen L, Zhao S, Liu E. Bradykinin receptors and EphB2/EphrinB2 pathway in response to high glucose-induced osteoblast dysfunction and hyperglycemia-induced bone deterioration in mice. Int J Mol Med. 2016;37:565-74 pubmed publisher
  330. Metz P, Lopez J, Kim S, Akimoto K, Ohno S, Chang J. Regulation of Asymmetric Division by Atypical Protein Kinase C Influences Early Specification of CD8(+) T Lymphocyte Fates. Sci Rep. 2016;6:19182 pubmed publisher
  331. Cloonan S, Glass K, Laucho Contreras M, Bhashyam A, Cervo M, Pabón M, et al. Mitochondrial iron chelation ameliorates cigarette smoke-induced bronchitis and emphysema in mice. Nat Med. 2016;22:163-74 pubmed publisher
  332. Li W, Zou J, Yue F, Song K, Chen Q, McKeehan W, et al. Defects in MAP1S-mediated autophagy cause reduction in mouse lifespans especially when fibronectin is overexpressed. Aging Cell. 2016;15:370-9 pubmed publisher
  333. Cao L, Li H, Lin W, Tan H, Xie L, Zhong Z, et al. Morphine, a potential antagonist of cisplatin cytotoxicity, inhibits cisplatin-induced apoptosis and suppression of tumor growth in nasopharyngeal carcinoma xenografts. Sci Rep. 2016;6:18706 pubmed publisher
  334. Lub S, Maes A, Maes K, De Veirman K, De Bruyne E, Menu E, et al. Inhibiting the anaphase promoting complex/cyclosome induces a metaphase arrest and cell death in multiple myeloma cells. Oncotarget. 2016;7:4062-76 pubmed publisher
  335. Abdel Hamid A, Firgany A, Ali E. Effect of memantine: A NMDA receptor blocker, on ethambutol-induced retinal injury. Ann Anat. 2016;204:86-92 pubmed publisher
  336. Bishayee A, Mandal A, Bhattacharyya P, Bhatia D. Pomegranate exerts chemoprevention of experimentally induced mammary tumorigenesis by suppression of cell proliferation and induction of apoptosis. Nutr Cancer. 2016;68:120-30 pubmed publisher
  337. Ranjan K, Pathak C. Expression of cFLIPL Determines the Basal Interaction of Bcl-2 With Beclin-1 and Regulates p53 Dependent Ubiquitination of Beclin-1 During Autophagic Stress. J Cell Biochem. 2016;117:1757-68 pubmed publisher
  338. Dupont T, Yang S, Patel J, Hatzi K, Malik A, Tam W, et al. Selective targeting of BCL6 induces oncogene addiction switching to BCL2 in B-cell lymphoma. Oncotarget. 2016;7:3520-32 pubmed publisher
  339. Martínez Martínez M, Mosqueda Taylor A, Delgado Azañero W, Rumayor Piña A, de Almeida O. Primary intraosseous squamous cell carcinoma arising in an odontogenic keratocyst previously treated with marsupialization: case report and immunohistochemical study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;121:e87-95 pubmed publisher
  340. Bo Q, Sun X, Liu J, Sui X, Li G. Antitumor action of the peroxisome proliferator-activated receptor-γ agonist rosiglitazone in hepatocellular carcinoma. Oncol Lett. 2015;10:1979-1984 pubmed
  341. De Luca T, Pelosi A, Trisciuoglio D, D Aguanno S, Desideri M, Farini V, et al. miR-211 and MITF modulation by Bcl-2 protein in melanoma cells. Mol Carcinog. 2016;55:2304-2312 pubmed publisher
  342. Wang S, Song T, Leng C, Lan K, Ning J, Chu H. Propofol protects against the neurotoxicity of 1‑methyl‑4‑phenylpyridinium. Mol Med Rep. 2016;13:309-14 pubmed publisher
  343. Fridriksdottir A, Kim J, Villadsen R, Klitgaard M, Hopkinson B, Petersen O, et al. Propagation of oestrogen receptor-positive and oestrogen-responsive normal human breast cells in culture. Nat Commun. 2015;6:8786 pubmed publisher
  344. Zucal C, D Agostino V, Casini A, Mantelli B, Thongon N, Soncini D, et al. EIF2A-dependent translational arrest protects leukemia cells from the energetic stress induced by NAMPT inhibition. BMC Cancer. 2015;15:855 pubmed publisher
  345. Amigo Jiménez I, Bailón E, Aguilera Montilla N, Terol M, García Marco J, García Pardo A. Bone marrow stroma-induced resistance of chronic lymphocytic leukemia cells to arsenic trioxide involves Mcl-1 upregulation and is overcome by inhibiting the PI3Kδ or PKCβ signaling pathways. Oncotarget. 2015;6:44832-48 pubmed publisher
  346. Herriott A, Tudhope S, Junge G, Rodrigues N, Patterson M, Woodhouse L, et al. PARP1 expression, activity and ex vivo sensitivity to the PARP inhibitor, talazoparib (BMN 673), in chronic lymphocytic leukaemia. Oncotarget. 2015;6:43978-91 pubmed publisher
  347. Zhao E, Maj T, Kryczek I, Li W, Wu K, Zhao L, et al. Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction. Nat Immunol. 2016;17:95-103 pubmed publisher
  348. Ting W, Kuo W, Hsieh D, Yeh Y, Day C, Chen Y, et al. Heat Killed Lactobacillus reuteri GMNL-263 Reduces Fibrosis Effects on the Liver and Heart in High Fat Diet-Hamsters via TGF-β Suppression. Int J Mol Sci. 2015;16:25881-96 pubmed publisher
  349. Antonucci L, Fagman J, Kim J, Todoric J, Gukovsky I, Mackey M, et al. Basal autophagy maintains pancreatic acinar cell homeostasis and protein synthesis and prevents ER stress. Proc Natl Acad Sci U S A. 2015;112:E6166-74 pubmed publisher
  350. Deisting W, Raum T, Kufer P, Baeuerle P, Münz M. Impact of Diverse Immune Evasion Mechanisms of Cancer Cells on T Cells Engaged by EpCAM/CD3-Bispecific Antibody Construct AMG 110. PLoS ONE. 2015;10:e0141669 pubmed publisher
  351. Chauhan S, Ahmed Z, Bradfute S, Arko Mensah J, Mandell M, Won Choi S, et al. Pharmaceutical screen identifies novel target processes for activation of autophagy with a broad translational potential. Nat Commun. 2015;6:8620 pubmed publisher
  352. Li M, Quan C, Toth R, Campbell D, MacKintosh C, Wang H, et al. Fasting and Systemic Insulin Signaling Regulate Phosphorylation of Brain Proteins That Modulate Cell Morphology and Link to Neurological Disorders. J Biol Chem. 2015;290:30030-41 pubmed publisher
  353. Nichols C, Shepherd D, Knuckles T, Thapa D, Stricker J, Stapleton P, et al. Cardiac and mitochondrial dysfunction following acute pulmonary exposure to mountaintop removal mining particulate matter. Am J Physiol Heart Circ Physiol. 2015;309:H2017-30 pubmed publisher
  354. Moncunill Massaguer C, Saura Esteller J, Pérez Perarnau A, Palmeri C, Núñez Vázquez S, Cosialls A, et al. A novel prohibitin-binding compound induces the mitochondrial apoptotic pathway through NOXA and BIM upregulation. Oncotarget. 2015;6:41750-65 pubmed publisher
  355. Kroon J, Puhr M, Buijs J, van der Horst G, Hemmer D, Marijt K, et al. Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer. Endocr Relat Cancer. 2016;23:35-45 pubmed publisher
  356. Guo W, Zhang Y, Ling Z, Liu X, Zhao X, Yuan Z, et al. Caspase-3 feedback loop enhances Bid-induced AIF/endoG and Bak activation in Bax and p53-independent manner. Cell Death Dis. 2015;6:e1919 pubmed publisher
  357. Sochalska M, Ottina E, Tuzlak S, Herzog S, Herold M, Villunger A. Conditional knockdown of BCL2A1 reveals rate-limiting roles in BCR-dependent B-cell survival. Cell Death Differ. 2016;23:628-39 pubmed publisher
  358. Ertoy Baydar D, Kosemehmetoglu K, Aydin O, Bridge J, Buyukeren B, Aki F. Primary sclerosing epithelioid fibrosarcoma of kidney with variant histomorphologic features: report of 2 cases and review of the literature. Diagn Pathol. 2015;10:186 pubmed publisher
  359. Ambroise G, Portier A, Roders N, Arnoult D, Vazquez A. Subcellular localization of PUMA regulates its pro-apoptotic activity in Burkitt's lymphoma B cells. Oncotarget. 2015;6:38181-94 pubmed publisher
  360. Anderson K, Russell A, Foletta V. NDRG2 promotes myoblast proliferation and caspase 3/7 activities during differentiation, and attenuates hydrogen peroxide - But not palmitate-induced toxicity. FEBS Open Bio. 2015;5:668-81 pubmed publisher
  361. Ray A, Vasudevan S, Sengupta S. 6-Shogaol Inhibits Breast Cancer Cells and Stem Cell-Like Spheroids by Modulation of Notch Signaling Pathway and Induction of Autophagic Cell Death. PLoS ONE. 2015;10:e0137614 pubmed publisher
  362. Salim H, Zong D, Hååg P, Novak M, Mörk B, Lewensohn R, et al. DKK1 is a potential novel mediator of cisplatin-refractoriness in non-small cell lung cancer cell lines. BMC Cancer. 2015;15:628 pubmed publisher
  363. Ramírez de Arellano A, Lopez Pulido E, Martínez Neri P, Estrada Chávez C, González Lucano R, Fafutis Morris M, et al. STAT3 activation is required for the antiapoptotic effects of prolactin in cervical cancer cells. Cancer Cell Int. 2015;15:83 pubmed publisher
  364. Lavik A, Zhong F, Chang M, Greenberg E, Choudhary Y, Smith M, et al. A synthetic peptide targeting the BH4 domain of Bcl-2 induces apoptosis in multiple myeloma and follicular lymphoma cells alone or in combination with agents targeting the BH3-binding pocket of Bcl-2. Oncotarget. 2015;6:27388-402 pubmed publisher
  365. Schmidt L, Kümmel A, Görlich D, Mohr M, Bröckling S, Mikesch J, et al. PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups. PLoS ONE. 2015;10:e0136023 pubmed publisher
  366. Kumarasamy V, Shin Y, White J, Sun D. Selective repression of RET proto-oncogene in medullary thyroid carcinoma by a natural alkaloid berberine. BMC Cancer. 2015;15:599 pubmed publisher
  367. Tiffen J, Gunatilake D, Gallagher S, Gowrishankar K, Heinemann A, Cullinane C, et al. Targeting activating mutations of EZH2 leads to potent cell growth inhibition in human melanoma by derepression of tumor suppressor genes. Oncotarget. 2015;6:27023-36 pubmed publisher
  368. Adachi K, Miki Y, Saito R, Hata S, Yamauchi M, Mikami Y, et al. Intracrine steroid production and mammalian target of rapamycin pathways in pulmonary lymphangioleiomyomatosis. Hum Pathol. 2015;46:1685-93 pubmed publisher
  369. Lorkova L, Scigelova M, Arrey T, Vit O, Pospisilova J, Doktorova E, et al. Detailed Functional and Proteomic Characterization of Fludarabine Resistance in Mantle Cell Lymphoma Cells. PLoS ONE. 2015;10:e0135314 pubmed publisher
  370. Chiang C, Uzoma I, Lane D, Memišević V, Alem F, Yao K, et al. A reverse-phase protein microarray-based screen identifies host signaling dynamics upon Burkholderia spp. infection. Front Microbiol. 2015;6:683 pubmed publisher
  371. Akahane K, Sanda T, Mansour M, Radimerski T, DeAngelo D, Weinstock D, et al. HSP90 inhibition leads to degradation of the TYK2 kinase and apoptotic cell death in T-cell acute lymphoblastic leukemia. Leukemia. 2016;30:219-28 pubmed publisher
  372. Oteiza A, Mechti N. Control of FoxO4 Activity and Cell Survival by TRIM22 Directs TLR3-Stimulated Cells Toward IFN Type I Gene Induction or Apoptosis. J Interferon Cytokine Res. 2015;35:859-74 pubmed publisher
  373. Luna Acosta J, Alba Betancourt C, Martínez Moreno C, Ramírez C, Carranza M, Luna M, et al. Direct antiapoptotic effects of growth hormone are mediated by PI3K/Akt pathway in the chicken bursa of Fabricius. Gen Comp Endocrinol. 2015;224:148-59 pubmed publisher
  374. Zhang X, Wang X, Wu T, Li B, Liu T, Wang R, et al. Isoliensinine induces apoptosis in triple-negative human breast cancer cells through ROS generation and p38 MAPK/JNK activation. Sci Rep. 2015;5:12579 pubmed publisher
  375. Patergnani S, Giorgi C, Maniero S, Missiroli S, Maniscalco P, Bononi I, et al. The endoplasmic reticulum mitochondrial calcium cross talk is downregulated in malignant pleural mesothelioma cells and plays a critical role in apoptosis inhibition. Oncotarget. 2015;6:23427-44 pubmed
  376. Wu C, Huang K, Yang T, Li Y, Wen C, Hsu S, et al. The Topoisomerase 1 Inhibitor Austrobailignan-1 Isolated from Koelreuteria henryi Induces a G2/M-Phase Arrest and Cell Death Independently of p53 in Non-Small Cell Lung Cancer Cells. PLoS ONE. 2015;10:e0132052 pubmed publisher
  377. Masotti A, Donninelli G, Da Sacco L, Varano B, Del Cornò M, Gessani S. HIV-1 gp120 influences the expression of microRNAs in human monocyte-derived dendritic cells via STAT3 activation. BMC Genomics. 2015;16:480 pubmed publisher
  378. Mavroeidis L, Sheldon H, Briasoulis E, Marselos M, Pappas P, Harris A. Metronomic vinorelbine: Anti-angiogenic activity in vitro in normoxic and severe hypoxic conditions, and severe hypoxia-induced resistance to its anti-proliferative effect with reversal by Akt inhibition. Int J Oncol. 2015;47:455-64 pubmed publisher
  379. Bresin A, Callegari E, D Abundo L, Cattani C, Bassi C, Zagatti B, et al. miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eµ-TCL1 mouse model. Oncotarget. 2015;6:19807-18 pubmed
  380. Heinemann A, Cullinane C, De Paoli Iseppi R, Wilmott J, Gunatilake D, Madore J, et al. Combining BET and HDAC inhibitors synergistically induces apoptosis of melanoma and suppresses AKT and YAP signaling. Oncotarget. 2015;6:21507-21 pubmed
  381. Balzamino B, Esposito G, Marino R, Keller F, Micera A. NGF Expression in Reelin-Deprived Retinal Cells: A Potential Neuroprotective Effect. Neuromolecular Med. 2015;17:314-25 pubmed publisher
  382. Andreasen S, Therkildsen M, Grauslund M, Friis Hansen L, Wessel I, Homøe P. Activation of the interleukin-6/Janus kinase/STAT3 pathway in pleomorphic adenoma of the parotid gland. APMIS. 2015;123:706-15 pubmed publisher
  383. Soares A, Müller T, Chege G, Williamson A, Burgers W. Transient global T cell activation after vaccination of rhesus macaques with a DNA-poxvirus vaccine regimen for HIV. Vaccine. 2015;33:3435-9 pubmed publisher
  384. García Cano J, Ambroise G, Pascual Serra R, Carrión M, Serrano Oviedo L, Ortega Muelas M, et al. Exploiting the potential of autophagy in cisplatin therapy: A new strategy to overcome resistance. Oncotarget. 2015;6:15551-65 pubmed
  385. Ohlmann C, Brecht I, Junker K, van der Zee J, Nistor A, Bohle R, et al. Sclerosing epithelioid fibrosarcoma of the kidney: clinicopathologic and molecular study of a rare neoplasm at a novel location. Ann Diagn Pathol. 2015;19:221-5 pubmed publisher
  386. Wang Z, Ma B, Ji X, Deng Y, Zhang T, Zhang X, et al. MicroRNA-378-5p suppresses cell proliferation and induces apoptosis in colorectal cancer cells by targeting BRAF. Cancer Cell Int. 2015;15:40 pubmed publisher
  387. Cuevas C, Tapia Rojas C, Cespedes C, Inestrosa N, Vio C. β-Catenin-Dependent Signaling Pathway Contributes to Renal Fibrosis in Hypertensive Rats. Biomed Res Int. 2015;2015:726012 pubmed publisher
  388. Mishra A, Kumar R, Tyagi A, Kohaar I, Hedau S, Bharti A, et al. Curcumin modulates cellular AP-1, NF-kB, and HPV16 E6 proteins in oral cancer. Ecancermedicalscience. 2015;9:525 pubmed publisher
  389. Vuillefroy de Silly R, Ducimetière L, Yacoub Maroun C, Dietrich P, Derouazi M, Walker P. Phenotypic switch of CD8(+) T cells reactivated under hypoxia toward IL-10 secreting, poorly proliferative effector cells. Eur J Immunol. 2015;45:2263-75 pubmed publisher
  390. Haschka M, Soratroi C, Kirschnek S, Hacker G, Hilbe R, Geley S, et al. The NOXA-MCL1-BIM axis defines lifespan on extended mitotic arrest. Nat Commun. 2015;6:6891 pubmed publisher
  391. Zou Z, Cai Y, Chen Y, Chen S, Liu L, Shen Z, et al. Bone marrow-derived mesenchymal stem cells attenuate acute liver injury and regulate the expression of fibrinogen-like-protein 1 and signal transducer and activator of transcription 3. Mol Med Rep. 2015;12:2089-97 pubmed publisher
  392. Nakada S, Minato H, Takegami T, Kurose N, Ikeda H, Kobayashi M, et al. NAB2-STAT6 fusion gene analysis in two cases of meningeal solitary fibrous tumor/hemangiopericytoma with late distant metastases. Brain Tumor Pathol. 2015;32:268-74 pubmed publisher
  393. Chen Y, Li X, Guo L, Wu X, He C, Zhang S, et al. Combining radiation with autophagy inhibition enhances suppression of tumor growth and angiogenesis in esophageal cancer. Mol Med Rep. 2015;12:1645-52 pubmed publisher
  394. Hotokezaka Y, Katayama I, van Leyen K, Nakamura T. GSK-3β-dependent downregulation of γ-taxilin and αNAC merge to regulate ER stress responses. Cell Death Dis. 2015;6:e1719 pubmed publisher
  395. Yang L, Zhang S, George S, Teng R, You X, Xu M, et al. Targeting Notch1 and proteasome as an effective strategy to suppress T-cell lymphoproliferative neoplasms. Oncotarget. 2015;6:14953-69 pubmed
  396. Maity G, De A, Das A, Banerjee S, Sarkar S, Banerjee S. Aspirin blocks growth of breast tumor cells and tumor-initiating cells and induces reprogramming factors of mesenchymal to epithelial transition. Lab Invest. 2015;95:702-17 pubmed publisher
  397. Zhang W, Hou J, Wang X, Jiang R, Yin Y, Ji J, et al. PTPRO-mediated autophagy prevents hepatosteatosis and tumorigenesis. Oncotarget. 2015;6:9420-33 pubmed
  398. McMillan E, Paré M, Baechler B, Graham D, Rush J, Quadrilatero J. Autophagic signaling and proteolytic enzyme activity in cardiac and skeletal muscle of spontaneously hypertensive rats following chronic aerobic exercise. PLoS ONE. 2015;10:e0119382 pubmed publisher
  399. Farrugia M, Sharma S, Lin C, McLaughlin S, Vanderbilt D, Ammer A, et al. Regulation of anti-apoptotic signaling by Kruppel-like factors 4 and 5 mediates lapatinib resistance in breast cancer. Cell Death Dis. 2015;6:e1699 pubmed publisher
  400. Freeman J, Feng Y, Demehri F, Dempsey P, Teitelbaum D. TPN-associated intestinal epithelial cell atrophy is modulated by TLR4/EGF signaling pathways. FASEB J. 2015;29:2943-58 pubmed publisher
  401. Giunta S, Castorina A, Marzagalli R, Szychlinska M, Pichler K, Mobasheri A, et al. Ameliorative effects of PACAP against cartilage degeneration. Morphological, immunohistochemical and biochemical evidence from in vivo and in vitro models of rat osteoarthritis. Int J Mol Sci. 2015;16:5922-44 pubmed publisher
  402. Schüll S, Günther S, Brodesser S, Seeger J, Tosetti B, Wiegmann K, et al. Cytochrome c oxidase deficiency accelerates mitochondrial apoptosis by activating ceramide synthase 6. Cell Death Dis. 2015;6:e1691 pubmed publisher
  403. Chen W, Xu B, Xiao A, Liu L, Fang X, Liu R, et al. TRPM7 inhibitor carvacrol protects brain from neonatal hypoxic-ischemic injury. Mol Brain. 2015;8:11 pubmed publisher
  404. Alikanoglu A, Yildirim M, Suren D, Tutus B, Kaya V, Topal C, et al. Expression of Cox-2 and Bcl-2 in Paget's disease of the breast. Asian Pac J Cancer Prev. 2015;16:1041-5 pubmed
  405. Pedro J, Wei Y, Sica V, Maiuri M, Zou Z, Kroemer G, et al. BAX and BAK1 are dispensable for ABT-737-induced dissociation of the BCL2-BECN1 complex and autophagy. Autophagy. 2015;11:452-9 pubmed publisher
  406. Shi S, Wang Q, Xu J, Jang J, Padilla M, Nyunoya T, et al. Synergistic anticancer effect of cisplatin and Chal-24 combination through IAP and c-FLIPL degradation, Ripoptosome formation and autophagy-mediated apoptosis. Oncotarget. 2015;6:1640-51 pubmed
  407. Meykler S, Baloch Z, Barroeta J. A case of marginal zone lymphoma with extensive emperipolesis diagnosed on pleural effusion cytology with immunocytochemistry and flow cytometry. Cytopathology. 2016;27:70-2 pubmed publisher
  408. Long J, Schoonen P, Graczyk D, O Prey J, Ryan K. p73 engages A2B receptor signalling to prime cancer cells to chemotherapy-induced death. Oncogene. 2015;34:5152-62 pubmed publisher
  409. Huang S, Cui Y, Guo X, Wang L, Li S, Lu Y, et al. 2,2',4,4'-Tetrabromodiphenyl ether disrupts spermatogenesis, impairs mitochondrial function and induces apoptosis of early leptotene spermatocytes in rats. Reprod Toxicol. 2015;51:114-24 pubmed publisher
  410. Guan J, Zhang X, Sun W, Qi L, Wu J, Qin Z. DRAM1 regulates apoptosis through increasing protein levels and lysosomal localization of BAX. Cell Death Dis. 2015;6:e1624 pubmed publisher
  411. Huang P, Hung S, Pao C, Wang T. N-(1-pyrenyl) maleimide induces bak oligomerization and mitochondrial dysfunction in Jurkat Cells. Biomed Res Int. 2015;2015:798489 pubmed publisher
  412. Hole S, Pedersen A, Hansen S, Lundqvist J, Yde C, Lykkesfeldt A. New cell culture model for aromatase inhibitor-resistant breast cancer shows sensitivity to fulvestrant treatment and cross-resistance between letrozole and exemestane. Int J Oncol. 2015;46:1481-90 pubmed publisher
  413. Suo H, Song J, Zhou Y, Liu Z, Yi R, Zhu K, et al. Induction of apoptosis in HCT-116 colon cancer cells by polysaccharide of Larimichthys crocea swim bladder. Oncol Lett. 2015;9:972-978 pubmed
  414. Singh K, Hjort M, Thorvaldson L, Sandler S. Concomitant analysis of Helios and Neuropilin-1 as a marker to detect thymic derived regulatory T cells in naïve mice. Sci Rep. 2015;5:7767 pubmed publisher
  415. Xia J, Chen S, Lv Y, Lu L, Hu W, Zhou Y. ZGDHu-1 induces Gâ‚‚/M phase arrest and apoptosis in Kasumi-1 cells. Mol Med Rep. 2015;11:3398-404 pubmed publisher
  416. Gurzu S, Kádár Z, Sugimura H, Bara T, Hălmaciu I, Jung I. Gastric cancer in young vs old Romanian patients: immunoprofile with emphasis on maspin and mena protein reactivity. APMIS. 2015;123:223-33 pubmed publisher
  417. Gültiken N, Guvenc T, Kaya D, Agaoglu A, Ay S, Kücükaslan I, et al. Tarantula cubensis extract alters the degree of apoptosis and mitosis in canine mammary adenocarcinomas. J Vet Sci. 2015;16:213-9 pubmed
  418. Papanikolaou V, Stefanou N, Dubos S, Papathanasiou I, Palianopoulou M, Valiakou V, et al. Synergy of leptin/STAT3 with HER2 receptor induces tamoxifen resistance in breast cancer cells through regulation of apoptosis-related genes. Cell Oncol (Dordr). 2015;38:155-64 pubmed publisher
  419. Green A, Caracappa D, Benhasouna A, Alshareeda A, Nolan C, Macmillan R, et al. Biological and clinical significance of PARP1 protein expression in breast cancer. Breast Cancer Res Treat. 2015;149:353-62 pubmed publisher
  420. Gomez Bougie P, Halliez M, Maïga S, Godon C, Kervoëlen C, Pellat Deceunynck C, et al. Curcumin induces cell death of the main molecular myeloma subtypes, particularly the poor prognosis subgroups. Cancer Biol Ther. 2015;16:60-5 pubmed publisher
  421. Song M, Chung J, Lee J, Yang D, Kim I, Shin D, et al. High Ki-67 expression in involved bone marrow predicts worse clinical outcome in diffuse large B cell lymphoma patients treated with R-CHOP therapy. Int J Hematol. 2015;101:140-7 pubmed publisher
  422. Huang C, Sheng S, Li R, Sun X, Liu J, Huang G. Lactate promotes resistance to glucose starvation via upregulation of Bcl-2 mediated by mTOR activation. Oncol Rep. 2015;33:875-84 pubmed publisher
  423. Chow L. Primary intraosseous hybrid nerve sheath tumor of femur: a hitherto undescribed occurrence in bone with secondary aneurysmal bone cyst formation resulting in pathological fracture. Pathol Res Pract. 2015;211:409-14 pubmed publisher
  424. Kim T, Kim H, Kang Y, Yoon S, Lee J, Choi W, et al. Psammaplin A induces Sirtuin 1-dependent autophagic cell death in doxorubicin-resistant MCF-7/adr human breast cancer cells and xenografts. Biochim Biophys Acta. 2015;1850:401-10 pubmed publisher
  425. Vogels R, Vlenterie M, Versleijen Jonkers Y, Ruijter E, Bekers E, Verdijk M, et al. Solitary fibrous tumor - clinicopathologic, immunohistochemical and molecular analysis of 28 cases. Diagn Pathol. 2014;9:224 pubmed publisher
  426. Stacchini A, Pacchioni D, Demurtas A, Aliberti S, Cassenti A, Isolato G, et al. Utilility of flow cytometry as ancillary study to improve the cytologic diagnosis of thyroid lymphomas. Cytometry B Clin Cytom. 2015;88:320-9 pubmed publisher
  427. Guo L, Shen Y, Zhao X, Guo L, Yu Z, Wang D, et al. Curcumin combined with oxaliplatin effectively suppress colorectal carcinoma in vivo through inducing apoptosis. Phytother Res. 2015;29:357-65 pubmed publisher
  428. Cho S, Cho M, Kim J, Kaeberlein M, Lee S, Suh Y. Syringaresinol protects against hypoxia/reoxygenation-induced cardiomyocytes injury and death by destabilization of HIF-1α in a FOXO3-dependent mechanism. Oncotarget. 2015;6:43-55 pubmed
  429. Tao W, Moore R, Smith E, Xu X. Hormonal induction and roles of Disabled-2 in lactation and involution. PLoS ONE. 2014;9:e110737 pubmed publisher
  430. Nie C, Luo Y, Zhao X, Luo N, Tong A, Liu X, et al. Caspase-9 mediates Puma activation in UCN-01-induced apoptosis. Cell Death Dis. 2014;5:e1495 pubmed publisher
  431. Raap M, Antonopoulos W, Dämmrich M, Christgen H, Steinmann D, Länger F, et al. High frequency of lobular breast cancer in distant metastases to the orbit. Cancer Med. 2015;4:104-11 pubmed publisher
  432. Wang T, Guo S, Liu Z, Wu L, Li M, Yang J, et al. CAMK2N1 inhibits prostate cancer progression through androgen receptor-dependent signaling. Oncotarget. 2014;5:10293-306 pubmed
  433. Waisberg J, de Souza Viana L, Affonso Junior R, Silva S, Denadai M, Margeotto F, et al. Overexpression of the ITGAV gene is associated with progression and spread of colorectal cancer. Anticancer Res. 2014;34:5599-607 pubmed
  434. Mylvaganam G, Velu V, Hong J, Sadagopal S, Kwa S, Basu R, et al. Diminished viral control during simian immunodeficiency virus infection is associated with aberrant PD-1hi CD4 T cell enrichment in the lymphoid follicles of the rectal mucosa. J Immunol. 2014;193:4527-36 pubmed publisher
  435. Zebboudj A, Maroui M, Dutrieux J, Touil Boukoffa C, Bourouba M, Chelbi Alix M, et al. Sodium arsenite induces apoptosis and Epstein-Barr virus reactivation in lymphoblastoid cells. Biochimie. 2014;107 Pt B:247-56 pubmed publisher
  436. Kudernatsch R, Letsch A, Guerreiro M, Löbel M, Bauer S, Volk H, et al. Human bone marrow contains a subset of quiescent early memory CD8(+) T cells characterized by high CD127 expression and efflux capacity. Eur J Immunol. 2014;44:3532-42 pubmed publisher
  437. Shi R, Zhu S, Li V, Gibson S, Xu X, Kong J. BNIP3 interacting with LC3 triggers excessive mitophagy in delayed neuronal death in stroke. CNS Neurosci Ther. 2014;20:1045-55 pubmed publisher
  438. Yang Y, Zhou W, Xia J, Gu Z, Wendlandt E, Zhan X, et al. NEK2 mediates ALDH1A1-dependent drug resistance in multiple myeloma. Oncotarget. 2014;5:11986-97 pubmed
  439. Merabova N, Sariyer I, Saribas A, Knezevic T, Gordon J, Turco M, et al. WW domain of BAG3 is required for the induction of autophagy in glioma cells. J Cell Physiol. 2015;230:831-41 pubmed publisher
  440. Pilchova I, Klacanova K, Chomova M, Tatarkova Z, Dobrota D, Racay P. Possible contribution of proteins of Bcl-2 family in neuronal death following transient global brain ischemia. Cell Mol Neurobiol. 2015;35:23-31 pubmed publisher
  441. Choi J, Kang S, Lee S, Bae Y. Prognostic significance of Bcl-2 expression in non-basal triple-negative breast cancer patients treated with anthracycline-based chemotherapy. Tumour Biol. 2014;35:12255-63 pubmed publisher
  442. Liu Y, Wan S, Zhang P, Zhang W, Zheng J, Lin J, et al. Expression levels of autophagy related proteins and their prognostic significance in retinocytoma and retinoblastoma. Int J Ophthalmol. 2014;7:594-601 pubmed publisher
  443. Thompson L, Bauer J, Chiosea S, McHugh J, Seethala R, Miettinen M, et al. Canalicular adenoma: a clinicopathologic and immunohistochemical analysis of 67 cases with a review of the literature. Head Neck Pathol. 2015;9:181-95 pubmed publisher
  444. Nicholson A, Guo X, Sullivan C, Cha C. Automated quantitative analysis of tissue microarray of 443 patients with colorectal adenocarcinoma: low expression of Bcl-2 predicts poor survival. J Am Coll Surg. 2014;219:977-87 pubmed publisher
  445. Park S, Park J, Kim Y, Song S, Kwon H, Lee Y. Suberoylanilide hydroxamic acid induces ROS-mediated cleavage of HSP90 in leukemia cells. Cell Stress Chaperones. 2015;20:149-57 pubmed publisher
  446. Kivisakk P, Francois K, Mbianda J, Gandhi R, Weiner H, Khoury S. Effect of natalizumab treatment on circulating plasmacytoid dendritic cells: a cross-sectional observational study in patients with multiple sclerosis. PLoS ONE. 2014;9:e103716 pubmed publisher
  447. Morita A, Ariyasu S, Wang B, Asanuma T, Onoda T, Sawa A, et al. AS-2, a novel inhibitor of p53-dependent apoptosis, prevents apoptotic mitochondrial dysfunction in a transcription-independent manner and protects mice from a lethal dose of ionizing radiation. Biochem Biophys Res Commun. 2014;450:1498-504 pubmed publisher
  448. Su C, Sun F, Cunningham R, Rybalchenko N, Singh M. ERK5/KLF4 signaling as a common mediator of the neuroprotective effects of both nerve growth factor and hydrogen peroxide preconditioning. Age (Dordr). 2014;36:9685 pubmed publisher
  449. Syed B, Green A, Nolan C, Morgan D, Ellis I, Cheung K. Biological characteristics and clinical outcome of triple negative primary breast cancer in older women - comparison with their younger counterparts. PLoS ONE. 2014;9:e100573 pubmed publisher
  450. Rizvi S, Mertens J, Bronk S, Hirsova P, Dai H, Roberts L, et al. Platelet-derived growth factor primes cancer-associated fibroblasts for apoptosis. J Biol Chem. 2014;289:22835-49 pubmed publisher
  451. Sezgin Alikanoglu A, Yildirim M, Suren D, Yildiz M, Kaya V, Donem Dilli U, et al. Expression of cyclooxygenase-2 and Bcl-2 in breast cancer and their relationship with triple-negative disease. J BUON. 2014;19:430-4 pubmed
  452. Bai L, Chen J, McEachern D, Liu L, Zhou H, Aguilar A, et al. BM-1197: a novel and specific Bcl-2/Bcl-xL inhibitor inducing complete and long-lasting tumor regression in vivo. PLoS ONE. 2014;9:e99404 pubmed publisher
  453. Bellas C, Garcia D, Vicente Y, Kilany L, Abraira V, Navarro B, et al. Immunohistochemical and molecular characteristics with prognostic significance in diffuse large B-cell lymphoma. PLoS ONE. 2014;9:e98169 pubmed publisher
  454. Neher M, Rich M, Keene C, Weckbach S, Bolden A, Losacco J, et al. Deficiency of complement receptors CR2/CR1 in Cr2?/? mice reduces the extent of secondary brain damage after closed head injury. J Neuroinflammation. 2014;11:95 pubmed publisher
  455. Raimondi L, Amodio N, Di Martino M, Altomare E, Leotta M, Caracciolo D, et al. Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: in vitro and in vivo anti-tumor activity. Oncotarget. 2014;5:3039-54 pubmed
  456. Zhang S, Li Y, He X, Dong S, Huang Y, Li X, et al. Photothermolysis mediated by gold nanorods modified with EGFR monoclonal antibody induces Hep-2 cells apoptosis in vitro and in vivo. Int J Nanomedicine. 2014;9:1931-46 pubmed publisher
  457. Cen B, Xiong Y, Song J, Mahajan S, DuPont R, McEachern K, et al. The Pim-1 protein kinase is an important regulator of MET receptor tyrosine kinase levels and signaling. Mol Cell Biol. 2014;34:2517-32 pubmed publisher
  458. Klaus C, Kaemmerer E, Reinartz A, Schneider U, Plum P, Jeon M, et al. TP53 status regulates ACSL5-induced expression of mitochondrial mortalin in enterocytes and colorectal adenocarcinomas. Cell Tissue Res. 2014;357:267-78 pubmed publisher
  459. Ding K, Banerjee A, Tan S, Zhao J, Zhuang Q, Li R, et al. Artemin, a member of the glial cell line-derived neurotrophic factor family of ligands, is HER2-regulated and mediates acquired trastuzumab resistance by promoting cancer stem cell-like behavior in mammary carcinoma cells. J Biol Chem. 2014;289:16057-71 pubmed publisher
  460. Capella C, Marando A, Longhi E, Bernasconi B, Finzi G, Parravicini C, et al. Primary gastric Merkel cell carcinoma harboring DNA polyomavirus: first description of an unusual high-grade neuroendocrine carcinoma. Hum Pathol. 2014;45:1310-4 pubmed publisher
  461. Baspinar S, Bircan S, Orhan H, Kapucuoglu N, Bozkurt K. The relation of beclin 1 and bcl-2 expressions in high grade prostatic intraepithelial neoplasia and prostate adenocarcinoma: a tissue microarray study. Pathol Res Pract. 2014;210:412-8 pubmed publisher
  462. Biaggio V, Alvarez Olmedo D, Pérez Chaca M, Salvetti N, Valdez S, Fanelli M, et al. Cytoprotective mechanisms in rats lung parenchyma with zinc deprivation. Biometals. 2014;27:305-15 pubmed publisher
  463. Yoon H, Choi Y, Song J, Do I, Kang S, Ko Y, et al. Targeted inhibition of FAK, PYK2 and BCL-XL synergistically enhances apoptosis in ovarian clear cell carcinoma cell lines. PLoS ONE. 2014;9:e88587 pubmed publisher
  464. Yurube T, Hirata H, Kakutani K, Maeno K, Takada T, Zhang Z, et al. Notochordal cell disappearance and modes of apoptotic cell death in a rat tail static compression-induced disc degeneration model. Arthritis Res Ther. 2014;16:R31 pubmed publisher
  465. Wang C, Wang J, Liu Z, Ma X, Wang X, Jin H, et al. Ubiquitin-specific protease 2a stabilizes MDM4 and facilitates the p53-mediated intrinsic apoptotic pathway in glioblastoma. Carcinogenesis. 2014;35:1500-9 pubmed publisher
  466. Hollevoet K, Antignani A, FitzGerald D, Pastan I. Combining the antimesothelin immunotoxin SS1P with the BH3-mimetic ABT-737 induces cell death in SS1P-resistant pancreatic cancer cells. J Immunother. 2014;37:8-15 pubmed publisher
  467. Crowther A, Gama V, Bevilacqua A, Chang S, Yuan H, Deshmukh M, et al. Tonic activation of Bax primes neural progenitors for rapid apoptosis through a mechanism preserved in medulloblastoma. J Neurosci. 2013;33:18098-108 pubmed publisher
  468. Tao L, Zhou X, Shen C, Liang C, Liu B, Tao Y, et al. Tetrandrine induces apoptosis and triggers a caspase cascade in U2-OS and MG-63 cells through the intrinsic and extrinsic pathways. Mol Med Rep. 2014;9:345-9 pubmed publisher
  469. Hou J, Xia Y, Jiang R, Chen D, Xu J, Deng L, et al. PTPRO plays a dual role in hepatic ischemia reperfusion injury through feedback activation of NF-?B. J Hepatol. 2014;60:306-12 pubmed publisher
  470. Caramuta S, Lee L, Ozata D, Akçakaya P, Georgii Hemming P, Xie H, et al. Role of microRNAs and microRNA machinery in the pathogenesis of diffuse large B-cell lymphoma. Blood Cancer J. 2013;3:e152 pubmed publisher
  471. Tan A, Hoang L, Chin D, Rasmussen E, Lopatin U, Hart S, et al. Reduction of HBV replication prolongs the early immunological response to IFN? therapy. J Hepatol. 2014;60:54-61 pubmed publisher
  472. Stacchini A, Aliberti S, Pacchioni D, Demurtas A, Isolato G, Gazzera C, et al. Flow cytometry significantly improves the diagnostic value of fine needle aspiration cytology of lymphoproliferative lesions of salivary glands. Cytopathology. 2014;25:231-40 pubmed publisher
  473. Razavi S, Hasheminia D, Mehdizade M, Movahedian B, Keshani F. The relation of pericoronal third molar follicle dimension and bcl-2/ki-67 expression: An immunohistochemical study. Dent Res J (Isfahan). 2012;9:S26-31 pubmed publisher
  474. Bradford C, Kumar B, Bellile E, Lee J, Taylor J, D SILVA N, et al. Biomarkers in advanced larynx cancer. Laryngoscope. 2014;124:179-87 pubmed publisher
  475. Ma T, Galimberti F, Erkmen C, Memoli V, Chinyengetere F, SEMPERE L, et al. Comparing histone deacetylase inhibitor responses in genetically engineered mouse lung cancer models and a window of opportunity trial in patients with lung cancer. Mol Cancer Ther. 2013;12:1545-55 pubmed publisher
  476. Goraczniak R, Wall B, Behlke M, Lennox K, Ho E, Zaphiros N, et al. U1 Adaptor Oligonucleotides Targeting BCL2 and GRM1 Suppress Growth of Human Melanoma Xenografts In Vivo. Mol Ther Nucleic Acids. 2013;2:e92 pubmed publisher
  477. Thompson R, Vardinogiannis I, Gilmore T. The sensitivity of diffuse large B-cell lymphoma cell lines to histone deacetylase inhibitor-induced apoptosis is modulated by BCL-2 family protein activity. PLoS ONE. 2013;8:e62822 pubmed publisher
  478. Hernandez A, Colvin E, Chen Y, Geiss S, Eller L, Fueger P. Upregulation of p21 activates the intrinsic apoptotic pathway in ?-cells. Am J Physiol Endocrinol Metab. 2013;304:E1281-90 pubmed publisher
  479. Nakanishi Y, Seno H, Fukuoka A, Ueo T, Yamaga Y, Maruno T, et al. Dclk1 distinguishes between tumor and normal stem cells in the intestine. Nat Genet. 2013;45:98-103 pubmed publisher
  480. Verma Y, Raghav P, Raj H, Tripathi R, Gangenahalli G. Enhanced heterodimerization of Bax by Bcl-2 mutants improves irradiated cell survival. Apoptosis. 2013;18:212-25 pubmed publisher
  481. Viana L, Affonso R, Silva S, Denadai M, Matos D, Salinas de Souza C, et al. Relationship between the expression of the extracellular matrix genes SPARC, SPP1, FN1, ITGA5 and ITGAV and clinicopathological parameters of tumor progression and colorectal cancer dissemination. Oncology. 2013;84:81-91 pubmed publisher
  482. Giaginis C, Politi E, Alexandrou P, Sfiniadakis J, Kouraklis G, Theocharis S. Expression of peroxisome proliferator activated receptor-gamma (PPAR-?) in human non-small cell lung carcinoma: correlation with clinicopathological parameters, proliferation and apoptosis related molecules and patients' survival. Pathol Oncol Res. 2012;18:875-83 pubmed
  483. Lúcio K, Rocha G, Monção Ribeiro L, Fernandes J, Takiya C, Gattass C. Oleanolic acid initiates apoptosis in non-small cell lung cancer cell lines and reduces metastasis of a B16F10 melanoma model in vivo. PLoS ONE. 2011;6:e28596 pubmed publisher
  484. Winzler C, Fantinato M, Giordan M, Calore E, Basso G, Messina C. CD4(+) T regulatory cells are more resistant to DNA damage compared to CD4(+) T effector cells as revealed by flow cytometric analysis. Cytometry A. 2011;79:903-11 pubmed publisher
  485. Xargay Torrent S, Lopez Guerra M, Saborit Villarroya I, Rosich L, Campo E, Roué G, et al. Vorinostat-induced apoptosis in mantle cell lymphoma is mediated by acetylation of proapoptotic BH3-only gene promoters. Clin Cancer Res. 2011;17:3956-68 pubmed publisher
  486. Donia M, Maksimovic Ivanic D, Mijatovic S, Mojic M, Miljkovic D, Timotijevic G, et al. In vitro and in vivo anticancer action of Saquinavir-NO, a novel nitric oxide-derivative of the protease inhibitor saquinavir, on hormone resistant prostate cancer cells. Cell Cycle. 2011;10:492-9 pubmed
  487. Hailemariam S, Vosbeck J, Cathomas G, Zlobec I, Mattarelli G, Eichenberger T, et al. Can molecular markers stratify the diagnostic value of high-grade prostatic intraepithelial neoplasia?. Hum Pathol. 2011;42:702-9 pubmed publisher
  488. Correia M, Costa A, Uhrberg M, Cardoso E, Arosa F. IL-15 induces CD8+ T cells to acquire functional NK receptors capable of modulating cytotoxicity and cytokine secretion. Immunobiology. 2011;216:604-12 pubmed publisher
  489. Cheuk W, Tam F, Chan A, Luk I, Yuen A, Chan W, et al. Idiopathic cervical fibrosis--a new member of IgG4-related sclerosing diseases: report of 4 cases, 1 complicated by composite lymphoma. Am J Surg Pathol. 2010;34:1678-85 pubmed publisher
  490. Hirata H, Hinoda Y, Nakajima K, Kawamoto K, Kikuno N, Ueno K, et al. Wnt antagonist DKK1 acts as a tumor suppressor gene that induces apoptosis and inhibits proliferation in human renal cell carcinoma. Int J Cancer. 2011;128:1793-803 pubmed publisher
  491. Yang Z, von Ballmoos M, Faessler D, Voelzmann J, Ortmann J, Diehm N, et al. Paracrine factors secreted by endothelial progenitor cells prevent oxidative stress-induced apoptosis of mature endothelial cells. Atherosclerosis. 2010;211:103-9 pubmed publisher
  492. Jung C, Choi Y, Lee K, Bae J, Kim H, Yoon S, et al. The cytological, clinical, and pathological features of the cribriform-morular variant of papillary thyroid carcinoma and mutation analysis of CTNNB1 and BRAF genes. Thyroid. 2009;19:905-13 pubmed publisher
  493. Snuderl M, Chi S, De Santis S, Stemmer Rachamimov A, Betensky R, De Girolami U, et al. Prognostic value of tumor microinvasion and metalloproteinases expression in intracranial pediatric ependymomas. J Neuropathol Exp Neurol. 2008;67:911-20 pubmed publisher
  494. Thomson S, Cox A, Cuddihy S, Pullar J, Hampton M. Inhibition of receptor-mediated apoptosis upon Bcl-2 overexpression is not associated with increased antioxidant status. Biochem Biophys Res Commun. 2008;375:145-50 pubmed publisher
  495. Rieger J, Lemke D, Maurer G, Weiler M, Frank B, Tabatabai G, et al. Enzastaurin-induced apoptosis in glioma cells is caspase-dependent and inhibited by BCL-XL. J Neurochem. 2008;106:2436-48 pubmed publisher
  496. Strauss G, Westhoff M, Fischer Posovszky P, Fulda S, Schanbacher M, Eckhoff S, et al. 4-hydroperoxy-cyclophosphamide mediates caspase-independent T-cell apoptosis involving oxidative stress-induced nuclear relocation of mitochondrial apoptogenic factors AIF and EndoG. Cell Death Differ. 2008;15:332-43 pubmed
  497. Takei H, Buckleair L, Powell S. Immunohistochemical expression of apoptosis regulating proteins and sex hormone receptors in meningiomas. Neuropathology. 2008;28:62-8 pubmed
  498. Cheuk W, Chan J, Nuovo G, Chan M, Fok M. Regression of gastric large B-Cell lymphoma accompanied by a florid lymphoma-like T-cell reaction: immunomodulatory effect of Ganoderma lucidum (Lingzhi)?. Int J Surg Pathol. 2007;15:180-6 pubmed
  499. Yoo J, Jung J, Lee M, Seo K, Shim B, Kim S, et al. Immunohistochemical analysis of non-small cell lung cancer: correlation with clinical parameters and prognosis. J Korean Med Sci. 2007;22:318-25 pubmed
  500. Martin Latil S, Mousson L, Autret A, Colbere Garapin F, Blondel B. Bax is activated during rotavirus-induced apoptosis through the mitochondrial pathway. J Virol. 2007;81:4457-64 pubmed
  501. Lawson J, Tran D. Localised breast cancers may have systemic influences on skin and hair. J Clin Pathol. 2007;60:180-4 pubmed
  502. Luo H, Yu S, Li T. Differential expression of apoptosis-related proteins in various cellular components of ameloblastomas. Int J Oral Maxillofac Surg. 2006;35:750-5 pubmed
  503. Sun B, Sun Y, Wang J, Zhao X, Wang X, Hao X. Extent, relationship and prognostic significance of apoptosis and cell proliferation in synovial sarcoma. Eur J Cancer Prev. 2006;15:258-65 pubmed
  504. Rivadeneyra Espinoza L, Ruiz Argüelles A. Cell-penetrating anti-native DNA antibodies trigger apoptosis through both the neglect and programmed pathways. J Autoimmun. 2006;26:52-6 pubmed
  505. Damron T, Horton J, Naqvi A, Margulies B, Strauss J, Grant W, et al. Decreased proliferation precedes growth factor changes after physeal irradiation. Clin Orthop Relat Res. 2004;:233-42 pubmed
  506. Sandalova E, Wei C, Masucci M, Levitsky V. Regulation of expression of Bcl-2 protein family member Bim by T cell receptor triggering. Proc Natl Acad Sci U S A. 2004;101:3011-6 pubmed
  507. Damron T, Mathur S, Horton J, Strauss J, Margulies B, Grant W, et al. Temporal changes in PTHrP, Bcl-2, Bax, caspase, TGF-beta, and FGF-2 expression following growth plate irradiation with or without radioprotectant. J Histochem Cytochem. 2004;52:157-67 pubmed
  508. Ng J, Han A, Edelson M, Rosenblum N. Oncoprotein profiles of primary peritoneal malignant mixed müllerian tumors. Int J Gynecol Cancer. 2003;13:870-4 pubmed
  509. Halperin R, Zehavi S, Hadas E, Habler L, Bukovsky I, Schneider D. Simultaneous carcinoma of the endometrium and ovary vs endometrial carcinoma with ovarian metastases: a clinical and immunohistochemical determination. Int J Gynecol Cancer. 2003;13:32-7 pubmed
  510. Zamai L, Canonico B, Gritzapis A, Luchetti F, Felici C, Della Felice M, et al. Intracellular detection of Bcl-2 and p53 proteins by flow cytometry: comparison of monoclonal antibodies and sample preparation protocols. J Biol Regul Homeost Agents. 2002;16:289-302 pubmed
  511. Tran D, Lawson J. Microcysts and breast cancer: a study of biological markers in archival biopsy material. Breast Cancer Res Treat. 2002;75:213-20 pubmed
  512. Solomides C, Miller A, Christman R, Talwar J, Simpkins H. Lymphomas of the oral cavity: histology, immunologic type, and incidence of Epstein-Barr virus infection. Hum Pathol. 2002;33:153-7 pubmed
  513. Desai B, Myers B, Schreiber S. FKBP12-rapamycin-associated protein associates with mitochondria and senses osmotic stress via mitochondrial dysfunction. Proc Natl Acad Sci U S A. 2002;99:4319-24 pubmed
  514. Shinoura N, Sakurai S, Asai A, Kirino T, Hamada H. Over-expression of APAF-1 and caspase-9 augments radiation-induced apoptosis in U-373MG glioma cells. Int J Cancer. 2001;93:252-61 pubmed
  515. Tanaka Y, Nomi M, Fujii K, Hubscher S, Maruo A, Matsumoto S, et al. Intercellular adhesion molecule 1 underlies the functional heterogeneity of synovial cells in patients with rheumatoid arthritis: involvement of cell cycle machinery. Arthritis Rheum. 2000;43:2513-22 pubmed
  516. Reis Filho J, Faoro L, Carrilho C, Bleggi Torres L, Schmitt F. Evaluation of cell proliferation, epidermal growth factor receptor, and bcl-2 immunoexpression as prognostic factors for patients with World Health Organization grade 2 oligodendroglioma. Cancer. 2000;88:862-9 pubmed
  517. Ashton Key M, Biddolph S, Stein H, Gatter K, Mason D. Heterogeneity of bcl-2 expression in MALT lymphoma. Histopathology. 1995;26:75-8 pubmed